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The epidemiological study of pathogens largely depends on three technologies, 
serology, microscopy and the polymerase chain reaction (PCR). Serological 
methods are unable to differentiate between current and past infections. 
Microscopy has historically been the mainstay of epidemiological study. In 
recent times the use of microscopy has been in decline, as it has been shown to 
have an inherent lack of sensitivity and specificity and produces many false 
negative results. PCR is now the method of choice for screening samples for the 
presence or absence of pathogens. Although PCR is widely regarded as an 
extremely sensitive technique, the fact that it assays a very small volume of 
sample is often overlooked. If the target pathogen is not present in the tiny 
aliquot of sample from an infected host, then a false negative results will occur. 
In endemic situations were the pathogen is present at low infection intensities, 
then the potential for false negatives results of this type is high. This intensity 
related false negative effect can lead to serious underestimation of diagnosed 
prevalence and incidence with consequent misinterpretation of the resulting 
data. This phenomenon has been reported in the literature for a range of 
pathogens and especially for epidemiological study of schistosomiasis. The 
extensive occurrence of false negatives during study of schistosomiasis 
samples was such an obstacle to epidemiological study it prompted the world 
health organisation to repeatedly call for quantitative methods to be employed to 
combat the problem. 
The main objectives of this thesis are to rationalise and simplify the methods of 
diagnosing African trypanosomes in epidemiological studies and to investigate 
the consequences of, and methods of dealing with infection intensity related 
false negative results that occur as a result of widespread sub-patent infections 
in the study population  
A new PCR assay was developed that was capable of analysing whole blood 
placed onto treated filter paper. The PCR assay was capable of differentiating 
between all the important African trypanosome species, producing a unique size 
of amplicon for each species of trypanosome. Initial results from repeated 
screening of human and cattle samples known to be parasitologically positive 
indicated that many false negative results occur. A more extensive analysis of 
thirty five bovine blood samples randomly chosen from a collection of field 
samples revealed that false negative results occurred regularly. The prevalence 
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of infection after a single screening was 14.3% whereas the cumulative 
prevalence after over 100 repeated screenings rose to 85.7%. This showed that 
a severe underestimation of prevalence occurs from a single screening of the 
samples. 
In order to investigate the consequences of, and develop methods of dealing 
with this problem, computer based simulations were used to model the 
dynamics of screening samples with sub-patent infections. In order to construct 
the model the data obtained from repeat screening of the thirty-five bovine blood 
samples was fitted to a number of mathematical distributions. A negative 
binomial distribution best described the distribution of trypanosomes across the 
hosts. Exploration of the phenomenon with the resulting model showed the 
extensive underestimation of true prevalence that is possible. The simulations 
also showed that it is possible for populations with very different patterns of 
infection and true prevalence to all have the same diagnosed prevalence from a 
single screening per sample. Statistical comparison of these very different 
populations by diagnosed prevalence alone would conclude there was no 
significant difference between the populations. It was therefore concluded that 
the diagnosed prevalence from a single (or even multiple) screenings is an 
inadequate and potentially misleading measure of both infected hosts and 
parasite numbers. 
In order to deal with these problems new methods were evaluated for use in 
epidemiological studies. A simple method of producing quantitative measures of 
infection was advocated. The insensitivity of existing screening methods in 
detecting significant difference between populations was highlighted and a 
greatly improved methodology was shown. Finally, a method for inferring the 
true population prevalence from the data obtained from repeat screening of 
samples was suggested. Although some of these new methodologies have 
limitations, they represent a great improvement on the use of a single diagnostic 
test for each host. The work presented in this thesis highlights a serious 
potential limitation to our understanding of the epidemiology of pathogens that 
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The detection threshold of a diagnostic technique is the minimum number of 
parasites (or fraction of a single parasite) that can be detected in the volume of 
sample analysed by the diagnostic technique. For whole parasites the practical 
lower limit of this threshold is one. It differs from the concept of sensitivity in that 
it accounts for the volume of sample analysed. It refers to and is a property of 
the diagnostic technique and does not infer information about the infection 
intensities within the host. 
Diagnosed Prevalence 
The prevalence achieved from a screening of samples with a diagnostic test. 
This may not be equivalent to the population prevalence. 
Diagnostic Sensitivity  
The diagnostic sensitivity of a test is the test's ability to detect hosts with the 
condition of interest in a population or group and is expressed as a proportion or 
percentage: the number of persons who have both the condition and a positive 
test result divided by the number of persons who have the condition. Diagnostic 
sensitivity often has more to do with the ability to obtain the target substance in a 
processed sample from a host who has the condition than with the ability to 
detect very low concentrations of a substance. If the target substance is not in 
the processed sample because of vagaries of sampling or processing, an assay 
with perfect analytical sensitivity still fails to give a positive result (Saah et al, 
1997). 
Infection Intensity 
This represents the number of pathogens / parasites present within an infected 
host. More specifically, in the context of this work it refers to the number of 
parasites per volume of blood. Typically, parasites / pathogens per millilitre, 
although occasionally per microlitre. 
IRFN 
Intensity Related False Negatives refers to negative diagnostic results obtained 
from infected hosts. This is a direct result of failing to obtain sufficient quantities 
of the parasite, in the aliquot drawn for a diagnostic test, to give a positive 
diagnostic test result. This will be intrinsically related to the infection intensity 




Describes the distribution of a pathogen / parasite across a host population or 
sub-population. If more parasites were found to occur in fewer hosts than would 
be expected assuming a random distribution of parasites then the parasites 
would be said to be overdispersed or aggregated. In many cases most hosts 
have low numbers of parasites or no parasites, whilst a few hosts harbor a large 
number. In this situation the parasites are said to be overdispersed. Such a 
distribution of parasites is frequently well described by a negative binomial 
distribution. The negative binomial distribution is described by the mean and 
overdispersion value K. In this case overdispersion (K) is a direct measure of 
overdispersion. 
Patent Infection 
A patent infection is usually defined as an infection that is present at an intensity 
that is detectable by the diagnostic technique. Because of stochastic effects in 
detection of the parasites (see the definition of sub-patent infection), for this 
work the definition will be modified. A patent infection is defined as infection with 
a parasite that has a high enough infection intensity to provide consistently 
repeatable positive results (no false negatives). 
Population Mean Infection Intensity  (or Mean infection intensity of the 
population) 
For a given population, the mean infection intensity is the sum of all the infection 
intensities of all infected hosts divided by the total number of individuals within 
the population of interest. 
Population Prevalence 
The population prevalence is the ‘true’ prevalence present in the population. In 
reality this value is unknown; ascertaining this value is the object of many types 
of epidemiological study. 
Repeatability 
Is defined as the degree of repeatability of a positive diagnostic results. For 
example a repeatability of 0.6 would infer that if a diagnostic test on an infected 
individual were to be repeated ten times only six tests would be positive, the 
remaining four would be false negatives. The false negative rate is equivalent to 





The more accepted understanding of a sub-patent infection is an infection that is 
present at too low an intensity to be detected by the diagnostic technique. This 
definition is somewhat imprecise, because infections are diagnosed on a 
stochastic basis not a definitive one. Even an infection that is present as one 
parasite per ten litres of blood has a (remote) probability of being detected. If a 
diagnostic technique is capable of detecting a single parasite and assays a 
single microlitre of sample, then a parasite which is present with an infection 
intensity of one parasite per two microlitres of blood only has a mean probability 
of detection in a single assay of 0.5. Therefore in this work the definition of sub-
patent infection will be modified. A sub-patent infection is defined as infection 
with a parasite that causes false negative results in repeated diagnostic rests, 




























1.1. African trypanosomiasis: An introduction 
The African trypanosomiases comprise a group of economically important 
animal diseases and medically important zoonotic diseases that affect much of 
sub Saharan Africa. The causative organisms are a few species and sub 
species of a heteroxenous parasite of the genus Trypanosoma, which are 
capable of infecting a wide range of mammalian and some reptilian species. 
(See table 1.1.) The African trypanosomes are transmitted by tsetse flies 
(Glossina spp.); a large biting fly of the order dipteral. The geographical range of 
African trypanosomiasis largely coincides with the range of the tsetse, some 8.7 
million square kilometres, between the latitudes 15oN to 25oS. Most of the areas 
affected are rural and relatively remote; this isolation compounds the effects of 
the disease. The diseases affect rural communities in two ways; firstly all 
species of African trypanosome affect livestock. Infection of cattle and other 
domestic livestock with Trypanosoma congolense or Trypanosoma vivax causes 
a serious disease locally known as Nagana. T. brucei s.l. is by contrast 
considered relatively non pathogenic in livestock and wildlife. Secondly, two sub 
species of Trypanosoma brucei; T.b.rhodesiense and T.b.gambiense are 
zoonotic and also infect humans, in which they are fatal. T. brucei infection in 
humans is called sleeping sickness and can be acute (T.b.rhodesiense) or 
chronic (T.b.gambiense) (Welburn et al, 2001). In many respects Nagana is of 
equal importance to the human form of the disease, susceptibility of domestic 
livestock to trypanosomiasis is responsible for livestock losses and poor 
productivity and prevents farmers from improving cattle stock. Therefore this 
disease is a major factor that holds back the further development of the sub 
Saharan African.  
1.2. The importance of human African trypanosomiasi s 
Current estimates suggest that 60 million people are at risk of infection, this 
number is spread over 36 different countries in sub Saharan Africa (WHO, 
2001). In seven countries the status is classed as highly endemic, four countries 
are classed as endemic; twelve are classed as moderately endemic and in 
thirteen countries the epidemiology is poorly understood. In some areas such as 
Angola, The Democratic Republic of Congo and Southern Sudan prevalence 
may reach as high as twenty to fifty percent (Moore et al., 1999); in these areas 
sleeping sickness may be the first or second highest cause of mortality after 
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HIV/AIDS (WHO, 2001). It is estimated that there are around 50,000 deaths per 
annum. 
Table 1.1. African trypanosomiasis: Important speci es and sub species 
Species Important Hosts Pathogenicity 
   
Trypanosoma brucei brucei Wide range of mammals 
birds and lizards 
Regarded as non 
pathogenic – not human 
infective 
Trypanosoma brucei gambiense Domestic livestock 
particularly cattle. 
Humans 
Human infective causing 
the chronic form of the 
disease 
Trypanosoma brucei rhodesiense Domestic livestock 
particularly cattle. 
Humans 
Human infective causing 
the acute form of the 
disease 
Trypanosoma congolense Domestic livestock Pathogenic to cattle 
causing Nagana 
Trypanosoma vivax Domestic livestock Pathogenic to cattle 
causing Nagana 
Table showing the species and sub species of the genus Trypanosoma that are 
responsible for human sleeping sickness and the disease known as Nagana in livestock. 
The table also lists important hosts of the particular trypanosome and gives a few details 
of pathogenicity. 
 
However, because most cases are in remote areas and therefore go 
undiagnosed, the world health organisation estimates the true number of deaths 
to be ten times this amount, 500,000 deaths per anum (Odiit et al., 2005). The 
cost in disability adjusted life years is estimated at 1,585,000. 
1.3. The importance of animal African trypanosomias is (Nagana) 
African trypanosomiasis has been described by the World Health Organisation 
as “One of the most important if not the most important constraints to livestock 
and mixed crop-livestock farming in tropical Africa” (WHO, 2001). This in spite of 
the fact that much of the land affected by tsetse borne trypanosomiasis is 
capable of supporting a much larger population of cattle, this land is prevented 
from being as productive as it might be by the presence of the tsetse and 
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trypanosomiasis. The disease affects millions of cattle, goats, sheep, donkeys, 
camels and horses, and makes it very difficult for essentially rural communities 
to make any kind of effective living from farming. On a national scale the 
disease generally holds back much of the benefits of efficient nutrient cycling, 
and animal traction for the farmers of a particular nation or area (Kristjanson et 
al., 1999). If farmers are forced to work the land by hand then it is impossible, in 
economic terms, to make the natural progression from hand working of the land 
to animal traction power and from there on to machine power; with the 
accompanying increases in productivity and gross domestic product that are 
associated with these transitions. The incomes to individual farmers from meat, 
milk and other livestock derived products are also reduced. It can be seen 
therefore that African trypanosomiasis reduces the amount of land that can be 
farmed, the efficiency with which a given area of land can be farmed, reduces 
the available workforce and the efficiency of that workforce. 
 
There are many socio-economic factors that compound these basic problems. 
Many parts of sub Saharan Africa suffer from civil unrest and war; the incidence 
of this disease is often increased following such social upheaval. In addition, 
government funded provision for veterinary healthcare in contemporary Africa is 
in decline (Eisler et al., 2003). Most of the communities affected are essentially 
rural and relatively remote, and are not likely to have access to medical or 
veterinary facilities. In addition the loss of potential production of crops, meat 
and milk reduces the nutritional quality of the diets of the inhabitants of these 
areas. 
1.4. Classification 
African Trypanosomes are protozoan parasites of the sub phylum Kinetoplasta. 
This sub phylum is divided into three families: - Bodonidae, Cryptobiidae and the 
family to which trypanosomes belong; Trypanosomatidae. Members of the 
genus Trypanosoma are all heteroxenous (except Trypanosoma equiperdum). 
Differentiation of trypanosomes at the genus level is difficult in many cases, 
many methods have been useful for differentiation, but none have proven 
universal. Members of the genus Trypanosoma have been divided into two 




The names of the two groups reflect the site within the vector where 
trypanosome development takes place. The stercorarian trypanosomes 
complete development in the posterior section, are present in the faeces and 
require the contamination of an open wound with the faeces of the vector for 
transmission. One of the most important trypanosomes in this group is 
Trypanosoma cruzi from the subgenus Schizotrypanum, an important 
pathogenic trypanosome of South America and Trypanosoma theileri from the 
subgenus megatrypanum, a large and ubiquitous trypanosome of cattle and 
other species that is thought to be largely non pathogenic (Rodrigues et al, 
2003). The salivarian trypanosomes complete development in the anterior 
section (salivary system) of the vector, they are directly transmitted by the bite of 
the vector. This group is divided into four subgenuses, almost all of which are 
transmitted by the tsetse fly (Glossina spp.), except T.equiperdum which is 
venerally transmitted amongst horses. Other species such as Trypanosoma 
evansi and Trypanosoma equinum are transmitted by tabanid flies. This group 
contains a number of important pathogenic trypanosomes of a variety of 
mammals including humans. Most important are Trypanosoma vivax of the 
Dutonella subgroup that causes Nagana in cattle, sheep, equines, goats and 
dogs. Trypanosoma congolense from the subgroup Nannomonas also cause 
Nagana in cattle, sheep and equines. Trypanosoma brucei of the Trypanozoon 
group, is divided into three subspecies; Trypanosoma brucei brucei infecting a wide 
variety of mammals and is regarded as only mildly pathogenic in domestic cattle 
(Taylor & Authie, 2004); Trypanosoma brucei gambiense causing the chronic form of 
human sleeping sickness and Trypanosoma brucei rhodesiense causing the acute form 
of human sleeping sickness (Welburn et al, 2001). 
The distinction between T.brucei brucei, T.brucei gambiense and T.brucei 
rhodesiense has long been problematic, all subspecies being morphologically 
indistinguishable from each other. Differentiation has been based largely on the 
differences in virulence in hosts and rodents, clinical course of disease, host 
infectivity and geographical range. T.brucei brucei is present across much of the 
range of the tsetse in sub Saharan Africa and is not infective to humans. 
T.brucei gambiense is human infective causing a chronic form of the disease 
and is present to the west of the Rift valley; whilst T.brucei rhodesiense causes 
an acute form of the disease and is present to the east of the Rift Valley 
(Welburn et al., 2001). See Figure 1.1 
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Table 1.2. Classification and characteristics of th e genus  Trypanosoma 
(Hoare, 1956;  1964; Hoare, 1966) 
The type species of each subgenus is cited first. 
A. STERCORARIA 
Free flagellum present; kinetoplast large, not terminal; posterior end of body pointed; multiplication 
in mammal discontinuous, typically in crithidial or leishmanial stages; typically non-pathogenic; 
development in vector in posterior station, transmission contaminative. 
Subgenus Megatrypanum 
 Large species; kinetoplast typically near nucleus, far from posterior end of body; includes T. (M.) 
theileri, Iragchphi, ingens, melophagium and others 
Subgenus Herpetosoma Medium-sized species; kinetoplast subterminal; includes T. (H.) lewisi, 
duttoni, nabiasi, and others 
Subgenus Schizotrypamun Small species, typically curved; kinetoplast voluminous, close to 
posterior end of body; includes T. (S. )  cruzi, vespetilionis, pipistrelli and others 




Free flagellum present or absent; kinetoplast terminal or subterminal; posterior end of body 
usually blunt; multiplication in mammal continuous in Trypanosomal stage; typically pathogenic; 
development in vector in anterior station and transmission inoculative; includes also some 
atypical species transmitted non-cyclically by arthropod vectors, or by coitus 
Subgenus Duttonella Monomorphic species; posterior end of body rounded; kinetoplast 
large, terminal; free flagellum present; development in vector (Glossina) in proboscis only; includes 
T. (D.) vivax, uniforme 
Subgenus Nannomonas Small species; monomorphic or polymorphic; kinetoplast of medium 
size, typically marginal; free flagellum usually absent; development in vector (Glossina) in midgut 
and proboscis; includes T. (N.) congolense, dimorphon, simiae 
Subgenus Pycnomonas Short, stout species; monomorphic; kinetoplast small, subterminal; free 
flagellum short; development in vector (Glossina) in midgut and salivary glands; includes T. (P.) suis 
Subgenus Trypanozoon Typically polymorphic species with small subterminal kinetoplast; 
development in vector (Glossina) in mid-gut and salivary glands; includes some aberrant species 








Figure 1.1. Map of Africa showing the relative rang es of east ( T.b.rhodesiense ) 












The line shows the approximate position of the rift valley. T.b.brucei is present across 
much of both ranges. (Map From World Health Organisation) 
1.5. Lifecycle 
Type example Trypanosoma brucei. 
The trypanosomes causing sleeping sickness and Nagana are heteroxenous parasites; 
their lifecycle alternates between the insect vectors and mammalian hosts. The insect 
vector is Glossina spp (tsetse fly); for Trypanosoma brucei the main species involved 
are Glossina mortisans, Glossina pallidipes and Glossina swynnertoni. The mammalian 
host can be cattle, sheep, equines, pigs, antelopes, waterbuck, camels, zebras, human 
or others depending on the species of trypanosome involved. Trypanosoma brucei 
brucei is also occasionally found in lizards (Njagu et al, 1999). Around 90% of tsetse 
flies are refractive to infection, it is not yet clear why this is the case (Welburn & Maudlin,  
1999). The lifecycle therefore begins when a trypanosome is ingested by a susceptible, 
teneral fly (a fly taking its first blood meal) with a blood meal.  Once ingested the 
trypanosome locates in the posterior section of the insects midgut where it multiplies in 
number, at this stage in the lifecycle the trypanosome is in the amastigote form. After 
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about ten days the slender forms migrate towards the anterior section of the gut 
(foregut). Between twelve to twenty days a further forward migration takes place; finally 
the trypanosomes end up in the salivary glands. Once in the salivary glands the 
trypanosomes transform into the epimastigote form and either are free in the lumen or 
attach themselves to the host cells, multiplication continues asexually. After several 
generations the trypanosomes transform into the metacyclic trypanomastigote form, this 
is the only stage in the vector that is infective to the vertebrate host. When the fly feeds 
as many as several thousand trypanosomes may be inoculated into the host. The entire 
lifecycle within the fly may be completed within fifteen to thirty five days. 
 
Once inoculated into the vertebrate host the trypanosomes enter the lymph and blood 
where they undergo intense multiplication by binary fission with a doubling time of 
around six hours (Vickerman, 1985). The level of parasitaemia present in the blood 
fluctuates; as the old antigenic type that is beginning to be recognized by the immune 
system is replaced by a new antigenic type that is not recognized. Early on in the 
infection slender forms dominate and later on stumpy forms dominate via an 
intermediate type. During the final stage of infection the human infective forms invade 
the central nervous system and can be found in the cerebro-spinal fluid. This stage of 
the infection gives rise to the classic sleeping sickness symptoms, disrupted sleeping 
patterns, disrupted speech, behavioral and motor functions and a general dementia, the 
patient eventually lapses into a coma. 
1.6. Epidemiology 
Elements of the epidemiology of both human and animal African 
trypanosomiasis have already been discussed. The epidemiology of both human 
and animal trypanosomiasis is extremely complex and subject to a myriad of 
interacting factors, some known, some suspected and some awaiting discovery. 
The classical tsetse – vertebrate transmission cycle is complicated by the 
number of vertebrate species that act as a reservoir for infection. An additional 
reservoir of infection is considered to be more important for spread of 
Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense than in 
Trypanosoma brucei gambiense. 
Reservoirs found for Trypanosoma brucei gambiense include hartebeest, kob, 
waterbuck, buffalo and significantly pigs and dogs (Gibson et al., 1978; Truc et 
al., 1997). How these animal reservoirs affect disease transmission depends 
upon the proximity of livestock and humans to the wild reservoir species. Clearly 
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pigs and dogs are more likely to be in closer proximity to humans and other 
livestock than the wild animal reservoirs. Disease transmission may also be 
affected by tsetse feeding preferences. However an animal reservoir is not 
considered to be as important in the gambiense form of the disease (Welburn et 
al, 2004) as this form of sleeping sickness is chronic in nature and may be 
asymptomatic for a long period, in this case human-tsetse-human is considered 
to be the most important transmission route (WHO, 1986). 
In Trypanosoma brucei rhodesiense the role of non-human reservoirs is considered to 
be much more important. Originally bushbuck were identified as a reservoir for 
Trypanosoma brucei rhodesiense (Heisch et al., 1958), since that time domestic cattle 
are now thought to play the most important role in the transmission of human 
rhodesiense sleeping sickness (Hide et al., 1996). In fact, study suggests that between 
21% and 33% of Trypanosoma brucei infected animals (especially cattle) can be 
infected with human infective trypanosomes, at least during an epidemic and that a fly 
infected with T.b.rhodesiense is five times more likely to have picked up the infection 
from domestic cattle than from a human (Welburn et al., 2001). This confirms the 
findings that cattle are the most important reservoir in rhodesiense sleeping sickness 
(Fevre et al, 2001). It was originally thought that T.b.rhodesiense was generally carried 
by Glossina mortisans and Glossina pallidipes (mortisans group) and that 
T.b.gambiense was carried by Glossina palpalis and Glossina tachinoides (palpalis 
group). However this distinction is now unclear, as exceptions have been found  
(Gibson, 1986). 
In addition, the geographical distribution of T.b.rhodesiense sleeping sickness cases is 
characteristic; rhodesiense sleeping sickness is characterized by long periods of 
endemicity punctuated by epidemics, in well-established endemic ‘foci’ (See Figure 
1.2.). For example the focus to the north of Lake Victoria in Uganda has seen four 
epidemics since 1900 interspersed by long periods of low endemicity (Hide, 1999). 
For Trypanosoma brucei brucei the picture is more confused, although this 
species is not human infective or pathogenic to domestic livestock, it is still of 
importance. This species is found in a very wide range of wild and domestic 
animals, most wild game, lions and other animals (Onyango et al, 1966; Heisch 
et al, 1958; Ashcroft et al, 1959; Baker et al, 1967; Sachs et al, 1967). For 
species such as Trypanosoma vivax and Trypanosoma congolense much less 
research has been carried out so the picture is much less clear. 
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Figure 1.2. Foci of Trypanosoma brucei rhodesiense  sleeping sickness in 
east Africa  
 
(Hide, 1999) 
    
1.7. Diagnostic methods 
1.7.1. Microscopy 
Perhaps the most widely used and simplest of diagnostic techniques are those 
relying on direct observation of the parasites either in blood, lymph or 
cerebrospinal fluid. There are many different microscopic techniques; each has 
its own merits.  The simplest is perhaps the wet blood film method; a drop of 
blood is placed on a microscope slide and the slide is then examined at x40 
(with x10 objective lens). This method is often used in conjunction with the 
preparation of a thick blood film; both are examined for diagnosis. Whilst this 
method is undoubtedly one of the simplest available, it is also the least 
sensitive. Thick blood films are slightly more sensitive as more blood is 
observed. These types of slides are often stained with giemsa.  
A number of techniques improve on this simple observation of parasites in 
blood.  The haematocrit centrifugation method (Woo, 1970) is widely used; is 
relatively simple and is considered to be more sensitive than the methods 
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previously described (Paris &McOdimba, 1982). However a centrifuge that can 
accommodate the microhaematoctrit tubes is required. Blood is mixed with 
sodium citrate (anticoagulant) and is drawn into the microhaematocrit tube, 
which are then sealed at one end. The tubes are spun in the centrifuge and then 
examined under the microscope; the trypanosomes will be concentrated in the 
area between the red blood cells and the plasma; known as`the buffy coat’. An 
alternative method of concentration is to filter the trypanosomes from the blood 
by a technique known as mini anion exchange centrifugation (m-AECT) 
(Lumsden et al, 1979).  Red blood cells are filtered out as they are held within a 
filtration matrix by virtue of the negative charge on their surface. The 
trypanosomes are less negatively charged so pass through the matrix, the 
resultant filtrate is then centrifuged to concentrate the trypanosomes and can be 
detected by microscopic examination (Buscher & Lejon, 2004). 
Other body fluids that are used for the diagnosis of trypanosomiasis are lymph 
aspirate (especially from glands draining the chancre), bone marrow (aspiration 
useful for early stage infection) and cerebro-spinal fluid obtained from lumbar 
puncture; this is widely used to confirm late stage sleeping sickness. However, 
some of these techniques require a high degree of skill and experience. 
A range of methods exist for microscopic diagnosis of trypanosomiasis, ranging 
from the very simple and cost effective, to technically involved and requiring 
equipment that may not be practical in the field. These techniques are 
something of a trade off between sensitivity and complication. As 
trypanosomiasis is largely a problem of rural and remote areas it may not be 
possible to carry out techniques like mini ion exchange centrifugation in the field. 
An additional problem for methods relying on direct observation is that 
Trypanosoma brucei brucei, Trypanosoma brucei gambiense and Trypanosoma 
brucei rhodesiense are morphologically indistinguishable; the identification of 
other species also requires a good deal of experience and careful observation. It 
is thought that microscopy techniques widely used in the field miss a large 
proportion of infections present, at least in the case of animal infections, which 





1.7.2. Serodiagnostic methods 
Card Agglutination Test for Trypanosomiasis (CATT) 
Indirect methods rely on the detection of antibodies to a current infection. The 
Card Agglutination Test for Trypanosomiasis (CATT) (Magnus et al., 1978) is a 
widely used indirect method for detection of Trypanosoma brucei gambiense infections 
only. Most mass screening programs rely on CATT, when tested on blood-impregnated 
filter papers a sensitivity of 91% was determined and reproducibility was found to be 
good (Chappuis et al., 2002). Whilst it is simple to use and reasonably cost effective it 
does not discriminate between current and previous infections (Kanmogne et al., 1996). 
The technique has undoubtedly proven useful but has limitations; a variable percentage 
of screened populations show as CATT positive with no clinical signs of infection or 
without visible confirmation of parasites. Limited sensitivity has also been cited as a 
problem; therefore some positives are missed. In addition cured patients can remain 
positive for up to three years (Radwanska et al., 2002). 
Enzyme Linked Immunosorbent Assay (ELISA) 
Although there have been some protocols for detection of a wider species range of 
trypanosomes than for the card agglutination test (Nantulya et al, 1992), although initial 
protocols were criticized as unreliable (Rebeski et al., 1997; Eisler et al., 1998). 
Efforts have been made since to improve the repeatability and sensitivity of the methods 
(Lejon et al., 2003b). 
1.7.3. Polymerase Chain Reaction 
Species diagnostic techniques for molecular epidemiological analysis are 
somewhat different from medical diagnostic techniques. This is because for 
epidemiological analysis the timeframe from sample collection to test result can 
be much longer. Previously analysed sample sets may be screened 
retrospectively with new techniques. In addition, more complex and technology 
intensive techniques can be employed, as much of the work is carried out in 
well-equipped laboratories away from the field. For medical diagnostic purposes 
the results of screening must be available quickly, and as a result they must be 
conducted in the field or as close to the field as possible. This places practical 
limits on the complexity of the diagnostic technique. 
Since the introduction of the polymerase chain reaction (PCR) the ability to both 
detect and differentiate species has improved considerably. Utilizing this 
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technique, species-specific primers can be designed for each species of interest 
so that a range of species diagnostic PCR’s can be carried out on a sample set.  
Table 1.3. PCR primers used for species screening  
 Adapted from (Masiga et al., 1992; Desquesnes & Dávila, 2002) 
Name Primer Sequence 
 Size 





(McLaughlin et al., 
1996) 
NRP CGA ATG AAT ATT AAA CAA TGC GCA GT 
AGA ACC ATT TAT TAG CTT TGT TGC 
 


















1500 Trypanozoon (Majiwa et al., 1994) 
MP CAACGACAAAGAGTCAGT 
ACGTGT TTT GTG TATGGT 
 





































































Previously the only method for achieving this was to examine the live 
trypanosomes microscopically. At present separate species specific techniques 
are used to screen for the various trypanosomes which are thought to be 
present, each involves an individual set of primers and an individual PCR 
protocol (See table 1.3.). 
1.8. Diagnostic techniques and false negative resul ts  
In 1970-1973 the world health organisation conducted an extensive project 
designed to investigate the epidemiology and control of malaria in the Sudan 
Savannah of West Africa. As a quality control 20% (n = 8427) of the blood slides 
were examined for 400 instead of the standard 200 fields. The 20% sample was 
representative of the wider study with respect to age, sex, time and 
geographical location. In the two groups of blood films obtained for the whole of 
the baseline data, it was found that doubling of the standard volume of blood 
examined produces a relative increase in diagnosed prevalence of 10% for 
Plasmodium falciparum, 24% for Plasmodium malariae and 21% for 
Plasmodium ovale (Molineaux & Gramiccia, 1980). Despite an extensive 307 
page report the matter was allocated only perhaps about ten lines of text and a 
table of results. This is however to the credit of the authors; as such matters are 
rarely reported in the literature. These results echoed an earlier finding, where it 
was noted that an increase in malaria positivity in a group of semi-immune 
adults resulted from prolonging the time for which blood slides were examined. It 
was shown that the observed parasite rate (38%) in routine 100 field thick film 
examinations was doubled when the examination time (and hence number of 
fields examined) was extended. This was due to the prevalence of scanty 
parasitaemias in this group of adults, which escaped detection in routine study 
(Dowling & Shute, 1966). Similar findings have been reported elsewhere 
(Bottius et al., 1996; Ohrt et al., 2002). 
Using PCR, another study investigating the epidemiology of malaria in 369 
samples from miners in an endemic area of the Brazilian Amazon reported the 
existence of false negative results, mainly in subjects with sub-clinical 
parasitaemia (Scopel et al., 2004). The authors further reported that the mean 
infection intensity of samples positive at the first screening as 598 parasites per 
microlitre of blood, whilst that of the samples found falsely negative at the first 
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screening to have a mean infection intensity of 12 parasites per microlitre. This 
indicated that the false negative results are due to low intensity infections.  
Direct statements of the occurrence of false negatives results for PCR tests are 
rare in the literature. Instead there is a wealth of ‘indirect’ evidence that points at 
the occurrence of false negative results and consequent under-detection of 
infection. This ‘indirect’ evidence largely comes from comparison of diagnostic 
techniques which report disagreement on which samples are infected. For a 
range of different pathogens, many find that PCR has given a negative result 
where another diagnostic technique has shown the same sample to be positive. 
Some examples in the literature are; malaria (Barker et al., 1994; Masake et al., 
1997a; Gonzales et al., 2006); leishmania (de Brujin et al., 1993) and 
trypanosomiasis (LeFrancois et al., 1999; Garcia et al., 2000; Penchenier et al., 
2000; Solano et al., 2002). A number of authors openly state that detection of 
low infection intensity samples is intermittent or difficult by PCR or any other 
currently available technique (Truc et al., 1994; Masake et al., 1997a; Garcia et 
al., 2000; Kyambadde et al., 2000; Ohrt et al., 2002; Solano et al., 2002; Lejon 
et al., 2003a; Scopel et al., 2004; Van den Bossche et al., 2004b; Koffi et al., 
2006). It appears that we are happy to report and base epidemiological 
conclusions on a diagnosed prevalence from 200 microscopy fields, or a single 
PCR assay, despite the knowledge that the prevalence is dependent on the 
number of fields or PCR tests examined. It may be argued that as long as the 
diagnosed prevalence is based on a standard number of fields, or PCR assays 
are standardised then valid comparisons can be made. There are however 
problems with this argument, in comparing underestimated results, important 
trends and differences in the data are also underestimated. The work presented 
here will highlight some of these difficulties. 
Information for control programmes and epidemiological studies of 
schistosomiasis is based on the detection and quantification of faecal egg 
counts (Katz et al., 1972; Mott & Cline, 1980). As has been the case for other 
pathogens, repeated examination of samples has shown that a significant 
number of light (low intensity infections) may be missed (false negatives), 
leading to an underestimation of prevalence (Jordan et al., 1975; Barreto et al., 
1978; Ruiz-Tiben et al., 1979; Mott & Cline, 1980; Sleigh et al., 1982; Polderman 
et al., 1985; da Cunha et al., 1987; Barreto et al., 1990; Gryseels et al., 1991). 
The underestimation of prevalence, even after repeated examination of samples 
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may be surprisingly large (de Vlas & Gryseels, 1992). These undiagnosed 
infections have been found to be responsible for the maintenance of 
transmission after chemotherapy regimes (Goddard, 1977; da Cunha et al., 
1987). For this reason the World Health Organisation has repeatedly advocated 
the use of quantitative methods in all aspects of the epidemiological study of 
schistosomiasis (WHO, 1967;1980). There is little in the reasoning of this 
recommendation by the WHO that does not potentially apply to other pathogens. 
Quantitative techniques have measurable variability and therefore their inherent 
differences in one application to another can be taken into account. This 
increases the accuracy of epidemiological measurements and improves the 
confidence and validity of conclusions derived from these data. Additionally, the 
use of quantitative measures improves the understanding between morbidity 
and intensity of infection (Mott & Cline, 1980). The use of a quantitative measure 
adds a further dimension to the data, rather than just measuring infected / 
uninfected hosts in a population, quantitative measures allow data to express 
how infected and record information on the distribution of the parasite. This 
extra dimension allows a more precise comparison of epidemiological situations, 
and allows the possibility to infer to what extent prevalence is being 
underestimated. 
1.9. The sensitivity of diagnostic techniques 
Examples of false negative results are perhaps not surprising, in that few doubt 
that whilst microscopy is an extremely practical and useful diagnostic technique, 
it is relatively ‘insensitive’ and misses a proportion of infections. Many studies 
evaluating the usefulness of microscopy have reached such conclusions (Paris 
et al., 1982; Brown et al., 1992; Snounou et al., 1993; Urdaneta et al., 1998; 
Tham et al., 1999; Cavasini et al., 2000; Craig et al., 2002; Owusu-Agyei et al., 
2002; Picozzi et al., 2002). All of the studies, which made comparisons between 
microscopy and PCR, conclude that PCR is a more sensitive technique and 
support adopting PCR for diagnostic testing and screening of samples. 
In this case the scientific community recognised a problem in the currently used 
technique (lack of sensitivity of microscopy), advocated the use of a more 
sensitive technique (PCR) and moved on. It is worth considering the nature of 
sensitivity in this context. Analytical sensitivity is defined as the ability to register 
small physical amounts, concentrations or differences in a target. Whereas, the 
diagnostic sensitivity of a test is the test's ability to detect hosts with the 
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condition of interest in a population or group and is expressed as a proportion or 
percentage: the number of persons who have both the condition and a positive 
test result divided by the number of persons who have the condition. Diagnostic 
sensitivity often has more to do with the ability to obtain the target substance in a 
processed sample from a host who has the condition than with the ability to 
detect very low concentrations of a substance. If the target substance is not in 
the processed sample because of the vagaries of sampling or processing, an 
assay with perfect analytical sensitivity may still give a false negative result 
(Saah et al,1997). This is an important distinction, and diagnostic sensitivity, 
which is the more relevant to detection of parasites, deserves further 
consideration. For the detection of parasites by microscopy and PCR we have a 
minimum unit, a single parasite. Microscopy is certainly capable of detecting a 
single parasite if the parasite happens to be present in the field of view. The 
ability of PCR to detect a single pathogen is also dependent upon the pathogen 
being present in the analysed sample volume. Somewhat ironically, not all PCR 
protocols are capable of detecting a single pathogen even if that pathogen is 
within the sample assayed by the PCR (Njiru et al, 2005; Li et al, 2007). 
Some PCR protocols make claims to be able to detect fractional parts of a 
parasite. For example, a species specific real time PCR assay for detection of T. 
brucei (Becker et al., 2004) claims to be able to detect 0.1 of a trypanosome. 
This claim is of course a result of using extracted DNA in solution and detecting 
a few copies of the many repeat copies forming the target sequence. Such 
claims are complicated by the fact that the target sequences are present on the 
genome in groups or clusters, and we have little knowledge of how they may 
‘break up’ in solution. For practical purposes the detection limit of both PCR and 
microscopy is a single parasite. The question of sensitivity is then not being able 
to detect ever decreasing fractions of a parasite – analytical sensitivity, but the 
capturing of a single parasite in the volume of blood or sample analysed by the 
diagnostic technique – diagnostic sensitivity. For small assay volumes and low 
infection intensities there is a large degree of chance that can effect the 
probability of obtaining a positive diagnostic result from an infected sample. 
Diagnostic sensitivity is therefore a stochastic process, doubling the assay 
volume doubles the probability of capturing a parasite for any particular level of 
infection intensity. The reason why microscopy is less diagnostically sensitive 
than PCR is that it assays a smaller volume of blood or tissue, so there is less 
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probability of obtaining the parasite in the volume of sample analysed. This 
gives rise to a further complication, the probability of obtaining the parasite in 
the analysed volume is also affected by the infection intensity in the host, or 
mean intensity present in the host population. Since this may differ in different 
epidemiological settings (endemic versus epidemic for example) the diagnostic 
sensitivity may likewise differ in different epidemiological settings. This 
phenomenon is known as ‘spectrum bias’ (Ransoff & Feinstein, 1978). 
The introduction of the technically complex PCR screening protocol has given 
an increase in sensitivity by increasing the volume of sample analysed. 
Microscopy is capable of analysing perhaps about 0.13 microlitres for a thin film 
and 0.32 microlitres for a thick film (Dowling & Shute, 1966). PCR is capable of 
analysing, typically, one microlitre (Cox et al., 2005). The issue of sensitivity is 
then perhaps a misnomer, the real issue is the volume of sample assayed. A 
single microlitre still represents a very tiny proportion of the total blood volume of 
a typical host. In the light of this information an important question arises; Has 
the original problem as previously described for the ‘sensitivity’ of microscopy 
really been solved or just shifted? 
1.10. Dealing with false negative results – previou s work 
In spite of the wide reporting of underestimation of prevalence for many different 
pathogens (See previous discussion), remarkably few attempts have been made 
to deal with the problem. Only in the field of schistosomiasis has any serious 
attempt been made to address the problem of underestimation. For example, on 
the basis of data obtained from a study of eight communities in St Lucia, the 
prevalence obtained from a single screening was related mathematically to the 
cumulative prevalence obtained from three screenings of the samples (Jordan et 
al., 1975). In this way an improved estimation of true prevalence could be 
gained from applying a formula describing the relationship between diagnosed 
prevalence from a single screening to cumulative prevalence from three 
screenings. However, this method does not take into account the fact that the 
prevalence from three repeated screenings may still also underestimate the 
population prevalence by an unknown amount. Additionally, the formula 
describing the relationship is likely only to apply to that particular population and 
screening methodology – spectrum bias. Whilst this method represented an 
improvement, clearly a more sophisticated methodology is required. It has been 
shown that the relationship between the diagnostic sensitivity and prevalence 
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(Jordan et al., 1975), is in fact due to the relationship between prevalence and 
infection intensity (Goddard, 1977). Goddard and co-workers modelled the 
probability of false negative outcome as a negative exponential function of the 
prevalence. A system of re-examination of a proportion of the negative samples 
in order to determine the false negative rate (FNR) has also been introduced to 
large studies (Jordan et al., 1975; Molineaux & Gramiccia, 1980). Again all 
these methods still significantly underestimate the true prevalence. 
A more sophisticated and interesting approach to solving the problem was 
attempted by de Vlas and co-workers (1992a), they developed a stochastic 
model incorporating inter and intra individual variation in schistosoma egg 
counts (based on a negative binomial distribution) to predict the true prevalence 
of infection from single egg counts per host. The parameters for the model were 
derived from a number of field studies. The model was later successfully 
validated on data obtained from another field study (de Vlas et al., 1992b). 
Although certain parameters of the model were found to be independent of the 
endemic situation, others have to be re-estimated for each particular setting. In 
order to address this inconvenience the authors constructed a reference chart 
that makes possible a projection of the true prevalence from any observed data 
set (de Vlas et al., 1993), although the data must be stratified into discrete age 
classes. Whilst this model is undoubtedly useful for schistomiasis, it is based on 
estimation of parameters from a number of studies examining the intra and inter 
individual variation in egg counts. Such detailed data is not available for many 
other parasites, and the model for schistosomiasis does not have the added 
complication that the parasites replicate within the host, as is the case for 
protozoans. 
1.11. Quantitative measures of infection intensity 
For blood borne parasites there is some difficulty in obtaining quantitative 
measures of infection intensity. Real time PCR may seem to be ideally suited to 
quantifying the pathogen load in a blood samples. However, real time PCR is 
essentially a PCR reaction, and suffers from the same problems as non-
quantitative PCR in detecting low infection intensities. It is therefore only useful 
to apply to samples where there exists prior knowledge that the repeatability of 
the sample is good (indicating a high infection intensity), that is samples where 
false negatives do not occur. A second problem with real time PCR, at least for 
trypanosomiasis where there are multiple coinfecting species to consider, is that 
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there is currently only one published protocol (for detecting T.brucei) (Becker et 
al., 2004). There also appears to be a degree of over-optimism regarding the 
abilities of real time PCR technology. There is a tendency to be more likely to 
overlook problematic aspects in new high technology solutions than with older 
tried and tested lower technology methods. For example, Becker et al (2004) 
developed a real time PCR assay for T. brucei and claimed to be able to detect 
100 parasites per millilitre. This claim gave the false impression that an infection 
intensity of this level could be reliably quantified. In actual fact, on scrutiny of the 
results, at parasite dilutions of 100 parasites per millilitre the cycle threshold 
(CT) value obtained was not in the linear range of the standard curve. This 
meant that the detection limit of the RT-PCR was indeed 100 parasites per 
millilitre, as a positive result was evident. However, the parasite intensity could 
not be reliably quantified at this level. In fact the limit of quantification was 
tenfold higher at 1000 parasites per millilitre. In fact when the RT-PCR was 
tested on 13 samples from parasitologically confirmed T. brucei gambiense 
patients, all patients were detected as positive, but could not be quantitatively 
assessed because the CT values fell outside the linear range of the standard 
curve. This, even though the positive samples used had been found positive by 
a, supposedly, less sensitive technique - microscopy. Furthermore, this protocol 
analysed 4 microlitres of template DNA, adapting an ordinary PCR assay, with 
the ability to detect a single parasite, such as ITS-PCR (Cox et al, 2005), to 
analyse this volume of sample would in principle increase the theoretical 
detection limit to 250 parasites per millilitre. This real time PCR assay is 
therefore still unable to accurately quantify the levels of infection intensity 
needed to assess sub-patent infections.  
Quantification of infection intensity with microsco py. 
Microscopy has been the method of choice for study of micro-parasites for many 
years, in more recent times it has been criticised because of a lack of sensitivity 
and specificity (Picozzi et al., 2002). However, microscopy can readily provide 
quantitative data. Although less sensitive than PCR; the quantitative data 
provided by microscopy may still be useful in determining the distribution of 
parasites with the host population. The accuracy of inferring the distribution of 
parasites within a host population by use of microscopy needs empirical 
support. Yet, should this prove practical, microscopy may be extremely effective. 
The difficulty with microscopy is the small volume of blood analysed, typically 
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0.3 microlitre per 200 fields of a thick film (Dowling & Shute, 1966). The scope 
for increasing this analysed volume is limited as 200 fields of view per sample is 
perhaps the limit of human endurance for a large epidemiological study. 
Nevertheless, some of the problems previously described for real time PCR also 
apply to the use of microscopy. 
1.12. Appropriateness of the negative binomial dist ribution in 
describing the distribution of trypanosomes amongst  the host 
population  
Before directly discussing the appropriateness of the negative binomial 
distribution to modelling the distribution of trypanosomes (or other pathogens) in 
a host population, a general outline of the negative binomial may be worthwhile. 
Parasitic organisms tend to be aggregated within or upon their hosts, with most 
hosts having low level infections with or no infection at all and a few hosts 
harbouring high levels of the pathogen in question. For example it is typical for 
80% of the population of helminth parasites of humans to be present in only 
15% of individuals (Gregory & Woolhouse, 1993). This phenomenon is variously 
termed ‘togetherness’, ‘aggregation’, ‘patchiness’, ‘contagion’ or ‘over-
dispersion’ (the later term will be used here). Such ‘overdispersed’ populations 
tend to have a variance which is greater than its mean, and indeed one measure 
of over-dispersion is the variance to mean ratio. When the pathogen population 
is not distributed randomly throughout the host population and tends toward 
aggregation, the frequency distribution of the different levels of abundance of 
the pathogen are best modelled with a negative binomial distribution. The 
negative binomial distribution is described by the mean and the dispersion factor 
k (another commonly used measure of over-dispersion). The dispersion factor k 
is an inverse measure of over-dispersion, as k approaches a value of zero the 
population is said to be over-dispersed, as k approaches infinity the population 
is said to be randomly distributed, in practice populations with values of k below 
eight are said to be over-dispersed (Elliot, 1977). 
Aggregation within the host population may be due to heterogeneity within the 
host species, this may be due to age or differential susceptibility to the 
pathogen, heterogeneity may also be due to the physical distribution of the 
pathogen in the environment or vector. The nature of this over-dispersion is of 
paramount importance for the transmission dynamics of the parasites in 
question. Often the tail of a negative binomial distribution, those hosts having 
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the highest infection intensities, play an important role in the transmission and 
persistence of infection (Medley & Anderson, 1985), and represent an important 
target for control strategies. It has been shown that an over-dispersed 
distribution of parasites amongst their hosts can reduce the levels of competition 
between species of parasites inhabiting the same hosts or vectors (Pacala & 
Dobson, 1988) and influence the regulation of host parasite communities 
(Anderson, 1982). 
Over-dispersion is an important characteristic of many populations, the negative 
binomial distribution has been shown to be the most appropriate empirical 
distribution describing populations of benthic macro-invertebrates (Orroth et al., 
2003), weed species (Gonzalez-Andujar & Saavedra, 2003), cotton bollworms 
(Beyo et al., 2004), mosquito’s (Zhou et al., 2004), ticks (Barrett et al., 1997; 
Tyre et al., 2003). Parasitic helminth populations have been most widely 
investigated, and it is remarkable how universally over-dispersed are the 
populations of various, filarial worms (Wucheria bancrofti, Brugia pharangi & 
Ochocerca spp.) (Srividya et al., 1991; Vivas-Martinez et al., 2000; Snow & 
Michael, 2002), nematodes (Ascaris spp) (Guyatt & Bundy, 1993), schistosomes 
(Schistosoma spp.) (Eppert et al., 2002; Feng et al., 2004) and tapeworms 
(Taeniaeformis spp.) (Theis & Schwab, 1992). Much less work has been 
conducted for microparasites, in this case the importance of overdipersion is 
less well researched. However, over-dispersion has been shown in the 
protozoan Cryptosporidium molnari (Sitja-Bobadilla et al., 2005), Borreliae spp 
in the tick (Hubalek et al., 1998), Babesia spp in engorged female ticks 
(Guglielmone et al., 1997), Theileria spp from cattle (Flach et al., 1993) 
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Effective control and management of African trypanosomiasis depends heavily upon 
knowledge of the epidemiology of the disease, which in turn relies upon methods 
that incorporate screening of both animal and human populations (Hutchinson et al., 
2003). Current methods of epidemiological screening include direct parasite 
examination using traditional dark ground microscopy, examination of buffy-coat and 
more recently molecular methodologies based on the polymerase chain reaction 
(PCR).  Microscopy is labour intensive and can lack sensitivity under field conditions 
due to routinely low peripheral parasitaemia in infected livestock (Picozzi et al., 
2002). It is believed that PCR based diagnostic methods have largely overcome 
difficulties associated with sensitivity and specificity. A number of methods have 
been developed for the following species and subspecies of Trypanosoma – 
Trypanozoon (Artama et al., 1992, Kabiri et al., 1999), Trypanosoma congolense 
(Riverine/Forest) (Masiga et al., 1992), Trypanosoma congolense (Kilifi) (Masiga et 
al., 1992), Trypanosoma congolense (Savannah) (Masiga et al., 1992), 
Trypanosoma vivax (Masake et al., 1994, Masake et al., 1997), Trypanosoma 
simiae (Masiga et al., 1992), Trypanosoma evansi (Artama et al., 1992), 
Trypanosoma congolense (Kenya Coast) (Masiga et al., 1992), Trypanosoma 
theileri (Rodrigues et al., 2003).  Using these approaches accurate species / sub 
species differentiation requires up to eight different PCR reactions per sample, 
which increases the costs and impacts on the practical application of the technique 
for large-scale epidemiological studies (Table 1.3). Furthermore, many of the PCR 
techniques developed in recent years are based on complex protocols requiring 
samples to be mouse passaged, and therefore mouse adapted, a process which 
some trypanosome isolates do not survive (Hoare, 1972, Masiga et al., 1992) 
resulting in loss of species or strains, selection and sampling bias (Welburn and 
Coleman, 2004).  
Recent developments in matrices for sample collection and archive, which permit 
direct PCR identification from tissue / fluids may overcome such bias.  Simplified 
protocols incorporating these improved sample collection techniques, together with 
rapid PCR-based screening methodologies for the direct analysis of field samples 
are therefore required. The internal transcribed spacers (ITS) located within the 
ribosomal RNA genes (Figure 2.1) have been used to establish relationships and 
differentiate species in an extremely wide range of organisms (Wesson et al., 1992, 
Schlotterer et al., 1994, Mai and Coleman, 1997, Samuel, 1998).  A high copy 
number combined with inter-species length variation makes the ITS region a useful 
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marker for species differentiation in trypanosomes, as has been recently 
demonstrated (McLaughlin et al., 1996, Desquesnes et al., 2001, Njiru et al., 2004). 
However, this technique was shown to be relatively insensitive and in some cases 
was problematic for detection of Trypanosoma vivax (the principal pathogenic 
species in cattle) in either concentrated genomic DNA or DNA extracted from field 
samples. In addition these techniques have not previously been evaluated for use 
directly on samples of whole blood. Here we test the technique developed by 
Desquesness et al (2001) on samples of whole blood and report the development of 
a simple nested PCR method, which detects the inter-specific length variation of the 
ITS regions of ribosomal genes and thereby producing a unique size of PCR product 
for each species of trypanosome.  The technique is able to detect the following 
African trypanosome species. (Trypanozoon , Trypanosoma congolense 
(River/Forest) , Trypanosoma congolense (Kilifi) , Trypanosoma congolense 
(Savannah) , Trypanosoma vivax , Trypanosoma simiae, Trypanosoma evansi, 
Trypanosoma congolense (Kenya Coast)  and Trypanosoma theileri).  It is able to 
detect a single trypanosome per analysed blood volume and has been optimised for 
PCR amplification of blood applied to filter paper (Whatman FTA™ ) permitting 
direct PCR analysis of field material. 
The work presented in this chapter was published in a peer reviewed journal (Cox et 
al, 2005) 







Ribosomal genes are present in tandem arrays of around 100 – 200 copies per 
trypanosome. Each gene consists of a number of conserved coding regions and non-coding 
spacer regions. Large boxes represent conserved coding regions (SSU = Small sub-unit, 
LSU = Large subunit) and small boxes represent spacer regions. The two spacers, internal 
transcribed spacers (ITS) 1 and 2 are known to vary in size between species and 
occasionally sub species. A set of nested primers designed to the conserved regions are 
represented by black arrows (outer primers) ITS1 & ITS2  and white arrows (inner primers) 
ITS3 & ITS4. 
LSU(1) 
 








2.2. Materials & Methods 
2.2.1. Samples 
Field samples consisted of two hundred and forty five samples of bovine blood taken 
from two villages in the Soroti & Tororo districts of Uganda and collected on 
Whatman FTA™ cards. Genomic DNA stocks are as detailed in Table2.1. 
Table 2.1. Details and origin of trypanosome genomi c DNA used in the 
development of the ITS-PCR protocol 
 
Species Stock Code Origin 
Trypanosoma brucei brucei BUTEBA135 


















IL3900 Burkina Faso 
Trypanosoma congolense 
(Kalifi) 
IL45.1 Kilifi, Kenya 
Trypanosoma vivax ILDatt1.2 Kenya 
Trypanosoma brucei OBUR C19 Soroti, Uganda, Cow, 2000 
Trypanosoma congolense 
(Forest) 
TSW103 Liberia, Pig 
Trypanosoma simiae TV008 Unknown 
 
2.2.2. Sample storage 
Samples were either stored as extracted liquid DNA which was stored at -20oC for 
long term storage or 4oC for short term storage. When in use the DNA samples were 
kept on ice. Alternatively the samples were stored (dry) on treated filter paper of one 
of two types, Whatman FTA Cards (Whatman Biosciences, Cambridge, UK) or 
IsoCode (Schleicher & Schuell Bioscience, Inc). Samples were stored at room 
temperature in foil pouches with silica desiccant in each pouch to protect against 
strong light and moisture. 
2.2.3. FTA cards 
Preparation of samples with Whatman FTA cards 
Blood & other samples were applied to the cards in accordance with 
recommendations of Whatman Biosciences. Samples were applied in a spiral 
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pattern with care not to over saturate the filter paper. Once applied the cards were 
allowed to dry for a minimum of ninety minutes at room temperature. 
FTA purification protocol 
A 3mm punch was removed from the sample, transferred to a suitable eppendorf 
tube, to which 200µl of FTA purification reagent was added (Whatman Biosciences, 
Cambridge, UK). The solution was then mixed by pippetting the solution up and 
down twice. The solution was then incubated for 5 minutes at room temperature. 
This process was repeated for a total of three times. After the final wash the 
purification reagent was carefully removed and 200µl of TE buffer (Sigma Aldrich, 
Dorset, UK) was added to the tube containing the washed punch, this was then 
incubated for 5 minutes. This step was then repeated one further time. The 
remaining TE buffer was discarded and the punches carefully transferred to a clean 
PCR tube. The ‘wet’ punch was then allowed to dry at room temperature for 90 
minutes before a PCR reaction was performed. 
2.2.4. Polymerase Chain Reaction protocols 
Re-suspension of stock primers 
Primers were re-suspended in TE buffer to a working concentration of 100µM and 
stored frozen at –20oC. The working stock was then diluted to a concentration of 
10µM before use and stored at 4oC. 
ITS PCR 
Although the development of ITS-PCR is described in this chapter, the full protocol 
is given here for ease of reference. ITS PCR is targeted to the ribosomal genes of 
African trypanosomes. The expected band size for a positive result will vary 
dependent upon the species of trypanosme (Table 2.4) The PCR was carried out 
using a nested method as two separate consecutive reactions. The primer 
sequences were - outer primers ITS1 (5’ – GAT TAC GTC CCT GCC ATT TG – 3’), 
ITS2 (5’ – TTG TTC GCT ATC GGT CTT CC – 3’) and inner primers ITS3 (5’ – GGA 
AGC AAA AGT CGT AAC AAG G – 3’), ITS4 (5’ – TGT TTT CTT TTC CTC CGC 
TG – 3’). All primers were synthesised by MWG Biotech. Each PCR was carried out 
using 25ul volumes containing the following components. 10mM Tris-HCl pH 9.0, 
1.5mM MgCl2, 50mM KCl, 0.1% TritonX-100, 0.01%  (w/v) stabilizer (Purchased as 
a 10X SuperTaq PCR buffer from HT biotechnologies, Cambridge), 2µM of each 
primer, 1mM total dNTP’s and 1.25 Units of Biotaq (Bioline Ltd, London) and 1µl of 
extracted template DNA or a single 3mm diameter washed and dried punch from the 
blood sample applied to a Whatman FTA card. The reaction conditions were as 
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follows; one cycle of 95oC for seven minutes, followed by 35 cycles of 94oC for 1 
minute, 54oC for 1 minute and 72oC for 2 minutes. The thermal cycling was carried 
out on a Stratogene – Robocycler. All PCR conditions were optimised using 
modified ‘Taguchi’ methods (Cobb & Clarkson, 1994). 
Trypanosoma brucei specific PCR 
Samples were screened for the presence of Trypanosoma brucei using primers 
targeted to a 177bp satellite DNA repeat present in the mini chromosomes (Moser et 
al., 1989). The expected amplicon size for a positive result is 164bp. 
The PCR amplification was carried out using the following primer sequences - TBR-
1 (5’ – GAA TAT TAA ACAATG CGC AG– 3’) & TBR-2 (5’ – CCA TTT ATT AGC 
TTT GTT GC– 3’). All primers were synthesised by MWG Biotech. Each PCR was 
carried out using 25µl volumes containing the following components. 10mM Tris-HCl 
pH 8.3, 1.5mM MgCl2, 50mM KCl, 0.01% gelatin, 200µM of each of the four dNTP’s, 
10µM of each oligonucleotide primer, 1.25 Units of Taq (Thermus aquaticus) DNA 
polymerase (Perkin Elmer Cetus, Norwalk, Connecticut) and 1µl of extracted 
template DNA or a single 3mm diameter washed and dried punch from the blood 
sample applied to a Whatman FTA card. The reaction conditions were as follows; 
one cycle of 94oC for seven minutes, followed by 27 cycles of 94oC for 30 seconds, 
55oC for 60 seconds, followed by 72oC for 30 seconds. 
Trypanosoma congolense (Forest) Specific PCR 
Samples were screened for the presence of Trypanosoma congolense (Forest) 
using primers targeted to a satellite DNA repeat present in the mini chromosomes 
(Masiga et al, 1992). The expected amplicon size for a positive result is 350bp. 
The PCR amplification was carried out using the following primer sequences; TCF-1 
(5’ – GGA CAC GCC AGA AGG TAC TT– 3’) & TCF-2 (5’ – GTT CTC GCA CCA 
CCA AC – 3’) all primers were synthesised by MWG Biotech. Each PCR was carried 
out using 25µl volumes containing the following components; 10mM Tris-HCl pH 
8.3, 1.5mM MgCl2, 50mM KCl, 200µM of each of the four dNTP’s, 1µM of each 
oligonucleotide primer, 2.5 Units of Biotaq (Bioline Ltd, London) and 1µl of extracted 
template DNA or a single 3mm diameter washed and dried punch from the blood 
sample applied to a Whatman FTA card. The reaction conditions were as follows: 
one cycle of 94oC for three minutes, 30 cycles of 94oC for 1 minute 60oC for 2 
minute and 74oC for 30 seconds. The thermal cycling was carried out on a Peltier 
Thermal Cycler DYAD DNA Engine (MJ Research, Waltham, MA, USA). 
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Trypanosoma congolense (Savannah) Specific PCR 
Samples were screened for the presence of Trypanosoma congolense (Savannah) 
using primers targeted to a satellite DNA repeat present in the mini chromosomes 
(Masiga et al, 1992). The expected amplicon size for a positive result is 316bp. 
The PCR amplification was carried out using the following primer sequences; TCS-1 
(5’ – CGA GAA CGG GCA CTT TGC GA– 3’) & TCS-2 (5 CCC GCA CA – 3’) all 
primers were synthesised by MWG Biotech. Each PCR was carried out using 25µl 
volumes containing the following components: 10mM Tris-HCl pH 8.3, 1.5mM 
MgCl2, 50mM KCl, 0.01% gelatin, 200µM of each of the four dNTP’s and 1µM of 
each oligonucleotide primer and 1.25 Units of Taq (Thermus aquaticus) DNA 
ploymerase (Perkin Elmer Cetus, Norwalk, Connecticut). 1µl of extracted template 
DNA or a single 3mm diameter washed and dried punch from the blood sample 
applied to Whatman FTA cards. The reaction conditions were as follows: one cycle 
of 94oC for seven minutes once followed by 27 cycles of 94oC for 30 seconds, 55oC 
for 60 seconds and 72oC for 30 seconds. The thermal cycling was carried out on a 
Peltier Thermal Cycler DYAD DNA Engine (MJ Research, Waltham, MA, USA). 
Trypanosoma congolense (Kilifi) Specific PCR 
Samples were screened for the presence of Trypanosoma congolense (Kilifi) using 
primers targeted to a satellite DNA repeat present in the mini chromosomes (Masiga 
et al, 1992). The expected amplicon size for a positive result is 294bp. 
The PCR amplification was carried out using the following primer sequences TCK-1 
(5’ – GTG CCC AAA TTT GAA GTG AT– 3’) and TCK-2 (5’ CCA TT ATT AGC TTT 
GTT GC – 3’) all primers were synthesised by MWG Biotech. Each PCR was carried 
out using 25µl volumes containing the following components: 10mM Tris-HCl pH 
8.3, 1.5mM MgCl2, 50mM KCl, 200µM of each of the four dNTP’s, 1µM of each 
oligonucleotide primer, 2.5 Units of Biotaq (Bioline Ltd, London) and 1µl of extracted 
template DNA or a single 3mm diameter washed and dried punch from the blood 
sample stored on a Whatman FTA card. The reaction conditions were as follows, 
one cycle of 94oC for three minutes, 30 cycles of 94oC for 1 minute, 60oC for 2 
minutes, 74oC for 30 seconds. The thermal cycling was carried out on a Peltier 
Thermal Cycler DYAD DNA Engine (MJ Research, Waltham, MA, USA). 
Trypanosoma vivax Specific PCR 
Samples were screened for the presence of Trypanosoma vivax using primers 
targeted to a satellite DNA repeat present in the mini chromosomes (Masiga et al, 
1992). The expected amplicon size for a positive result is 150bp. 
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The PCR amplification was carried out using the following primer sequences TVW-1 
(5’ – CTG AGT GCT CCA TGT GCC AC– 3’) & TVW-2 (5’ –CCA CCA GAA CAC 
CAA CCT GA – 3’) all primers were synthesised by MWG Biotech. Each PCR was 
carried out using 25µl volumes containing the following components: 10mM Tris-HCl 
pH 8.3, 1.5mM MgCl2, 50mM KCl, 200µM of each of the four dNTP’s, 1µM of each 
oligonucleotide primer, 2.5 Units of Biotaq (Bioline Ltd, London) and 1µl of extracted 
template DNA or a single 3mm diameter washed and dried punch from the blood 
sample stored on a Whatman FTA card. The reaction conditions were as follows; 
one cycle of 94oC for three minutes, followed by 30 cycles of 94oC for 1 minute, 
60oC for 2 minutes, 74oC for 30 seconds. The thermal cycling was carried out on a 
Peltier Thermal Cycler DYAD DNA Engine (MJ Research, Waltham, MA, USA). 
Mammalian Specific Tubulin PCR 
This PCR method is targeted to mammalian tubulin genes and is as described by 
Terry et al (2001). Tubulin genes are present in thousands of copies throughout the 
mammalian genome and the sequences of the primers are specific to mammalian 
tubulin only. This protocol is often used to verify the integrity of DNA samples.The 
PCR was carried out using the following primer sequences; 
MtubF (5’-CGTGAGTGCATCTCCATCCAT-3’), & MtubR 
(GCCCTCACCCACATACCAGTG-3’) all primers were synthesised by MWG 
Biotech. Each PCR was carried out using 25µl volumes containing the following 
components, 10mM Tris-HCl pH 9.0, 1.5mM MgCl2, 50mM KCl, 0.1% TritonX-100, 
0.01% (w/v) stabiliser (Purchased as a 10X SuperTaq PCR buffer from HT 
biotechnologies, Cambridge), 2uM of each primer, 1mM total dNTP’s ,1.25 Units of 
Biotaq (Bioline Ltd, London) and 1µl of extracted template DNA or a single 3mm 
diameter washed and dried punch from the blood sample stored on a Whatman FTA 
card. The reaction conditions were as follows; one cycle of 94oC for five minutes, 40 
cycles of 94oC for 50 seconds followed by 55oC for 1 minute, 72oC for 1 minute 30 
seconds with a final step of 72 oC for 10 minutes. 
2.2.5. DNA extraction 
DNA was extracted from blood samples by use of a QIAamp DNA Blood Mini Kit 
(Qiagen GmbH, Germany).The protocol was as per the manufacturer’s instructions. 
Briefly the samples and AE Buffer were allowed to equilibrate at room temperature 
(15-25oC). 20µl of protease were pipetted into the 1.5ml microcentrifuge tube 
provided. To this 200µl of sample were added, then 200µl of buffer AL was added. 
The resulting mix was then vortexed for 15 seconds. The sample was then 
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incubated at 56oC for 10 minutes. The sample was then subject to centrifugation in 
order to remove drops from the inside of the tube. 200µl ethanol (96-100%) was 
added to the tube and the mix was again subject to pulse vortexing for 15 seconds. 
The tube was again centrifuged briefly. The mixture was then carefully added to the 
QIAamp spin column, which was placed in a 2ml collection tube, this was 
centrifuged at 6000xg (8000rpm) for 1 minute. The spin column was then placed in a 
clean 2ml collection tube and the previous filtrate was discarded. 500µl of buffer 
AW1 was added to the spin column and the sample was subject to centrifugation at 
6000xg (8000rpm) for 1 minute. Again the spin column was placed in a clean 2ml 
collection tube and the previous filtrate discarded. 500µl of Buffer AW2 was added 
to the spin column, the sample was then centrifuged at 20,000xg (14000rpm) for 3 
minutes. The spin column was placed in a fresh collection tube and the previous 
filtrate was discarded. 200µl of buffer AE was added and the sample was incubated 
at room temperature for 1 minute, the sample was then centrifuged for the final time 
at 6000xg (8000rpm) for 1 minute. The resulting liquid contains the extracted DNA. 
2.2.6. Extraction of DNA from agarose gels 
PCR product was extracted from agarose gels using a QIAquick Gel Extraction Kit. 
(Qiagen GmbH, Germany). The protocol was as the manufacturers instructions. 
Briefly the band of interest was excised from the gel taking care to leave as little 
excess gel as possible and using clean DNA free blades for each excision. The slice 
was weighed and three volumes of buffer QG were added to 1 volume of gel (100µl 
buffer for100mg weight of gel). This was incubated at 50oC for 10 minutes, until the 
gel slice had dissolved. One volume of isopropanol alcohol was then added to the 
mix. The mixture was placed in a QIAquick spin column which in turn was placed in 
a 2ml collection tube. This was then centrifuged for one minute. The spin column 
was then placed in a fresh collection tube and 0.5ml of buffer QG was added. The 
previously collected filtrate was discarded. The column was then centrifuged for one 
minute. The resulting filtrate was discarded and the column placed in a fresh 
collection tube and centrifuged for an additional minute at 13000xg (~13900rpm). 
The spin column was then placed in a clean collection tube and 50µl of buffer EB 
(10mM Tris-Cl, pH 8.5) added. This was then centrifuged for 1 minute. The resulting 
eluate contains the extracted PCR product (DNA). 
2.2.7. Sequencing of PCR products 
In order to sequence the PCR products the amplicons were eluted from the gel as 
described in Section 2.2.6. The resulting eluate was sent for sequencing to Lark 
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Technologies Inc. (Takely, Essex,UK) as per recommendations. Sequences 
received from Lark Technologies were analysed using Bioedit sequence alignment 
editor version 5.0.9 (Hall, 1999) available from 
http://www.mbio.ncsu.edu/BioEdit/bioedit.html and MegAlign version 4.0 (DNA Star 
Inc, Madison, WI, USA). 
2.2.8. Gel loading buffer 
The loading buffer used in electrophoresis of the PCR products consisted of the 
following 15% Ficoll, 10mM Tris pH8.0, 10mM EDTA, 0.1% SDS, 0.1% 
Bromophenol Blue in distilled water. 
2.2.9. Electrophoresis & gel visualisation 
In all cases electrophoresis was carried out with a 30cm by 20cm 1.5% agarose gel. 
The gel was prepared by adding 10ml of Tris-Borate-EDTA 10x concentrate (Sigma 
Aldrich, Dorset, UK) to 90ml of distilled water and then adding Ethidium Bromide to 
the buffer at 0.5g ml-1. To this buffer 1.5g of general purpose agarose (Sigma 
Aldrich, Dorset, UK) was added. The mixture was heated until the agarose was 
disolved, poured into the tray and allowed to cool until set. 10µl of PCR product was 
mixed with an equal quantity of loading buffer, this was loaded into the wells.10µl of 
Superladder-Mid 100bp Ladder (Abgene, Epsom, UK) size reference marker was 
loaded, at each end of the row, on each gel. The electrophoresis was then  
conducted at 100 volts for around one hour. The resulting gel was then visualised on 
a Biorad electrophoresis gel visualiser (Milan, Italy) and bands were sized using 
Biorad Gel Doc, Quantity One v4.1.0 (Biorad, Hercules, CA, USA). 
2.2.10. Investigation of PCR performance on differe nt dilution series types 
In order to evaluate existing protocols targeted to ribosomal genes for use directly 
on whole blood samples, a set of different types of dilution series were constructed. 
The aim of this was to measure the relative performance of the PCR (KIN primers) 
as described by McLaughlin et al (1996). The dilution series were constructed to 
provide a progression from genomic DNA suspended in water (on which the 
protocols performed well) to whole trypanosomes in blood (on which the tested 
protocol did not work) by adding stepwise one element (filter paper sample media, 
genomic DNA, whole trypanosomes, blood serum, red blood cells, white blood cells) 
at a time. In this way the cause of any inhibition of the PCR could be ascertained. 





Dilution series 1: Genomic DNA in liquid form 
A stock of T.brucei Buteba135 genomic DNA at a concentration of 80µg ml-1 was 
diluted with sterile water in tenfold dilutions, the dilutions used ranged from neat 
genomic DNA to a dilution of 1:106; calculated to be an equivalent of a single 
trypanosome genome per microlitre. 
Dilution series 2: Genomic DNA placed on treated fi lter paper 
The stock of T.brucei Buteba135 genomic DNA was diluted with sterile water in 
tenfold dilution, the dilutions used ranged from neat genomic DNA to a dilution of 
1:106. The dilutions were then placed on to Whatman FTA cards and allowed to dry 
before PCR analysis. 
Dilution series 3: Trypanosomes placed on treated f ilter paper 
T.brucei Buteba135 cultured metacyclic trypanosomes at an original concentration 
of 109 trypanosomes per millilitre were diluted in phosphate buffered saline. The 
tenfold dilution series ranged from 106 trypanosomes per millilitre to a 1:108 dilution 
of the original stock. The dilutions were then placed on to Whatman FTA cards and 
allowed to dry before PCR analysis. 
Dilution series 4: Trypanosomes and blood placed on  treated filter paper 
T.brucei Buteba135 cultured procyclic trypanosomes were diluted in bovine blood. 
The tenfold dilution series ranged from 106 trypanosomes per millilitre to a 1:108 
dilution of the original stock. The dilutions were then placed on to Whatman FTA 
cards and allowed to dry before PCR analysis. 
Dilution series 5: Red blood cells with trypanosome s placed on treated filter 
paper 
White blood cells were removed from uninfected bovine blood by extraction of the 
buffy coat. The red blood cell suspension was then spun and the plasma removed in 
order to concentrate the red blood cells. The enriched red blood cell suspension was 
then subject to tenfold dilution with phosphate buffered saline to a final dilution of 
1:108. To each dilution a volume of T.brucei Buteba135 procyclic trypanosomes 
were added so that the final number of trypanosomes for each of the dilutions was 
103 trypanosomes per millilitre. The dilutions were then placed on to Whatman FTA 
cards and allowed to dry before PCR analysis. 
Dilution series 6: White blood cells with trypanoso mes placed on treated filter paper 
Red blood cells were removed from uninfected bovine blood by extraction of the 
buffy coat. The white blood cell suspension was then spun and the plasma removed 
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in order to concentrate the red blood cells. The enriched white blood cell suspension 
was the subject to tenfold dilution with phosphate buffered saline to a final dilution of 
1:108. To each dilution a volume of T.brucei Buteba135 metacyclic trypanosomes 
were added so that the final number of trypanosomes for each of the dilutions was 
103 trypanosomes per millilitre. The dilutions were then placed on to Whatman FTA 
cards and allowed to dry before PCR analysis. 
Dilution series 7: Plasma with trypanosomes placed on treated filter paper 
The plasma was extracted from a sample of uninfected bovine blood by 
centrifugation. The plasma was then subject to tenfold dilutions using phosphate 
buffered saline to a final dilution of 1:108. To each dilution a volume of T.brucei 
Buteba135 metacyclic trypanosomes were added so that the final number of 
trypanosomes for each of the dilutions was 103 trypanosomes per millilitre. The 
dilutions were then placed on to Whatman FTA cards and allowed to dry before 
PCR analysis. 
2.2.11. Measurement of trypanosome and DNA concentr ations 
All cell counts were made using a haemocytometer; each count was calculated from 
an average of separate counts from five aliquots from the samples. In the case of 
trypanosome counts these were also verified by an independent count by another 
colleague. The cell counts were made on the initial dilution and subsequent 
concentrations were calculated according to the resulting dilution 
The concentration of all extracted genomic DNA was calculated by measurement of 
optical density at 260nm using a Hitachi U-2001 spectrophotometer. According to 
the manufacturers manual at this wavelength one OD unit is equivalent to 50µg ml-1 
of double stranded DNA. 
Calculation of equivalent numbers of trypanosomes f or genomic DNA 
samples 
For conversion of concentration of genomic DNA to equivalent number of 
trypanosome genomes the following parameters were used. 
Size of haploid Trypanosome genome 3.5 x 107bp (Sanger Centre) 
GC content of genome assumed to be 50% 
Molecular weight of GC basepair = 650 Da 
Molecular weight of AT basepair =649 Da 
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Molecular weight subtracted for each base pairing due to loss of water in 
condensation reaction = 36 DA 
Calculated weight of trypanosome haploid genome = 0.0713 pg 
The figure given by Desquesnes and Davila (2002) is 0.1pg of DNA per single 
trypanosome, in view of this difference the more conservative figure (0.0713pg), 
which would estimate greater trypanosome numbers and so over estimate sensitivity 
in comparison to the published figure was used. 
2.2.12. Primer Design 
Sixteen trypanosome ribosomal DNA sequences were selected from the NCBI 
database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Nucleotide). T.brucei 
AF306771, AF306772, AF306773, AF306774, AF306775 AF306776, AF306777, 
X05862; T.congolense U22315; T.congolense (Kilifi) U22316; T.congolense 
(River/Forest) U22317; T.congolense (Tsavo) U22318; T.vivax U22319, T.simiae 
U22320.  Two additional sequences (Trypanosoma cruzi AY362826 & Trypanosoma 
rangeli AY230240) were selected for comparison as out-groups to ensure optimal 
specificity of the primers.  Sequences were aligned with CLUSTALX software 
(ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalX/) (Thompson et al., 1997) and viewed using 
the Bioedit programme (Hall, 1999).  A set of nested primers targeting the ribosomal 
gene locus was selected using PRIMER3 web primer selection software 
(http://www.broad.mit.edu/cgi-bin/primer/primer3_www.cgi). 
Primers were evaluated using NETPRIMER software available at 
(http://www.premierbiosoft.com/netprimer/netprlaunch/netprlaunch.html).The 
specificity of the primers was evaluated using a BLAST search against human and 
mouse genomes (http://www.ncbi.nlm.nih.gov/BLAST/). The outer primer sequences 
were ITS1 (5’ – GAT TAC GTC CCT GCC ATT TG – 3’), and ITS2 (5’ – TTG TTC 
GCT ATC GGT CTT CC – 3’( MWG Biotech), and inner primer sequences ITS3 (5’ – 
GGA AGC AAA AGT CGT AAC AAG G – 3’), and ITS4 (5’ – TGT TTT CTT TTC 
CTC CGC TG – 3’) ( MWG Biotech).  All PCR conditions were optimised using 
modified ‘Taguchi’ methods (Cobb and Clarkson, 1994).  Expected band sizes were 
calculated from the distance between the primer locations as determined from the 
sequences for each trypanosome species present in bioinformatic databases.  The 
expected band sizes are shown in Table 2.4. 
During design of the outer primers the highest design emphasis was given to 
specificity (as few blast hits with human and mouse genomes as possible) at the 
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expense of stringency in primer design, so that the outer primers are best suited to 
cope with high amounts of background DNA present in blood samples. For design of 
the inner primers emphasis was given to primer design parameters such as hairpins, 
cross dimers, melting temperatures etc. at the expense of BLAST hits on human 
and mouse genomes. As during the second round the amount of background DNA 
is greatly reduced. 
2.2.13. Bioinformatics and DNA sequences  
The details of all sequences used obtained from bioinformatics databases are 
shown in Table 2.2. The alignment of the four primers against all trypanosome DNA 
sequences is shown in Figure 2.2. 
Table 2.2. Details of sequences contained in bioinf ormatic databases  
Accession Number Strain Reference Species / Sub-spe cies 
   
AF306771 H3 T.brucei 
AF306772 STIB215 T.brucei 
AF306773 B8-18 T.brucei 
AF306774 KP2 T.brucei 
AF306775 DA1972 T.brucei 
AF306776 SUZENA T.brucei 
AF306777 NW2 T.brucei 
X05682  T.brucei 
U22315  T.congolense 
U22316  T.congolense (Kilifi) 
U22317  T.congolense (River/Forest) 
U22318  T.congolense (Tsavo) 
U22319  T.vivax 
U22320  T.simiae 
AY230240  T.ranglei 
AY362826  T.cruzi 
   
The table above lists all the sequences for complete and partial ribosomal subunits used in 
this work. The details of accession number and strain type (Where appropriate) are shown. 
The sequences for Trypanosoma ranglei and Trypanosoma cruzi were used as outgroups. 
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Figure 2.2. Alignment of Trypanosome small ribosoma l subunits in relation to the ITS PCR inner and out er primers 
(The central portion of the sequences are omitted in order to save space) 
                        10        20        30        40        50        60        70        80        90       100 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
T.b_AF306774   ----------------------------------------------------TGGTGCAATACAGGTGATCGGACCGTCGCTCGTCTCGG--GCGACCGA  
T.b_AF306775   ----------------------------------------------------TGGTGCAATACAGGTGATCGGACCGTCGCTCGTCTCGG--GCGACCGA  
T.b_AF306776   ----------------------------------------------------TGGTGCAATACAGGTGATCGGACCGTCGCTCGTCTCGG--GCGACCGA  
T.b_AF306772   ----------------------------------------------------TGGTGCAATACAGGTGATCGGACCGTCGCTCGTCTCGG--GCGACCGA  
T.b_AF306773   ----------------------------------------------------TGGTGCAATACAGGTGATCGGACCGTCGCTCGTCTCGG--GCGACCGA  
T.b_AF306771   ----------------------------------------------------TGGTGCAATACAGGTGATCGGACCGTCGCTCGTCTCGG--GCGACCGA  
T.b_AF306777   ----------------------------------------------------TGGTGCAATACAGGTGATCGGACCGTCGCTCGTCTCGG--GCGACCGA  
T.c_U22315     GCCGATTACGTCCCTGCCATTTGTACACACCGCCCGTCGTTGTTTCCGATGATGGTGCAATACAGGTGATCGGACCGTCGCGTGTCTCAC--GTGACCGA  
T.c_U22316     GCCGATTACGTCCCTGCCATTTGTACACACCGCCCGTCGTTGTTTCCGATGCTGGCGCAATACAGGTGATTGGACCGCCGGGCGCCTCGC--CCG-CGGG  
T.v_U22319     GCCGATTACGTCCCTGCCATTTGTACACACCGCCCGTCGTTGTTTCCGATGATGGTGCAATACAGGTGATCGGACCGTCGCGTGTCTCAC--GTGACCGA  
T.s_U22320     GCCGATTACGTCCCTGCCATTTGTACACACCGCCCGTCGTTGTTTCCGATGATGGTGCAATACAGGTGATCGGACCGTCGCGTGTTTCAC--GCGACCGA  
T.c_U22317     GCCGATTACGTCCCTGCCATTTGTACACACCGCCCGTCGTTGTTTCCGATGATGGTGCAATACAGGTGATCGGACCGTCGCGTGTCTCAC--GTGACCGA  
T.c_22318      GCCGATTACGTCCCTGCCATTTGTACACACCGCCCGTCGTTGTTTCCGATGATGGTGCAATACAGGTGATCGGACCGTCGCGTGCCTCAC--GCGACCGA  
T.cr_AY362826  -----------------------TTCCGATGATTTGTTACATATATATATATATATATAATATATATACGGNTGTGTGTGTATAATATAT-GNNGNACAC  
T.r_AY230240   -------------------------------------------------------------GTAGGTGAACCTGCAGCTGGATCATTTTCCGATGATTTC  
ITS1           ~~~GATTACGTCCCTGCCATTTG                                                                               
ITS3           ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
ITS2           ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  















                       110       120       130       140       150       160       170       180       190       200 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
T.b_AF306774   AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCTGATATCCAT-TATAC  
T.b_AF306775   AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCTGATATCCAT-TATAC  
T.b_AF306776   AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCTGATATCCAT-TATAC  
T.b_AF306772   AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCTGATATCCAT-TATAC  
T.b_AF306773   AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCTGATATCCAT-TATAC  
T.b_AF306771   A-GTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCTGATATCCAT-TATAC  
T.b_AF306777   AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCTGATATCCAT-TATAC  
T.c_U22315     AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGCTCATTTTCCGATGATAATATATAT  
T.c_U22316     AAGTTCACCGATATTGCCTCATTAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCCGA-------------  
T.v_U22319     AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGCTCATTTTCCGATGATAAAA---AA  
T.s_U22320     AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCCGATA-----------  
T.c_U22317     AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCCGATGATACGATCCAA  
T.c_22318      AAGTTCACCGATATTGCTTCAATAGAGGAAGCAAAAGTCGTAAC--AAGGTAGCTGTAGGTGAACCTGCAGCTGGATCATTTTCCGATA-----------  
T.cr_AY362826  ACACAATCAGGCAACAAAACTCTGGCGTGTATATATATTACTAC-TATGCTACTAATATAATATACTCTGTGCTGNGTGTGTTGNTGTTGCCGCGCGGGA  
T.r_AY230240   ATAATACCCTATAATACATGTGTG-CGTATATATATATATATATATATG-TGCGCGTACA------TGCATGCGAGAGGAACAACTGTGATGACTCCACA  
ITS1                                                                                                                 
ITS3           ~~~~~~~~~~~~~~~~~~~~~~~~~~GGAAGCAAAAGTCGTAAC~~AAGG                                                    
ITS2           ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  



















                       1710      1720      1730      1740      1750      1760      1770      1780      1790      1800 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
T.b_AF306774   ----------------------------------------------------------------------------------------------------  
T.b_AF306775   ----------------------------------------------------------------------------------------------------  
T.b_AF306776   ----------------------------------------------------------------------------------------------------  
T.b_AF306772   ----------------------------------------------------------------------------------------------------  
T.b_AF306773   ----------------------------------------------------------------------------------------------------  
T.b_AF306771   ----------------------------------------------------------------------------------------------------  
T.b_AF306777   ----------------------------------------------------------------------------------------------------  
T.c_U22315     TCAGTCAGCGGCGAGCGAAGAGGGAACGAACTCGTTGCCGAATCGGGTCTGAA-----TGGCCTCGAGTTGTGGCATGACGTGCCGCCTTGGGGGCTGGT  
T.c_U22316     TCAGTCAGCGGCGAGCGAACAGGGACACAACTCGCTGCCGAATCGCGCCTCAA-----GGGCGCCGACCTGTGGCACGCAACGCGGCGC--ACGGCTGGC  
T.v_U22319     TCAGTCAGCGGCGAGCGAAGAGGGAACGAACTCGTTGCCGAATCGGGTCTGAA-----AGGCCTCGAGTTGTGGCATGACGTGCCGCCTTGGGGGCTGGT  
T.s_U22320     TCAGTCAGCGGCGAGCGAAGAGGGACGGAACTCGTTGCCGAATCTGGTCCCCATGTGGGGGCCTTGAGTTGTGGCATGACGCGCCGTCT--GGGGCAGGT  
T.c_U22317     TCAGTCAGCGGCGAGCGAAGAGGGAACCAACTCGTTGCCGAATCGGGTCTGAA-----GGGCCTCGAGTTGTGGCATGACGCGCCGCCTTGGGGGCTGGT  
T.c_22318      TCAGTCAGCGGCGAGCGAAGAGGGACGGAACTCGTTGCCGAATCTTGTCCCCGCGAGGGGGCCTTGAGTTGTGGCATGACGCGCCGTCT--GGGGCAGGT  
T.cr_AY362826  ----------------------------------------------------------------------------------------------------  
T.r_AY230240   TATATATATATATATATGTTTTTTTCTTGTTTGTTTACAGACCTGAGTGTGGCAGGACTACCCGC-----------------------------------  
ITS1                                                                                                                 
ITS3                                                                                                                 
ITS2           ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  


















                       2010      2020      2030      2040      2050      2060      2070 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|... 
T.b_AF306774   ------------------------------------------------------------------------------  
T.b_AF306775   ------------------------------------------------------------------------------  
T.b_AF306776   ------------------------------------------------------------------------------  
T.b_AF306772   ------------------------------------------------------------------------------  
T.b_AF306773   ------------------------------------------------------------------------------  
T.b_AF306771   ------------------------------------------------------------------------------  
T.b_AF306777   ------------------------------------------------------------------------------  
T.c_U22315     AGAGTAGGAAGACCGATAGCGAACAAGTAGCGTGAGCGAAAGTTTGAAAAGCACTTTGGAAAGAGAGTGACATAGAAC  
T.c_U22316     AGAGCGGGAAGACCGATAGCGAACAAGTAGCGTGAGCGAAAGTTTGAAAAGCACTTTGGAAAGAGAGTGACATAGAAC  
T.v_U22319     AGAGTAGGAAGACCGATAGCGAACAAGTAGCGTGAGCGAAAGTTTGAAAAGCACTTTGGAAAGAGAGTGACATAGAAC  
T.s_U22320     AGAGTAGGAAGACCGATAGCGAACAAGTAGCGTGAGCGAAAGTTTGAAAAGCACTTTGGAAAGAGAGTGACATAGAAC  
T.c_U22317     AGAGTAGGAAGACCGATAGCGAACAAGTAGCGTGAGCGAAAGTTTGAAAAGCACTTTGGAAAGAGAGTGACATAGAAC  
T.c_22318      AGAGTAGGAAGACCGATATGTAACAAGTAGCGTGAGCGAAAGTTTGAAAAGCACTTTGGAAAGAGAGTGACATAGAAC  
T.cr_AY362826  ------------------------------------------------------------------------------  
T.r_AY230240   ------------------------------------------------------------------------------  
ITS1                                                                                           
ITS3                                                                                           
ITS2           ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GGAAGACCGATAGCGAACAA   










In order to differentiate important species (and some sub species) of African 
trypanosome a nested PCR reaction was developed which amplified the 
variable ITS region of the ribosomal gene locus, using primers designed to the 
conserved flanking sequences (Figure 2.1.). 
2.3.1. Evaluation of PCR techniques on different sa mple media. 
Application of the PCR technique described by Desquesnes (2001) to blood 
samples stored on FTA cards failed to produce any results. In order to ascertain 
the reason(s) for this, the same technique was applied to different types of 
dilution series to ascertain the limit of sensitivity of the technique for each 
dilution series type (See Table 2.3.). The results obtained showed that there 
was no difference in the sensitivity of the technique (Desquesnes, 2001) 
between the different types of dilution series that did not contain blood. The 
sensitivity achieved for the dilution series that contained blood was between ten 
to one hundred times less than that on other dilution series types. When the 
technique was applied to dilutions of different components of blood (red blood 
cells, white blood cells and plasma) with a constant level of trypanosome DNA 
only the dilution series of red blood cells showed significant inhibition of the PCR 
as the number of red blood cells increased. The original IRT PCR technique 
(Desquesnes, 2001) did not provide any positive results on these types of 
dilutions. 
Application of the new ITS PCR technique described in this paper to the 
different types of dilution series showed that the PCR was able to detect a single 
trypanosome across all types of dilution series. No inhibition of PCR was noted 
when blood was present in the sample tested. 
2.3.2. Specificity 
Amplification of genomic DNA from trypanosome stocks resulted in a specific 
size band for each species, which was within the bounds of measurement error 
and was in complete agreement with the expected band sizes (Table 2.4.).  
Control DNA samples were not available for some trypanosome species (e.g. T. 






Table 2.3. Performance of Polymerase Chain Reaction  protocols on different types 
of dilution series 
 Limit of Detection (trypanosomes per µl) 
Dilution Series Type IRT PCR  
(McLaughlin et al, 1996) 
ITS PCR 
   
Genomic DNA diluted with water >70 1 
Genomic DNA diluted with water 
on filter cards 
>70 1 
Whole trypanosomes diluted with 
water on filter cards 
>70 1 
Whole trypanosomes diluted with 
bovine blood on filter cards 
350 ~ 3000 1 
Dilution series of elements of blood with constant target DNA concentration 
103 trypanosomes per ML with 
dilutions of rbc’s 
All Negative 
PCR Inhibition at  10x rbc’s per 
ml 
103 trypanosomes per Ml with 
dilutions of wbc’s 
All Negative All positive 
103 trypanosomes per Ml with 
dilutions of Plasma 
All Negative All positive 
Shows the mean limit of sensitivity of the previously published single round IRT PCR 
(McLaughlin et al, 1996) and ITS PCR as measured against different types of dilution 
series of the sample and other components present in the sample. The different types of 
dilution series are designed so as to highlight the cause of any PCR inhibition that might 
be attributable to the component that is present in that dilution series but not in the other 
dilution series. 
Table 2.4. Observed and expected amplicon sizes 
Species Expected band size from NCBI Database 
Band sizes 
obtained 
T.congolense (Forest) 1513bp 1501bp 
T.congolense 




T.congolense (Tsavo) 954bp 951bp 
T.brucei 1207~1224bp 1215bp 
T.simiae 850bp 847bp 
T.vivax 611bp 620bp 





bands were cut out, sequenced and compared with database sequences to 
confirm species identity (Data not shown).  The specificity of the primers was 
further tested by PCR amplification with host DNA (human, cow and mouse), 
which produced no visible bands. 
2.3.3. Sensitivity 
To investigate the sensitivity of the nested PCR, the technique was tested on a 
dilution series of whole trypanosomes (diluted in phosphate buffered saline) on 
Whatman FTA™ cards and a dilution series of genomic DNA (diluted in water) 
in liquid form and also applied to Whatman FTA™ cards.  In the two dilutions of 
genomic DNA positive amplification was detected at a DNA concentration of 
49pg ml-1 (or less than a single trypanosome equivalent).  To investigate the 
efficacy of the technique on samples containing host material, trypanosomes 
were diluted in bovine blood (UK origin) and applied to Whatman FTA cards to 
mimic field samples.  Positive amplification was detected at DNA a 
concentration of 55pg ml-1, which is again equivalent to less than a single 
trypanosome. 
2.3.4. Application to field samples 
Application of the nested ITS primers to two hundred and forty five samples of 
bovine blood taken from the Soroti &Tororo districts of Uganda and collected on 
Whatman FTA™ cards resulted in successful amplification of the target ITS 
region as shown by species specific band sizes.  This technique was also able 
to show samples infected with multiple species (Figure 2.3; lanes 2, 16 and 19), 
as shown by the presence of multiple bands. 
2.3.5. Technique evaluation 
The efficacy of the technique was tested against the most widely used screening 
method; individual species specific PCR’s (Artama et al., 1992, Masiga et al., 
1992, Majiwa et al., 1994, Masake et al., 1997, Clausen et al., 1998), using 
samples collected from two different villages in Uganda (Cow blood applied to 
Whatman FTA™ cards). Analysis of the two hundred and forty five samples 
using the individual species-specific PCR screening method demonstrated a low 
prevalence of trypanosomes in cows from the first village and a high prevalence 
of trypanosomes in cows from the second village (Data courtesy of Jenna Fyfe 
and Francis McOdimba, CTVM, University of Edinburgh). Application of the ITS-
PCR method showed that a comparable prevalence and greater number of 
species were detected in each case (Table 2.5). 
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Figure 2.3. Representative gel showing bands obtain ed from PCR amplification 
(using nested ITS primers) of 19 blood samples (on Whatman FTA cards) taken 
from cattle in the Tororo district of Uganda 
 
Samples 2, 3, 8, 16 & 19 are all positive for T.brucei, Samples 2, 9, 16 ,18 & 19 are 
positive for T.theileri. Sample 17 is positive for T.simiae, sample 5 is positive for T.vivax 
and samples 1, 6, 7, 10, 11, 12, 13, 14 are negative. Lane M represents a marker 
graduated in 100bp intervals (band sizes illustrated).  Mixed species infections were 
found in lanes 2,3,4,5,16 & 17. 
Table 2.5. Evaluation of the detection of trypanoso me DNA from Whatman 
FTA™ cards 
Low prevalence village High prevalence village 








T. brucei 5 7 32 33 
T. theileri ND 3 ND 47 
T. congolense 0 1 1 5 
T. vivax 1 1 8 5 
T. simiae ND 0 ND 2 
     
 ND = Not Done (N=101) ND = Not Done (N=144) 
The filter paper cards contained bovine blood samples from cattle in villages in the 
Tororo and Soroti districts of Uganda, the two groups of samples had been previously 
screened with individual species specific primers (Artama et al., 1992; Masiga et al., 
1992; Majiwa et al., 1994; Masake et al., 1997b; Clausen et al., 1998). The prevalence 
from the two sample sets were therefore known prior to the second screening with ITS-
PCR. This second screening was conducted without knowledge of the prevalence of the 
sample set (blind). Data from species specific techniques courtesy of Jenna Fyfe and 




Existing methods for screening samples for detection and differentiation of 
trypanosomes are not suited to large-scale epidemiological study.  This work 
addressed the requirement for improved techniques that simplify the sample 
analysis process but maintain the diagnostic sensitivity and specificity required 
for directly analysing field samples.  
Initial tests of a single round PCR targeted to the ribosomal gene subunit 
internal transcribed spacer (McLaughlin et al, 1996) were successful on 
genomic DNA extracted after mouse passage. However the same PCR when 
applied to blood samples stored on treated filter paper failed to produce any 
results. In order to determine the reasons for this the limit of sensitivity of the 
PCR was tested on a number of different types of dilution series. Each dilution 
series was designed so as to represent a gradual transition from genomic DNA 
in liquid form (on which the PCR was known to work) to trypanosomes in blood 
stored on treated filter paper cards (on which the PCR did not work). Any 
differences in the limit of sensitivity (the lowest dilution that consistently 
produced a positive result) between types of dilution series would then highlight 
the probable cause of the inhibition. There was no difference in the sensitivity of 
the PCR between the liquid genomic DNA dilution series and the same dilution 
series when placed on the treated filter paper cards, the highest dilution 
detected for both was equivalent to greater than 70 trypanosomes. From this we 
could conclude that the storage on the filter paper cards did not cause any 
inhibition of the PCR. An identical minimum level of detection was consistently 
achieved for the next type of dilution series; that of whole trypanosomes diluted 
with sterile water placed onto the treated filter paper cards. From this we could 
conclude that the adequate presence of whole trypanosomes instead of 
genomic DNA did not inhibit the PCR. In the next dilution series whole 
trypanosomes were diluted in uninfected cow blood (U.K. origin) and the 
dilutions placed on the filter cards. PCR on this type of sample showed that the 
limit of detection was consistently between five to fifty times less than with all the 
other dilution series (300 ~ 3000 trypanosomes detected). From this result it 
was evident that the addition of blood to the sample had an inhibitory effect on 
the PCR technique used. 
 In order to identify the specific component of blood that was the cause of the 
inhibition further sets of dilutions were prepared. In these dilutions the numbers 
of trypanosomes were kept at a stable level and the various components of 
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blood (red blood cells, white blood cells and plasma) were diluted in tenfold 
series. In order to achieve a useful dilution series the red and white blood cell 
components were enriched prior to the preparation of the dilution series, so that 
the starting dilutions were much higher than would be found in a blood sample. 
Results from PCR (with the ITS PCR technique) of these dilution series showed 
that red blood cells to be the major PCR inhibitory factor present in blood. This 
is in line with other work that identified heme, present in the red blood cells, to 
be one of the major PCR inhibitory components of blood (Akane et al, 1994). 
White blood cells showed only a minor inhibitory effect, probably due to the fact 
that they increase the amount of background DNA present. 
In addition to the inhibitory effect of blood on the PCR the dilution series also 
showed that the single round IRT PCR (Desquesnes, 2001) was not sensitive 
enough for use on field samples. The levels that might be expected to be found 
in infected blood are likely to be very much lower than the maximum detection 
limit for this technique of around seventy parasites (disregarding the inhibition 
shown due to the presence of blood). As blood samples for screening are likely 
to be from any stage of infection the number of parasites present in the sample 
will vary considerably. For practical purposes the only sensible detection level 
for a PCR designed to detect infection is a single parasite cell. This is the target 
detection limit (in the presence of inhibitory factors from blood) that was set for 
the design of the subsequent ITS-PCR.  In order to achieve this target it was 
clear that different strategy was required. It was decided that a nested PCR 
technique should be used, a nested PCR is two separate PCR reactions; the 
second carried out on the product of the first. The second set of primers is 
designed to amplify inside the first round amplicon. This makes the technique 
very much more sensitive, and in this application a two round amplification 
strategy has a second desirable effect. In the second round of the PCR the 
amount of the target is increased, whilst the amount of potentially inhibitory 
factors are greatly diluted.  
In light of the evaluation of existing techniques we therefore developed, a new 
nested PCR targeted to include both internal transcribed spacers of the 
ribosomal RNA genes (ITS PCR), that was capable of detecting trypanosomes 
in the presence of host DNA and the PCR inhibitors present in blood (Heme, 
Lactoferrin, IgG and non-target DNA). This nested technique was found to be 
sensitive enough for detection of a single parasite in blood samples and has 
been shown to be able to differentiate all important African trypanosome species 
and some sub species.  In order to simplify the sample collection and 
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processing methodology, we investigated the storage of samples on treated 
filter paper cards, which make possible the direct analysis of biological samples, 
in addition to circumventing the requirement for mouse passage.  When the 
nested technique was evaluated against the current single PCR per species 
screening method, using a complete sample set containing positive and 
negative samples, it was found to have a similar level of detection, but was 
capable of detecting a greater number of species in both high and low 
prevalence sample sets. 
The epidemiology of African trypanosomiasis is complex and poorly understood 
and requires large-scale field based investigation. This newly developed 
technique has greatly simplified epidemiological studies involving sample 
screening.  As a result the costs and time involved in screening samples for the 
eight major species/sub-species of trypanosome have been reduced by a factor 
of four (conservative estimate).  This nested PCR technique can be used to 
screen large numbers of biological samples directly, quickly and accurately, 
making it a simple, cost effective, robust and reliable tool for investigating the 













Chapter 3: Mixed species trypanosoma infections in 























The extent to which African trypanosome species co-exist within the same host has 
been studied most extensively in tsetse. Far less work has been carried out to 
investigate the frequency of mixed trypanosome species infections in cattle and 
other non-domestic animals. Although mixed species infections have been widely 
documented in tsetse, the reported prevalence varies considerably, for example, 
dissection of 9306 tsetse from Zimbabwe showed that mixed species infections 
accounted for only 6.2% of the positives observed (Woolhouse et al., 1996). In 
contrast, dissection in of 688 tsetse from Cote d’Ivoire showed that mixed species 
infections accounted for 64% of the positives observed (McNamara et al., 1995). In 
addition, it has been shown that it is possible for tsetse to acquire mixed infections 
experimentally. Of 140 tsetse fed on cattle which were experimentally infected with 
both Trypanosoma congolense and Trypanosoma brucei, 33% (46) were found to 
have picked up an infection. Of these, 63% were diagnosed as single Trypanosoma 
congolense infections, 8.7% were diagnosed as single Trypanosoma brucei 
infections and 28% were diagnosed as mixed species infections (Van den Bossche 
et al., 2004a). Similar findings have been reported elsewhere (Moloo, 1982). 
Furthermore, it has been demonstrated experimentally that tsetse can acquire mixed 
species infections via sequential in vitro feeds with single species infections (Gibson 
& Ferris, 1992). 
Whilst there have been fewer investigations into the existence of mixed species 
infections in cattle, the picture is similar to that for tsetse. Reported proportions of 
mixed species infections amongst trypanosome positive cattle varies from 5.4% in a 
study of 1617 cattle from Tanzania (Connor & Halliwell, 1987) to 47.8% in a study of 
422 cattle in Ghana (Kayang et al., 1997). As with tsetse it has also been shown that 
it is possible for cattle to acquire mixed infections under experimental conditions, 
from tsetse infected with mixed species and from sequential feeds of single species 
infected tsetse (Masake et al., 1984; Kayang et al., 1997; Mattioli et al., 1999). 
Whilst there is evidence that mixed trypanosome species infections exist within the 
vector and host, there are a number of important questions that remain unclear, 
most notably ‘How widespread are mixed species infections in the host and vector?’ 
and ‘Do the different species of trypanosome interact in mixed infections?’ questions 




In this study we set out to investigate the extent and composition of mixed species 
trypanosome infections in a group of African zebu cattle using a single nested PCR 
targeted to the intergenic spacers of the small ribosomal sub-unit genes (Cox et al., 
2005). The method is capable of detecting all important African trypanosome 
species – including Trypanosoma theileri (a species largely ignored in other studies) 
and provides a unique band size for each of the species of interest. Trypanosoma 
theileri is commonly found in cattle worldwide (Ogassawara et al., 1981; Nunes et 
al., 1983; Samad & Shahidullah, 1985; Kennedy, 1988; Farrar & Klei, 1990; Tarimo-
Nesbitt et al., 1999; Greco et al., 2000; Verloo et al., 2000) and is generally 
regarded as largely non-pathogenic (Schafler, 1979; Hussain et al., 1985; Doherty, 
1993; Seifi, 1995). Despite the widespread distribution of T. theileri, its presence is 
seldom reported in the literature. This may be due, in part, to its supposed non-
pathogenicity and to the fact that until recently it has not been possible to detect this 
species by PCR (Rodrigues et al., 2003), although it is easily identified by 
microscopy. The importance of this species in the context of coinfection with other 
trypanosome species has not yet been established. 
The direct analysis of the blood samples used in this study, combined with repeated 
PCR analysis of the same samples (allowing analyses of up to 114 microlitres of 
blood) constitutes what is the most sensitive and in depth analysis of blood samples 
yet reported in this field. 
3.2. Materials & Methods 
3.2.1. Sample description 
Thirty-five blood samples were randomly selected from a large set of samples 
collected from the ears of 35 Zebu cattle in the village of Ojilai, Tororo in Uganda in 
June 2001. Approximately 200µl of blood from the ear vein of each cow was applied 
to Whatman FTA™ cards and allowed to dry for a minimum of twenty-four hours at 
room temperature.  
3.2.2. Mapping of PCR results 
Each blood sample present on the FTA card was subject to between 92 and 114 
separate PCR assays (depending on the amount of blood available on the sample) 
and the position of each sample punch taken from the FTA card was recorded so 
that a positive result could be related back to the position on the card from which the 
sample punch was taken The total number of trypanosome positive and negative 
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samples was recorded for each sample. The number of positives for each species 
was also recorded. 
3.2.3. Controls 
Uninfected bovine blood (UK origin) was used as a negative control to ensure that 
the results were not biased by false positives during repeated PCR assays. A 
positive control sample was constructed with known numbers of trypanosomes 
(procyclic Trypanosoma brucei) diluted in cow blood (UK origin). The resultant 
concentration of trypanosomes was calculated with allowance for the dilution factor, 
at 508 trypanosomes per millilitre using a mean of thirty readings from a Neubauer 
haemocytometer. The positive and negative controls were subjected to the same 
treatment as the other samples. For the positive control the total number of PCR 
assays conducted and the total number of positives obtained were recorded. 
3.2.4. Comparison of observed and expected frequenc ies 
The prevalence of each species was used as the probability of detecting that 
particular species in a calculation of the expected frequency of each permutation of 
the species present. A monte-carlo simulation (@Risk V4.1, Palisade Corp) was set 
up to repeat the calculation over 10,000 iterations, thus simulating the variability 
inherent in probabilistic associations of elements. Over the 10,000 iterations of the 
calculation, the mean and 95% confidence intervals of the expected frequencies 
were calculated, this would be equivalent to the range of results that would be found 
if the species associated randomly. If the observed results fall outside these 
confidence intervals there would be a significant association between the relevant 
species, which may be either negative or positive. 
3.3. Results 
In this study we investigated the extent and composition of mixed infections in a 
group of African Zebu cattle. A total of 3602 PCR reactions were carried out on 35 
filter paper cards containing whole blood samples taken from African zebu cattle 
selected randomly from a herd in Ojilai, Uganda. The diagnostic results and position 
on the filter paper card of each result was recorded (Figure 3.1. shows examples of 
the results from a high, medium and low intensity infection samples). Table 3.1. 
shows the data obtained for the thirty-five cattle, only five cattle remained uninfected 
after repeated PCR screenings. The negative control samples remained negative 
throughout repeated PCR assays. Table 3.2. shows the cumulative prevalence of 
each trypanosome species or combinations of species in this sample of the herd. 
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The proportions of single and mixed species infections are shown in Table 3.3. The 
majority 18/30 (60%) of positive animals contained mixed species infections, All 
single species infections contained Trypanosoma theileri. Furthermore, the mixed 
species infections all involved T. theileri. 
The comparison of the observed frequencies of the mixed infections to those 
expected assuming random association between species showed the frequency of 
all the combinations of species observed in this sample set (including the 
occurrence of single species infections) were within the 95% confidence intervals. 
This indicated that for this sample set, the occurrence of species combinations was 




















Table 3.1. Results obtained from multiple PCR of th irty five blood samples from zebu 
cattle 
Sample 




      
1 12 0 0 0 80 
2 2 0 0 0 101 
3 6 3 7 0 85 
4 1 1 0 0 98 
5 0 0 0 0 109 
6 2 2 4 2 88 
7 4 0 0 0 100 
8 8 7 4 0 91 
9 8 0 0 13 83 
10 7 0 2 0 92 
11 3 0 0 1 106 
12 10 2 0 3 87 
13 0 0 0 0 110 
14 2 1 3 0 100 
15 21 10 6 0 65 
16 6 0 3 0 96 
17 12 0 0 0 90 
18 1 0 1 0 98 
19 3 0 3 2 94 
20 3 0 0 0 100 
21 19 0 0 0 85 
22 18 1 2 0 78 
23 0 0 0 0 102 
24 0 0 0 0 107 
25 3 0 3 0 95 
26 4 1 2 0 101 
27 0 0 0 0 98 
28 4 0 0 0 97 
29 1 1 0 0 100 
30 1 0 3 3 95 
31 1 1 0 1 100 
32 15 0 0 0 99 
33 2 0 0 0 100 
34 9 3 14 14 73 
35 2 0 1 0 99 
Negative 
control 
0 0 0 0 107 
Positive 
control 
0 45 0 0 56 
The frequency of positive results for T.theileri, T. brucei, T. congolense, T. vivax and of 
negative results is recorded in columns 2 to 6 respectively. 
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Table 3.2.   Prevalence of trypanosome species in African zebu cattle  




(%) Upper (%) Lower (%) 
    
T.theileri 85.7 69.7 95.2 
T.brucei 34.3 19.1 52.2 
T.congolense 42.9 26.3 60.6 
T.vivax 22.9 10.4 40.1 
Any trypanosome 85.7 69.7 95.2 
Mixed Infections    
Prevalence 60 42.1 76.1 
Proportion of positives 70   
Table showing the cumulative prevalence of the different species of trypanosome and the 
prevalence of mixed infections detected in thirty-five blood samples collected from Zebu 
cattle together with the exact binomial confidence intervals. These samples were subject to 
repeated PCR samplings until the sample was exhausted, between 92 to 114 ten times 
each. 
 
Table 3.3. Proportion of mixed species infections p resent in positives samples  







    
Single Species Infections 30 T.t 30 
    
T.t, T.b 6.7 
T.t, T.v 6.7 
Two Species Infection 30 
T.t, T.c 16.7 
    
T.t, T.b, T.c 20 
Three Species Infection 33 
T.t, T.b, T.v 6.7 
  T.t, Tc, T.v 6.7 
    
Four Species Infection 6.7 T.t, T.b, T.c, T.v 6.7 
The table above shows proportion of the positive samples found to be single, two or three 
species infections. Details of the specific species combinations found are also given on the 
right of the table. T.t, Trypanosoma theileri; T.b, Trypanosoma brucei; T.v, Trypanosoma 
vivax; T. c, Trypanosoma congolense. 
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Table 3.4. Results of Monte Carlo simulations showi ng the observed and expected 






N) 95% CI 
Tt, Tb 2 4.54 (2 ~ 8) 
Tt, Tc 5 6.50 (3 ~ 10) 
Tt,Tv 2 2.58 (0 ~ 5) 
Tb, Tc 0 0.56 (0 ~ 2) 
Tb, Tv 0 0.22 (0 ~ 1) 
Tc, Tv 0 0.32 (0 ~ 1) 
    
Tt, Tb, Tc 6 0.39 (1 ~ 6) 
Tt, Tb, Tv 2 1.36 (0 ~ 3) 
Tt, Tc, Tv 2 1.94 (0 ~ 4) 
Tb, Tc, Tv 0 0.17 (0 ~ 1) 
    
Tt, Tb, Tc, Tv 2 1.01 (0 ~ 3) 
    
Tt Only 9 8.66 (5 ~ 13) 
Tb Only 0 0.75 (0 ~ 2) 
Tc Only 0 1.10 (0 ~ 3) 
Tv Only 0 0.43 (0 ~ 2) 
    
Negative 5 10.12 (5 ~ 15) 
 
For each combination of species the table details the observed numbers of each particular 
species combination present The numbers expected if each species were distributed at 
random is shown for comparison The expected frequencies and their respective 95% 
confidence intervals were determined from 10,000 iterations of a Monte Carlo simulation. 
The observed and expected frequencies are for those combinations exactly, for instance the 










Figure 3.1. Three examples of the sample maps produ ced from the repeated PCR of 
blood samples stored on filter paper 
 
 
The figure shows three diagrammatic representations of the repeated PCR of blood samples 
from Zebu cattle. The large circles represent the area on the filter paper card where the 
blood sample was applied. Each small circle or shape represents a punch (or aliquot) taken 
for PCR analysis. The positions of each punch were recorded and the results for that PCR 
were related back to the position on the original sample Examples of a low (OJ20), medium 
(OJ25) and high (OJ18) infection intensity results are shown..  
Key; o, negative PCR result; ●, T. theileri; ▲, T.brucei; ■, T.congolense.  
3.4. Discussion 
Most field based studies of African trypanosomiasis approach the analysis of the 
samples in a similar way; a large number of samples are collected and subject to a 
single diagnostic test for presence or absence of a particular species of 
trypanosome for each sample (Connor & Halliwell, 1987; Waiswa & Katunguka-
Rwakishaya, 2004; Magona et al., 2005). From the resulting data prevalence for 
each species is then calculated the raw data may also be used for statistical 
analysis. 
In terms of detection of mixed infections, there are several inherent problems with 
this approach to large scale sampling. The use of genomic DNA extracted from 
blood samples makes study of mixed species infections difficult to interpret as the 
target DNA (often present in multiple copies throughout the genome) is free to 
disperse in the liquid media. Positive results by PCR may therefore result from 
target DNA representing less than a single trypanosome, this makes accurate 
interpretation of the proportions of species present difficult. In addition, extraction of 
genomic DNA from blood samples involves a complex processing protocol, in which 
a proportion of the DNA present in the sample may be lost or degraded. 
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An additional problem associated with conventional studies of this type is that 
individual species specific PCR reactions are utilised for each of the species of 
interest, this approach immediately excludes from the analysis any species not 
targeted by the specific PCR reaction being used, and may also give biased results 
if the sensitivities of each technique differ. The detection of Trypanosoma theileri in 
this study illustrates this point; conventional studies have excluded this prevalent 
trypanosome. 
It is clear from these results that PCR or microscopy, used in a conventional manner 
would have detected few if any of the mixed infections, as the number of 
trypanosomes in the 200µl blood samples was very low. This is not due to the 
sensitivity of the techniques as such, but due to the probabilistic effect of acquiring a 
trypanosome in the aliquot of blood taken for analysis when infection intensity is low. 
In contrast this study attempted a more ‘in depth’ look at the information contained in 
a smaller number of samples. In order to analyse a large amount of blood, up to 114 
PCR reactions were conducted on each blood sample, each single PCR reaction 
being capable of detecting and differentiating a range of trypanosome species (Cox 
et al., 2005). This approach combined with the application of the blood samples to 
Whatman FTA filter paper allowed a unique unbiased assessment of the ratios of 
different species present in mixed Trypanosoma species infections. This was 
possible because DNA from individual trypanosomes is captured in situ on the 
matrix of the filter paper and therefore the pattern of positive results obtained is 
representative of the distribution of parasites in the blood sample. This is evident 
from the maps of PCR results plotted for all samples; a selection of which are shown 
in Figure 3.1. The advantage of analysing blood samples from filter paper, apart 
from cost and simplicity, is that the results obtained are a more accurate 
representation of the natural parasite population present in the blood sample.  
Very little is known about the occurrence of mixed species trypanosome infections in 
African Zebu cattle, although mixed infections have been reported, they have been 
found to be present in only a low percentage of cattle (Connor & Halliwell, 1987; 
Kidanemariam et al., 2002; Magona et al., 2003). This study clearly shows that 
mixed species infections are present at low parasitaemia in most of the infected 
cattle. In fact mixed species infections were present in 21 of 35 samples (60%) this 
is much higher than has been noted before. Two, three and four species mixed 
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infections involving various combinations of species were all detected in this study 
and all involved T.theileri. 
Although the results obtained indicated that the frequency of the combinations of 
trypanosomes involved in mixed infections was no different to that which would be 
expected from a random association of species with respect to the measured 
prevalence, this by no means rules out the possibility that there is some element of 
competition or association between the species present, as only a relatively small 
number of samples were analysed.  
The high prevalence of T.theileri found in this study is in line with prevalence’s 
reported elsewhere. In this set of samples T.theileri appeared be the most dominant 
species. It is most interesting to note that all single infections were T.theileri, 
suggesting a reduction in the ability of other species to establish a single infection 
when T. theileri is present (Although not found to be significant in the Monte-Carlo 
analysis). Should some form of competition exist between the trypanosome species 
when infecting a common host, then T.theileri cannot be excluded from the 
epidemiology of what have been regarded as the more important African 
trypanosome species? It is at least a possibility that exclusion of this ‘dominant’ 
parasite from the cattle by blanket drug treatment regimes combined with reduction 
in the tabanid population, the main vector of this species (Rodrigues et al., 2003), 
could eventually lead to a much greater prevalence in the cattle of the other, 
pathogenic, tsetse transmitted species. 
None of the cattle examined in this study showed any clinical signs of 
trypanosomiasis when examined in the field by experienced veterinarians. The fact 
that almost all of the randomly chosen cattle samples examined were found to be 
positive for trypanosomes after repeated analysis is perhaps one of the most 
important findings of this study. The data suggests that the majority of infections are 
asymptomatic and that a high proportion of the animals act as parasite carriers. If 
this were true in the wider population, it would have important consequences for our 
understanding of the epidemiology of trypanosomiasis and how the disease may be 
diagnosed and controlled. This observation is particularly important for human 
sleeping sickness; the cumulative prevalence for T. brucei was 34.3%, this 
prevalence is much higher than is usually reported, given that it has been reported 
that Trypanosoma brucei rhodesiense, causing the acute form of human sleeping 
sickness, exists in T.brucei populations at a proportion of around 33% (Welburn & 
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Coleman, 2004), then many of these animals may be acting as carriers of the 
human infective sub species. 
The results presented here provide novel information on the presence of mixed 
infections and Trypanosoma theileri as well as showing that in this study group 
asymptomatic infection was present at a high prevalence. Whilst this extensive and 
in depth analysis of a few samples is not practical for widespread screening it has 
provided an insight that can form a basis for further investigations. The most 
important question raised in this work is how these results might apply to the wider 
population. Future work will focus on extending this study to determine if these 









Chapter 4: An empirical investigation into the 
occurrence of false negative results in populations  




One of the key results obtained from the repeat screening of the 35 samples shown 
in the previous chapter was that the cumulative prevalence appeared to increase 
with every repeat screening of the samples. This result may have very important 
implications for epidemiological studies and diagnosis of infection, the remaining 
work is devoted to investigating this phenomenon. 
Prevalence and incidence are perhaps two of the most basic epidemiological 
measures. Prevalence can be defined as “the amount of infection in a known 
population, at a designated time, without distinction between old and new cases”. 
Similarly, incidence is defined as “the expression of the number of new infections 
that occur in a known population over a period of time” (both definitions are adapted 
from Thrusfield, 1986). In practice, both measures are based on achieving accurate 
quantitative measurement of the numbers of infected and uninfected subjects. The 
implication of this is that for prevalence and incidence to be correct a high degree of 
confidence in the infected state or aetiological agent is important. In the case of the 
thirty-five samples examined in the previous chapter, diagnosed prevalence for all 
trypanosome species of 14.3% (8.5% for all species except T. theileri) was indicated 
from the first round of screening of these samples (one diagnostic test per sample). 
The mean diagnosed prevalence for all screenings was 9.7% whilst the cumulative 
diagnosed prevalence from over 100 screenings was much higher at 85.7% (60% 
for all species except T. theileri). If this type of situation is widespread in field based 
epidemiological studies, then underestimation of prevalence and incidence will also 
be widespread. 
Further problems are also evident from the examination of the sample maps, 
examples of which are presented in Figure 3.1. It is apparent that the diagnostic 
result obtained depends on which portion of the blood sample is selected for 
analysis. To be more specific, for the three infected samples shown, both the 
diagnosis as infected and the species of parasite diagnosed are all probabilistic in 
nature. This probabilistic diagnosis would appear to be dependent on the infection 
intensity of the parasite within the blood, in that there is a greater probability of 
obtaining a positive diagnostic result from the sample with the higher infection 
intensity. Although all the cattle from which these samples were taken were infected 
with trypanosomes, there are a large number of false negative results. It follows that 
prevalence obtained from a single screening may be completely representative of 
the population if infection intensities are generally very high, of may be a severe 
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underestimate of the population prevalence if infection intensities are generally very 
low in the population. Epidemiological screening methods, as currently applied, do 
not take a quantitative view of the parasite population and instead deal with infected 
hosts rather than parasite numbers. 
The probabilistic nature of diagnosing low intensity infections as positive leads to 
false negative results. The false negative results in turn lead to underestimation of 
the prevalence and incidence. In this work I have termed this effect as infection 
‘Intensity Related False Negatives’ (IRFN) to distinguish them from other types of 
false negative results that may occur for other reasons (failure or inhibition of the 
diagnostic technique) and the objective of the remaining chapters is to explore this 
phenomenon. 
Perhaps most important is the question of how widespread are the low infection 
intensities that are capable of producing the false negative results (sub-patent 
infections). If false negative results are frequently obtained from other sample sets 
then IRFN become more important. For example if IRFN is frequently found 
elsewhere in other sample sets, populations and for other pathogens then it is 
potentially of great importance. 
Although the cause of IRFN would, at first, appear to be infection intensity, it is 
important to establish if any other factors may have an caused the phenomenon, 
observed here; perhaps overdispersion of the parasites within the population, 
factors relating to the sensitivity of the diagnostic technique may also play a role. 
These key questions need to be investigated not only with samples stored on filter 
paper cards (as in this study), but in other sample media such as extracted DNA in 
solution. Underestimation of true prevalence is one obvious consequence of IRFN. 
However there may be other serious consequences? For example, how might IRFN 
effect different types of epidemiological study (cross sectional, longitudinal, 
comparisons between populations). A further important issue is the role of low 
intensity infection in transmission dynamics. Although IRFN may result in 
underestimation of prevalence, do animals with low intensity infections make a 
significant contribution to transmission?  
Widely used methods for screening populations by PCR are generally not 
quantitative and therefore view the epidemiology of the parasite from the standpoint 
of infected hosts. A further important question is how we might begin to deal with 
IRFN in a cost effective and practical way. Whilst IRFN would at first seem to 
present a difficult problem, it also presents an opportunity to move the focus of 
 
63 
epidemiological studies away from the dynamics of infected and uninfected hosts 
towards the dynamics of the parasite population. 
The work presented in the following chapter(s) attempts to address some of these 
questions by looking at how widespread the problem is, investigating the 
relationship between the different parameters involved, exploring the consequences 
of the phenomenon and attempting to develop some practical methods of dealing 
with the problem of IRFN. 
4.2. Materials and Methods 
4.2.1. Samples 
Samples of human blood known to be infected with T. brucei rhodesianse were 
obtained from the University of Salford, Centre for molecular Epidemiology. Samples 
were of whole blood stored on Whatman FTA cards obtained from Angola in 2000. 
Samples of bovine blood, other than those mentioned in the previous chapter, were 
chosen randomly from a large set of samples obtained from a longitudinal study 
carried out by the University of Edinburgh, Centre for Tropical Veterinary Medicine. 
The samples were of whole blood stored on Whatman FTA cards obtained from 
Sitengo, Uganda in 2002. 
Sample Preparation 
Sample preparation was as described in section 2.2.3 
4.2.2. Diagnostic techniques 
ITS - PCR 
The protocol and primer sequences are as described by Cox et al (2005) and in 
Section 2.2.4. 
Mammalian tubulin specific PCR 
For further details of this protocol see Section 2.2.4. 
Electrophoresis 
Electrophoresis is as described in Section 2.2.9. 
4.2.3. Calculated infection intensity 
The estimated infection intensity was calculated by counting the number of positive 
and negative results obtained for each sample and calculating the volume of blood 
analysed by the PCR assays given that a single 2mm punch taken from the card 
contained a single microlitre of blood. This calculation makes the assumption that at 
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low infection intensities (below 1000 parasites per millilitre) positive results generally 
represent the presence of a single trypanosome on the sampled 2mm disc. The 
accuracy of this method of assessing parasitaemia was tested using uninfected 
blood spiked with known numbers of trypanosomes (the positive control). 
4.2.4. Fitting negative binomial and Poisson distri butions to the data 
An empirical distribution (either Negative Binomial or Poisson) was selected with 
parameters that maximised the probability of obtaining the given data set, this was 
carried out using maximum likelihood methods. Tests of goodness of fit to this 
theoretical distribution were carried out using a Chi square test. Values of k, the 
dispersion parameter for the negative binomial distribution, were calculated first as 
an estimate using a corrected moment estimate (Elliot, 1977) and more accurately 
by maximum likelihood methods (Pacala & Dobson, 1988). 
4.2.5. Simulation: Screening of four populations 
In order to theoretically demonstrate the effects of screening samples from 
populations with different patterns of infection, four models were set up using the 
mathematical programming language of R version 1.8.1 (Ikaha & Gentleman, 1986). 
The sequence of the model is as follows: A vector containing 1x106 data points, 
representing a population of hosts is generated, each data point is assigned an 
infection intensity according to the distribution assumption of the simulation. A value 
of zero denotes an uninfected host. The distribution of infection intensities 
throughout the simulated population are assigned in one of two ways.  
Population infection patterns generated from a negative binomial distribution 
Firstly, the infection intensities are randomly chosen from a negative binomial 
distribution having the properties ‘mean intensity’ – denoting the mean infection 
intensity of the population (theoretically, the total number of parasites present in the 
population, divided by the number of hosts), and the dispersion factor ‘K’ – 
describing how the parasite population is distributed among the host population. The 
dispersion factor k is an inverse measure of over-dispersion, as k approaches a 
value of zero the population is said to be over-dispersed, where relatively few hosts 
harbour the majority of all parasites in a population. As K approaches infinity the 
population is said to be randomly distributed, in practice populations with values of k 
below eight are said to be over-dispersed (Elliot, 1977). The negative binomial 
distribution was chosen on the basis of an analysis which fitted a Poisson and 
negative binomial distribution to the data collected from field samples (See this 
chapter Figure 4.6 and Table 4.4). 
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Population infection patterns not conforming to a distribution. 
In this population the data points are allowed to take two values for infection 
intensity, zero for uninfected or an infection intensity of 10,000 (parasites per 
millilitre) for infected hosts. This represents a high infection intensity that will give 
fully repeatable results with the diagnostic test, for the purposes of the model the 
fact that each infected host possesses the same infection intensity is unimportant for 
high infection intensity values. The number of infected hosts within the population 
vector was assigned according to the desired population prevalence, in this case 
14.5%. 
Each model is independent of other models, once the population is generated the 
remaining calculations are the same in all cases. Once the population vectors have 
been constructed the population prevalence is calculated and stored in a data frame 
ready for output. 
Number of samples drawn for analysis 
A number of samples are drawn from the population vector for analysis to simulate 
the sampling of a host population in epidemiological studies. The number of 
samples drawn for analysis was calculated for a population survey or descriptive 
study using random (non-cluster) sampling. The expected frequency was 50% (as 
this is the ‘worst case’  level assumed in epidemiological studies which have no prior 
expectation of the likely prevalence) in a population of 1x106 individuals. A 95% 
confidence interval with a confidence level of 5% gave an estimated sample size of 
382. The calculation was performed after the method of Bristol (1989), the 
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n = Sample size 
Z = Z value (e.g. 1.96 for 95% confidence interval) 
p = Expected frequency 
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C = Confidence level (expressed  as a decimal e.g. 0.05  = +/- 5%) 
nc = Corrected sample size 
P = Population size 
 
The vector of infection intensities is then converted to the number of parasites per 
microlitre by dividing by 1000. This is because the values given to infected hosts 
within the population are in parasites per millilitre, the diagnostic technique modelled 
is assumed to be capable of detecting a single parasite in one microlitre of blood 
(one microlitre is a typical volume analysed in PCR assays). Hence dividing the 
infection intensity by 1000 gives the number of parasites per microlitre, the analysed 
volume. This value describes the mean number of parasites per analysed volume of 
sample. In practice parasites are not uniformly distributed in the blood or sample 
and so the number will be subject to stochastic variation. In this case the probability 
of obtaining any give count of the parasite can be modelled as a Poisson distribution 
with ‘mean per microlitre’ as the mean of a Poisson distribution for that blood 
sample. This allows for the probabilistic effects of obtaining a parasite in the 
analysed volume due to both the infection intensity and the random distribution of 
parasites throughout the sample. The number of parasites obtained in that 
diagnostic test is then determined from the Poisson distribution modelled for each 
sample. If the sample contains a count of greater than or equal to one parasite then 
that is determined as a positive diagnostic test. If no parasites are present in the 
analysed volume then that is determined as a negative result. Having determined 
the result of the diagnostic test (infected or uninfected) for each sample a diagnosed 
prevalence is then calculated and the data is then stored. 
Monte Carlo simulations 
Because the model is essentially stochastic in nature there will be variation in the 
results obtained for each iteration of the model. In order to allow for this variation, 
the model was repeated for many iterations (typically 1,000 or 10.000), the results of 
each iteration are then stored in an output data frame. After completion of the 
iterations, the mean and 95% confidence intervals of the population prevalence and 
diagnosed prevalence are calculated. 
4.3. Results 
A blood sample from a human patient known to be infected with Trypanosoma 
brucei gambiense was screened using a trypanosome specific PCR protocol 
targeting the small ribosomal subunit (ITS-PCR). The diagnostic test was repeated 
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six times on the same sample (Figure 4.1. (A)), three of the six samples were 
positive for Trypanosoma brucei the other three samples were false negatives. In 
order to determine if the lack of repeatability was due to inhibition of the PCR or 
deterioration of the sample, a PCR targeted to the host DNA (specifically 
mammalian tubulin) was used to repeat screen the same sample (Figure 4.1. (B)). In 
this case no false negative results were obtained indicating that the lack of 
repeatability observed in the first screening was not due to sample degradation or 
inhibition of the PCR reaction. 
A sample of blood from an African zebu cow known to be infected with 
Trypanosoma brucei was repeat screened thirty three times using ITS-PCR (Figure 
4.2.). In this case only thirteen of the thirty three (39.4%) of the samples were 
positive for trypanosomes. Twelve of the samples were positive for T. brucei and 
one was positive Trypanosoma congolense. These result showed that 20 of the 
tests gave false negative results and for the positive results different species can be 
diagnosed in different assays. 
False negative results have been found to occur in other parasite species (Data and 
pictures courtesy of Olga Tosas-Auguet, University of Edinburgh), during screening 
of a large number of samples of DNA (in solution) extracted from tick salivary glands 
for infection with Theileria parva the same intermittent positive results have been 
observed (Figure 4.3). To investigate the cause of the false negatives a dilution 
series was produced from a sample known to be positive for T. parva, each dilution 
was screened five times. The results showed that at high concentration all repeated 
tests are positive, whilst as the DNA becomes more diluted false negatives begin to 
occur. When there is less than one copy of the target gene per microlitre positive 
results are rarely obtained. 
The previous results indicated that the intermittent positive results could be due to 
low infection intensities. To examine the effect of a range of different infection 
intensities, a sample of uninfected bovine blood (U.K. origin) was spiked with known 
numbers of cultured Trypanosoma brucei. By diluting aliquots of this with further 
quantities of uninfected bovine blood a dilution series was constructed. Each dilution 
was screened eight times (Figure 4.4). At a dilution of 1:10-5 all samples were 
positive, indicating complete repeatability of the diagnostic test. Performing repeat 
diagnostic tests on the next dilution 1:10-6 demonstrated false negative results with 
only two of the eight samples. Repeat analysis of the 1:10-7 sample demonstrated 
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that repeatability had deteriorated further with only one sample (and one very weak 
sample) testing positive. 
Figure 4.1. False negative results obtained from a human blood sample 
parasitologically positive for T.b.gambiense  
  (a) 
 
 





The figure shows a repeated PCR screening of blood from a human patient known to be 
infected with T.brucei gambiense. There are a number of false negative results. Lanes 1, 2 & 
5 are negative, 3,4 & 6 are positive, 7 is a negative control, 8 is a positive control and M is a 
DNA size marker. (B) In order to confirm that the results are not related to PCR inhibition the 
same sample was also screened with a PCR specific for mammalian tubulin, all the results 
for this screening are positive. Lanes 1 – 6 are positive, lane 7 is a positive control, 8 & 9 are 
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Figure 4.2. False negative results in a sample of b ovine blood from a cow known to be 




The figure shows a repeated screening of the same blood sample taken from an African 
zebu cow. There are many false negative results and in some cases different species are 
detected in different PCR screenings. Lanes 1,2,6,7,9,17,36,37,38 are all positive for T. 
brucei, whilst lane 30 is positive for T. congolense. Lane 19 is a positive control, lane 18 is a 





















The figure shows serial dilutions of genomic DNA from a T.parva stock. As the dilution of the 
DNA increases the number of positive results declines. The estimated number of copies of 
target sequences in the extracted DNA is shown. 
(Results courtesy of Olga Tosas-Auguet, University of Edinburgh) 




A quantity of cultured T.brucei brucei was diluted in cow blood and placed onto Whatman 
FTA cards. The results shown here show that as the dilution of the T.brucei brucei increases 





The false negative rate was further investigated exploring the data obtained from 
repeat screening of thirty five randomly chosen blood samples taken from African 
Zebu cattle of unknown infection status. Each sample was repeatedly screened until 
the sample was exhausted. The results of conducting 3621 PCR based diagnostic 
tests on the thirty five samples are shown in Table 4.1. The mean number of 
diagnostic tests performed per sample was 103, but the actual number was 
dependent on the volume of blood available. The IRFN rate ranged from 64 false 
negative results for every 100 tests, to as high as 98 IRFN results for every 100 
diagnostic tests, with a mean of 89 IRFN results per hundred tests. From the results 
of these screenings, estimated infection intensity was calculated for each sample 
(see materials and methods – ‘calculated infection intensity’), the results are shown 
in Table 4.2  
The prevalence at each round of screening of the thirty five samples was recorded. 
Table 4.3. shows the diagnosed prevalence at the first round and the cumulative 
prevalence after repeated screenings. The total prevalence for any trypanosome 
species obtained from the first round of screening each sample only once was 
14.3% (8.5% excluding T. theileri). Each sample was screened repeatedly, and the 
cumulative prevalence was recorded, after 92 rounds of screening the cumulative 
prevalence for any trypanosome species risen to 85.7%. The mean prevalence for 
any trypanosome species across all repeat screenings was 9.7%. Figure 4.5 shows 
the cumulative prevalence, mean prevalence and the cross sectional prevalence for 
any trypanosome species obtained at each round of screening. Up to fifteen rounds 
of screening the prevalence rises sharply and almost continuously with each 
additional screening. After fifteen rounds of screening the increase in cumulative 











Table 4.1. Results obtained from multiple PCR of th irty five blood samples from zebu 
cattle (Standardised to positives per 100 repeat tests) 
Sample 
No. T. theileri T. brucei T. congolense T.vivax All Not T. theileri  
       
OJ01 13 0 0 0 13 0 
OJ02 2 0 0 0 2 0 
OJ03 6 3 7 0 16 10 
OJ04 1 1 0 0 2 1 
OJ06 0 0 0 0 0 0 
OJ07 2 2 4 2 10 8 
OJ08 4 0 0 0 4 0 
OJ09 7 6 4 0 17 10 
OJ10 8 0 0 13 20 13 
OJ13 7 0 2 0 9 2 
OJ14 3 0 0 1 4 1 
OJ15 10 2 0 3 15 5 
OJ16 0 0 0 0 0 0 
OJ17 2 1 3 0 6 4 
OJ18 21 10 6 0 36 16 
OJ19 6 0 3 0 9 3 
OJ20 12 0 0 0 12 0 
OJ21 1 0 1 0 2 1 
OJ22 3 0 3 2 8 5 
OJ23 3 0 0 0 3 0 
OJ24 18 0 0 0 18 0 
OJ25 18 1 2 0 21 3 
OJ26 0 0 0 0 0 0 
OJ27 0 0 0 0 0 0 
OJ28 3 0 3 0 6 3 
OJ33 4 1 2 0 6 3 
OJ34 0 0 0 0 0 0 
OJ36 4 0 0 0 4 0 
OJ38 1 1 0 0 2 1 
OJ39 1 0 3 3 7 6 
OJ40 1 1 0 1 3 2 
OJ45 13 0 0 0 13 0 
OJ46 2 0 0 0 2 0 
OJ47 8 3 12 12 35 27 
OJ49 2 0 1 0 3 1 
       
Negative 
Control 0 0 0 0 0 0 
Positive 
Control 0 44 0 0 0 44 
 
The frequency of positive results for T.theileri, T. brucei, T. congolense, T. vivax all species 
and all species except T. theileri is shown in the table. The number of positive results has 
been standardised so that the number of positive results per 100 repeat tests is shown. This 





Table 4.2. Estimated infection intensity calculated  for each sample and each species 
Sample 
No. T.theileri T.brucei T.congolense T.vivax Not T.theileri All 
       
OJ01 130 0 0 0 0 130 
OJ02 19 0 0 0 0 19 
OJ03 59 30 69 0 99 158 
OJ04 10 10 0 0 10 20 
OJ06 0 0 0 0 0 0 
OJ07 20 20 41 20 82 102 
OJ08 39 0 0 0 0 39 
OJ09 73 64 36 0 100 173 
OJ10 77 0 0 125 125 202 
OJ13 69 0 20 0 20 89 
OJ14 27 0 0 9 9 36 
OJ15 98 20 0 29 49 147 
OJ16 0 0 0 0 0 0 
OJ17 19 9 28 0 38 57 
OJ18 206 98 59 0 157 363 
OJ19 57 0 29 0 29 86 
OJ20 118 0 0 0 0 118 
OJ21 10 0 10 0 10 20 
OJ22 29 0 29 20 49 78 
OJ23 29 0 0 0 0 29 
OJ24 183 0 0 0 0 183 
OJ25 182 10 20 0 30 212 
OJ26 0 0 0 0 0 0 
OJ27 0 0 0 0 0 0 
OJ28 30 0 30 0 30 59 
OJ33 37 9 19 0 28 65 
OJ34 0 0 0 0 0 0 
OJ36 40 0 0 0 0 40 
OJ38 10 10 0 0 10 20 
OJ39 10 0 29 29 59 69 
OJ40 10 10 0 10 19 29 
OJ45 132 0 0 0 0 132 
OJ46 20 0 0 0 0 20 
OJ47 80 27 124 124 274 354 
OJ49 20 0 10 0 10 29 
Negative 
control 
0 0 0 0 0 0 
Positive 
control 
0 437 0 0 437 437 
 
The figure shows the estimated infection intensity by species for each sample. The 
estimated intensity was calculated from the number of positive results obtained from each 
sample. The column entitled ‘Not T.theileri’ is the total estimated intensity of T.brucei, 
T.congolense and T.vivax. The final column shows the infection intensities for all 
trypanosomes combined. For details of how the parasitaemia was calculated refer to 







Table 4.3. Prevalence of trypanosome species in Afr ican zebu cattle at the first round 
of screening and after repeated screening 
Species 
Single PCR per 
Sample 
Prevalence (%) 
Multiple PCR per 
Sample 
Prevalence (%) 
T. theileri 5.7* 85.7 
T. brucei 2.9* 34.3 
T. congolense 5.7* 42.9 
T vivax 0* 22.9 
All trypanosomes 14.3* 85.71 
Mixed Infections 





Table showing (In the first column) the prevalence of the different species of trypanosomes 
and the prevalence of mixed infections detected in thirty-five blood samples collected from 
zebu cattle. In the second column the cumulative prevalence of the different species of 
trypanosomes and the prevalence of mixed infections is shown. These samples were subject 
to repeated PCR samplings until the sample was exhausted, between 92 to 110 times each. 
* denotes prevalence obtained from the first round of screening, all samples tested once. 
This would have been the prevalence assumed in an epidemiological study.The mean 















Figure 4.5. Cumulative prevalence achieved at each round of screening of blood 
samples taken from thirty five African zebu cattle 
 
The figure above shows the plot of the cumulative prevalence (red) for any species of 
trypanosome at each round of screening of the thirty five blood samples. As the number of 
screenings increases the cumulative prevalence also continues to increase as new samples 
are found positive. The cross sectional prevalence at each round of screening is also shown 
(black). The mean cross sectional prevalence across all screenings is shown by the dotted 









The frequency distributions of each species individually and all species are shown in 
Figure 4.6. The distributions for T.brucei, T.congolense, and T.vivax contained few 
positive results in comparison to the number of negative results. The frequency 
distribution of T.theileri alone and all species appeared to be consistent with what 
might be expected from an empirical distribution. 
The data obtained from analysis of the thirty five blood samples were fitted to either 
a Poisson or a negative binomial model in order to determine which, if any, empirical 
distribution provided the best fit to the data. In addition, the variance to mean ratio 
and K were calculated as measures of over-dispersion. However, K was only 
calculated for those datasets that provided a good fit to the negative binomial 
distribution as it is only appropriate in those cases. Tests of goodness of fit were 
carried out using a Chi square test against an empirical distribution with parameters 
that maximise the probability of obtaining the given data set (determined using 
maximum likelihood methods) the results are shown in Table 4.4. No data set 
provided a fit to a Poisson distribution, indicating a significant departure from 
randomness. Only T.theileri and all species combined provided fits to a negative 
binomial distribution. The values of K for these samples showed a high level of over-
dispersion as in each case the value of K was below one. All the variance to mean 



















Figure 4.6. The frequency distributions of positive  results per 100 repeat screenings 




The x axis shows the number of positives per 100 repeat tests obtained from the samples (n 
= 35) the y axis shows the frequency of observations within given ranges of infection 
intensity. Observed values are shown by the black bars, whilst the values expected for a 
negative binomial distribution with mean value (P) and overdispersion (K) estimated by 







Table 4.4. Results obtained from fitting a negative  binomial distribution (NBD) and a 
Poisson distribution to the data obtained from the samples 
Species NBD Poisson K^ µ Mean/Var 
      
T.theileri -df -df 0.99 5.43 6.21 
T.brucei -df  -df 0.27 0.94 4.68 
T.congolense -df -df 0.35 1.66 4.90 
T.vivax -df  -df 0.11 1.11 9.23 
Not T.theileri 0.339 (0.913)  <0.001 (84.5) 0.39 3.71 10.60 
All 0.437 (1.654)  <0.001 (96.7) 0.91 9.14 10.34 
The values shown for the fit are the p values and Chi-square test value in brackets. P values 
of greater than 0.05 indicate no significant difference to the empirical distribution under 
comparison. Where the data was found to be well described by a NBD the value of ‘K^’ is 
shown (Dispersion parameter for the NBD) as calculated by maximum likelihood methods 
and corrected moment estimate in brackets. The mean to variance ratio is also shown for all 
data. (-df) indicates that there were not enough degrees of freedom left to perform the Chi-
Square test, more specifically to few bins with observed values of greater than or equal to 
five were obtained to make a valid statistical test . 
Simulation of the consequences of false negative re sults in comparison of 
four different populations 
The outputs from four models simulating diagnostic screening of samples randomly 
drawn from four populations with different patterns of infection are shown in Table 
4.5. The details of how the infection patterns of each population of one million hosts 
differs is also shown in Figure 4.7. In population (A) 14.5% of the population are 
infected and have very high infection intensities of greater than 104 parasites per 
millilitre of blood. In population (B) 28% of the population are infected with a range of 
different high, low and medium infection intensities. (C) 65.5% of the population are 
infected most of which have infection intensities below 103 parasites per millilitre of 
blood. Finally in population (E) the entire population is infected with very low level 
infection intensities less than 103 parasites per millilitre of blood. The results of 
Monte Carlo simulations of each of the models are shown in Table 4.5., despite the 
obvious differences in the population prevalence and patterns of infection of each 
simulated population, the mean diagnosed prevalence from a single screening of 
382 samples was around 14.5% in all cases. Clearly the levels of infection intensity 







Table 4.5. Characteristic parameters of differing p atterns of parasite infection in four 












14.5 3000 N/A1 14.58 11.26 / 18.12 
26.7 6000 0.027 14.5 11.52 / 17.55 
66 200 0.15 14.77 10.99 / 18.32 
100 150 8 14.69 10.72 / 18.20 
1 – This population was not modelled with a distribution. In this model 14.5% of the hosts were assigned infection  
intensities greater than 10,000 parasites per ml, whilst  the rest were uninfected. 
The diagnosed prevalence and associated 95% confidence intervals obtained from a Monte 
Carlo simulation are shown (1000 iterations). The model was designed to simulate screening 
382 samples from each of the populations with a diagnostic technique capable of detecting a 
single parasite per microlitre. Although the true population prevalence varies greatly the 
diagnosed prevalence for each population is remarkably similar. The mean diagnosed 


















Figure 4.7. Theoretical demonstration of how differ ing patterns of infection in four 
host populations can result in a similar diagnosed prevalence 
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Each histogram represents the pattern of parasite infection within each of four different host 
populations. The proportion of hosts is shown on the Y axis. The population has been 
divided into four categories on the X axis. Firstly, the proportion of uninfected hosts (no fill). 
The next category shows the proportion of hosts with infection intensities below 1,000 
parasites per millilitre and which will show a high false negative rate. The next bin shows 
infection intensities of between 1,000 to 10,000 parasites per millilitre, these hosts will exhibit 
a lower false negative rate with the diagnostic technique but may not present with overt 
clinical signs. The next category shows those hosts with the highest infection intensities 
(greater then 10,000 per millilitre) and correspond to the most clinically ill hosts which are 
likely to present with clinical signs and no false negative results. The infection intensities 
selected for these last two categories are arbitrary, and have been selected in order to 
demonstrate a point, and are not based on current knowledge. The true prevalence of 
infection in each population is shown above each histogram. Each of the four histograms 
represents data used for computer simulations of an epidemiological screening of a 
population of 1x106 hosts. 382 samples (calculated as an appropriate sample size) were 
drawn at random from each of the four populations and each sample was screened once 
with a (simulated) diagnostic technique capable of detecting a single parasite per microlitre, 
the probability of detection was directly related to the infection intensity of each host. The 
mean diagnosed prevalence achieved from the four simulations was as follows: (A) 14.58% 
(B) 14.5% (C) 14.77% (D) 14.69%. Further details of these results are given in Table 4.5. 
The inaccuracy of these results derives from the proportion of animals with low infection 






The work conducted in the previous chapter investigated the data obtained from 
repeated screening of thirty-five blood samples and showed a high proportion of 
mixed infections within those samples. However, there are additional aspects 
consequent from the results obtained from this repeat test study. It is apparent from 
these results that not all aliquots drawn from clearly infected blood samples provide 
positive diagnostic results (the existence of many false negative results). A second 
aspect is that the prevalence achieved from a single round of screening is very 
different from the cumulative prevalence achieved after multiple rounds of 
screening. These issues are clearly of great potential importance for epidemiological 
studies in that there is a clear underestimation of prevalence in this case. The work 
presented in this chapter was designed to investigate these aspects in greater 
detail, and in particular to assess the potential consequences and importance of this 
phenomenon. In order to achieve this it was necessary to determine if this effect 
occurred in other species and geographical areas or was restricted to only this 
sample set. Possible causes for the occurrence of false negative results in these 
samples were then investigated. A theoretical distribution was fitted to the infection 
intensity data in order to provide a means of modelling the problem, this allowed 
further investigation and assessment of the consequences of the phenomenon.  
Initial investigation indicated that the occurrence of false negatives was not 
restricted to the set of samples examined in the previous chapter. Repeated testing 
of a number of blood samples from patients diagnosed with the chronic form of 
sleeping sickness (Trypanosoma brucei gambiense) also showed false negative 
results (Figure 4.1.a). False negative results were also found in samples from other 
cattle known to be positive for Trypanosoma brucei brucei (Figure 4.2.) and has also 
been shown in other samples taken from cattle from different geographical regions 
which were infected with T.brucei brucei, T. congolense, T. vivax and T. theileri 
(data not shown). These results provide strong evidence that the phenomena is 
more widespread and is not restricted to the thirty five samples subject to repeat 
testing in the previous chapter. 
It was therefore postulated that the effect could either be due to inhibition of the 
PCR technique by elements within the blood sample or by the low intensity of the 
parasites within the blood. The T. brucei gambiense infected human blood samples 
which had previously been repeat tested were subject to a further repeat screening 
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with a PCR protocol targeted to mammalian tubulin genes. As the target of this PCR 
was present in the white blood cells of the patient, repeated testing of the samples 
should not produce false negative results unless the PCR reaction was under 
inhibition. The samples were tested six times each and all results were positive 
(Figure 5.3.1.b.), this indicated that the false negative results are unlikely to have 
been related to the inhibition of PCR by elements within the blood or by excess DNA 
present in the sample.  
To determine if low infection intensity could be the cause of the intermittent nature of 
positive results a sample of uninfected bovine blood was spiked with a known 
concentration of cultured trypanosomes, the spiked blood was then used to produce 
a dilution series which was subject to the same repeat testing as the field samples. 
At a dilution of 1:105 all repeated tests were positive, at a further dilution of 1:106 
three false negative results occurred. At a dilution of 1:107 seven false negative 
results were obtained from eight repeated diagnostic tests (Figure 4.4.). These 
findings are augmented by other work which showed that dilution of a known 
concentration of DNA extracted from tick salivary glands infected with Theileria 
parva (the causative organism of East Coast Fever in Cattle) produced the same 
effect when aliquots from a dilution series were examined (Figure 4.3. [results 
courtesy of Dr Olga Tosas-Auguet, University of Edinburgh]). Such false negative 
results have also occurred in field samples of genomic DNA extracted from the 
blood cattle infected with Theileria parva (personal communication; Dr Olga Tosas-
Auguet, University of Edinburgh). This latter work was also important in that it 
provided evidence that IRFN results could also be obtained from extracted genomic 
DNA in liquid form in addition to blood applied to filter paper.  
These results provide very strong evidence that the occurrence of false negative 
results is related to the infection intensity of the parasites. Hence if the diagnostic 
target is not present in the aliquot drawn from the sample then the test will be 
negative despite the fact that the host may be infected with the diagnostic target (in 
this case the parasite). A similar situation occurs with the use of microscopy in that 
the parasite will not always be present in every field of view examined, and even 
examination of 200 fields does not definitively denote an uninfected host.  
For the repeated testing of the dilution series of the spiked blood sample (Figure 
4.4.) the number of positive and negative repeat tests obtained from each dilution 
was approximately consistent with the number of positives that would be expected 
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to be obtained from the concentration of parasites per millilitre for each dilution in 
the series. The initial concentration of trypanosomes in the spiked blood sample was 
measured at 1.0 x 109 trypanosomes per millilitre, when this sample was diluted by 
1:105 the resultant infection intensity in the sample would be expected to be 104 
parasites per millilitre. This infection intensity would rarely be expected to give false 
negative results as the infection intensity is high, and this proved to be the case. A 
further ten-fold dilution would give an intensity of 103 parasites per millilitre, enough 
give a moderate number of false negative results. The final ten-fold dilution resulted 
in a parasite intensity of 102 parasites per millilitre, which would be expected to 
produce many false negative results; again the results obtained were consistent with 
one positive from eight repeated tests. During the more extensive repeated 
screening of the 35 samples and controls shown in the previous chapter a control 
sample with estimated infection intensity after serial dilution of 508 parasites per 
millilitre was also subject to the same repeat screening. This sample gave 44 
positive results from 100 repeated tests. With the assumption that when the positive 
results are widely spaced on the filter paper containing the blood sample (infection 
intensities are low) that one positive result generally equates to the presence of a 
single parasite in the microlitre of blood taken for that particular test, the estimated 
parasitaemia from the number of positives obtained would work out at approximately 
437 parasites per millilitre. This estimated intensity is remarkably close to the 
measured value. It is evident therefore that the number of positive results obtained 
from repeated screening has an approximate relationship to the infection intensity in 
the blood sample. This is provided that the parasites are randomly distributed in the 
blood and that the spatial distribution of the parasites is preserved when the blood is 
applied to the filter paper.  
During screening and mapping of the thirty five blood samples it was evident that the 
mean prevalence from repeated screening of the samples (9% for all trypanosome 
species) was very different to the cumulative prevalence obtained after more than 
100 repeated tests (85.71% for all trypanosome species) see Table 4.3. The 
cumulative prevalence of trypanosomes increased with the number of repeated 
tests. The cumulative prevalence at each round of screening is shown in Figure 4.5., 
initially the increase in cumulative prevalence was rapid, although after 
approximately 20 repeated tests the increase after each round was considerably 
less. Since the prevalence of many epidemiological studies is determined from a 
single PCR test of each sample, or screening of 200 fields by microscopy, the 
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findings presented here raise important questions for the use of prevalence as an 
epidemiological measure; in that, in such cases as described here it is not clear 
what the prevalence of infection obtained from a single screening of samples 
actually represents. Additionally, it is evident that for populations with low intensity 
infections the samples detected as positive in the first round of screening were not 
necessarily those detected as positive in the second round of screening, as is 
evidenced by the increasing cumulative prevalence. This too has important 
implications for the diagnosis of infected hosts and measurement of agreement 
between diagnostic techniques. 
Using the infection intensity estimated from the number of positive results obtained 
from each of the thirty-five samples, the frequency distributions for different ranges 
of infection intensity were plotted for each species separately and for all species 
combined (Figure 4.6.). The shape of these distributions and the degree of 
overdispersion indicated that the distribution of infection intensities in the samples 
may be modelled with a negative binomial distribution. In order to test this 
hypothesis the data was fitted to both a negative binomial distribution and a Poisson 
distribution, and the goodness of fit was tested (Table 4.4.). The data was tested for 
each species individually, for all species and for all species except T. theileri. None 
of the data was found to provide an acceptable fit with a Poisson distribution, 
whereas the data for T. theileri, the most prevalent trypanosome, and for all species 
combined was not found to be significantly different from that of a negative binomial 
distribution. For the other species it was not possible to conduct a ‘goodness of fit’ 
test as the low number of positives for these species failed to provide observations 
of greater than five in many of the bins in the frequency distribution. The Chi square 
test requires at least five observations to be valid. Importantly, this does not mean 
that the data did not fit a negative binomial distribution. These findings are useful to 
the wider objectives of this and subsequent work, in that it provides an important, if 
somewhat tentative, model for the distribution of infection intensities within the host 
population. This model can be used to investigate the theoretical effects and 
importance of IRFN results.  
In order to demonstrate the possible consequences of IRFN results the NBD was 
then used in simulations of sample screening using conventional methods (a single 
screening to obtain prevalence). Exploration of the phenomenon in this way 
revealed a further consequence of infection IRFN. A simulation was constructed to 
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model the conventional screening of four populations with very different patterns of 
distribution of infection intensities and population prevalence (Figure 4.7 and Table 
4.5.). The results obtained from the simulation showed that even though the ‘true’ 
population prevalence varied between the four populations (from 14.5% to 100%,), 
the mean diagnosed prevalence (from 1,000 iterations of the model) from a single 
screening of samples drawn from each population was around 14.6% in all four 
cases. In the first case (population A) 75 of the 500 hosts sampled were infected 
with intensities of greater than 103 parasites per millilitre. At this intensity level 
repeated diagnostic testing of samples produced no false negatives, and all of the 
infected hosts were diagnosed as positive with a single testing of the samples. This 
situation equates to a conventional understanding of how prevalence is produced in 
epidemiological studies, the diagnosed prevalence accurately represents the 
population prevalence. In population B the infection intensities were distributed 
according to a negative binomial distribution with a mean infection intensity of 6000 
parasites per millilitre and very high overdispersion (K = 0.027). The population 
prevalence was 26.6%, yet because a number of the hosts in the population present 
with low infection intensities which are only stochastically detectable, some of the 
infected hosts in the sample were diagnosed with false negative results, this leads to 
an underestimation of the ‘true’ population prevalence, as a result the diagnosed 
mean prevalence was 14.5%. For population C, the infection intensities are again 
distributed according to a negative binomial distribution with a mean infection 
intensity of 200 parasites per millilitre and overdispersion of K = 0.15, this population 
would approximate that found in the thirty five samples which were subject to 
repeated PCR analysis in this study. Here the population prevalence was 66%, yet 
because many of the hosts presented with low intensity infections, which are again 
only detectable on a stochastic basis, many of the infections were falsely diagnosed 
as negative. The resulting diagnosed mean prevalence was 14.9%. In the final 
population all of the hosts are infected with very low level infections. There is no 
overdispersion in the data and the distribution approximates that of a Poisson. In 
spite of 100% true prevalence in the population the single screening produced a 
mean diagnosed prevalence of 14.97%. Clearly, on the basis of diagnosed 
prevalence from a single screening of these samples, there is no difference between 
the four populations, all the four cases produced a diagnosed prevalence of infection 
of around 14.6%. This is clearly not the case despite the large sample size used (n 
= 500), it is difficult to imagine four more different populations. Furthermore, this 
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point does not depend upon the aggregation pattern of parasites within the host 
population fitting that of a negative binomial distribution, whilst another population 
approximated a Poisson distribution. Standard epidemiological methodology is 
clearly lacking in three of these cases, statistical methodologies would also be found 
to be in error in the latter three populations. Methods for calculating sample size, 
power, confidence intervals and agreement between different diagnostic techniques 
would all give highly misleading results in three of the four cases. Although the 
population infection patterns were chosen in this case for demonstration of the point, 
the question arises as to how plausible are these types of infection patterns? 
It can be argued that all of these types of infection patterns are likely to exist. In 
situations of acute infection with a virulent pathogen and little resistance in the host 
population a number of animals may present with very high infection intensities, 
approximating population A. In chronic disease with a high level of resistance in the 
population infections may be widespread but well controlled in the population, this 
‘endemic’ situation may equate to that of population D. Clearly all degrees are 
possible within these two extremes making the likelihood of these patterns of 
distribution being present in field situations very high. Furthermore, it is likely that 
this is applicable to a wide range of pathogens. Additionally, it is evident that 
information regarding the patterns of distribution of parasites within the hosts and 
samples are in highly informative with regard to the epidemiology of the parasite in 
question. 
The conventional approach of obtaining a simple prevalence from a single screening 
of the samples does not discriminate among these patterns of infection within the 
host population and can lead to serious misinterpretation of the situation. A revised 
method is required to determine both if a conventional approach is applicable, and 
to provide information on the distribution of parasites within hosts. An approach that 
only determines infection or no infection can be highly misleading, a quantitative 
assessment of infection in each infected host / sample must be included in any 
future approaches designed to account for this problem. Additionally, the 
applicability of statistical and epidemiological methods such as the calculation of 
confidence intervals, sample size and power calculations, methods of statistical 







Chapter 5: An exploration into the effect of differ ent 








Work in the previous chapter highlighted a number of important problems related to 
the epidemiological screening of blood samples for trypanosomiasis. Under certain 
conditions positive results from a diagnostic test are not repeatable, and this leads 
to a serious underestimation of the population prevalence. Furthermore, use of a 
simulation indicated that it is possible for populations with markedly different true 
prevalence and patterns of infection to have the same diagnosed prevalence. For 
epidemiological studies, the object of screening samples for the presence of a 
particular haemoparasite is to estimate the prevalence of infection within a 
population of interest. The presence of sub-patent infections within these 
populations can lead to serious misinterpretation of the prevalence, incidence and 
therefore the epidemiology. 
In order to investigate this phenomenon further, it is necessary to understand the 
relationship between each of the parameters which may influence the measurement 
of prevalence. There are clearly five parameters directly related to the infection of 
haemoparasites within a population. Definitions of each of the parameters are given 
after the definitions on page xiii 
As can be seen from the previous chapter, initial data from repeated screening of 
thirty-five blood samples suggested that a negative binomial distribution would best 
describe the distribution of parasites within the host population. For a negative 
binomial distribution, which has been used frequently to describe the distribution of 
parasites in their hosts (Snow & Michael, 2002, Guyatt et al, 1990, Eppert et al, 
2002, Theis & Schwab, 1992, Sitja-Bobadilla et al, 2005, Flach et al, 1993, Pecora 
et al, 1980), the defining parameters are the mean and the dispersion parameter ‘K’. 
The mean in this case is taken as the mean infection intensity within the population. 
If the infection intensity in the host is responsible for the occurrence of false negative 
results it is evident that there are two aspects to this phenomenon, firstly whether 
the parasite is at such allow intensity it cannot be present in every aliquot of sample 
drawn for diagnostic screening. If this were the only factor then once the parasite 
reached an infection intensity of one per aliquot, then false negatives would cease to 
occur. However, this assumes that the parasite is uniformly distributed in the 
sample. It is important to note that the parasite will be randomly distributed in the 
host and because of this non-uniform distribution false negatives will still occur at 
infection intensities well above the theoretical threshold of one parasite per 
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diagnostic aliquot. Such a random distribution of parasite counts per blood volume 
can be modelled with a Poisson distribution. It is therefore important to understand 
at what infection intensity results in individual hosts become consistently repeatable, 
and more specifically to describe the relationship between the infection intensity in a 
single host and the occurrence of false negatives [= 1 – repeatability of positive 
result]). Secondly, it is also important to understand that assuming the parasite is 
distributed according to a negative binomial distribution at what mean infection 
intensity in the population positive diagnostic results become consistently repeatable 
across the population and therefore diagnosed prevalence is equivalent to the 
population prevalence. 
The aims of this chapter are therefore; To explore the relationships between mean 
infection intensity of the population, overdispersion, population prevalence and 
diagnosed prevalence. Additionally, for clarity, underestimation of true prevalence 
will also be included. To establish the relationship between infection intensity in a 
single host and the probability of false negative results. To establish the relationship 
between mean infection intensity of the population and the probability of false 
negative results. 
5.2. Materials and Methods 
5.2.1. Simulation to produce a data frame of values  for all five variables 
In order to explore the relationship between each of the five variables, a simple 
model was constructed to simulate a large population of hosts from which samples 
are drawn and analysed by a diagnostic technique. For particular levels of 
population prevalence, mean infection intensity and overdispersion, the simulation 
calculated the diagnosed prevalence and extent of underestimation of true 
prevalence obtained from screening a set of samples, given the errors associated 
with IRFN. The process is repeated in a Monte Carlo simulation up to 104 times for 
different levels of population prevalence, mean infection intensity and 
overdispersion. The levels of all parameters are stored in a database; this database 
is then used to examine the relationship between the variables. The basic structure 
of the simulation is described by the flowchart in Appendix figure 5.1. The simulation 
was written in the language of ‘R’ version 2.3.0 (Ikaha & Gentleman, 1999).The 
structure for this simple simulation forms the basis of all subsequent simulations 
presented in later chapters.  
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Initially, the simulation randomly selects the overdispersion (K) and mean intensity 
(P) parameters of a negative binomial distribution. Where overdispersion (K) is 
allowed to vary in the range of 0 ~ 0.4 and mean intensity (P) is allowed to vary in 
the range of 100 ~ 2000 parasites per millilitre. Next, a population of hosts / samples 
(N=105) is generated within the simulation. Each host /sample is assigned a value 
for infection intensity, where a value of zero denotes an uninfected host and a value 
of greater than zero denotes an infected host / sample. The infection intensities are 
assigned to the samples / hosts from a negative binomial distribution. Once infection 
intensity values have been assigned according to the distribution parameters 
selected for this iteration of the simulation, the population prevalence can be 
calculated. This is achieved by dividing the number of hosts / samples with an 
assigned infection intensity value of greater than zero by the total size of the 
population (N = 105). 
The infection intensity for each host, in number of parasites per millilitre, is then 
converted to the mean number of parasites per microlitre. For example, a host or 
sample with an infection intensity of 500 parasites per millilitre would have a mean 
count of parasites per microlitre (the analysed volume of sample) of 0.5 (infection 
intensity / 1000 = 0.5). 
To simulate the epidemiological screening of the population of hosts created in the 
simulation, a number of samples are randomly selected from the population (n = 382 
[see Section 4.2.5]). A set of diagnostic results are generated from each sample by 
determining the count of parasites that would be obtained in the analysed sample 
volume. This is determined from a Poisson distribution for each sample with the 
mean count of parasites per analysed volume previously calculated. A count of 
greater than or equal to one parasite in the analysed sample volume is recorded as 
a positive result. The diagnosed prevalence is then calculated by summing all the 
positive results and dividing by the total number of samples screened. The 
underestimation is then determined by simply taking the difference between the 
population prevalence and the diagnosed prevalence. The levels of overdispersion 
(K), Mean Intensity (P), population prevalence, diagnosed prevalence and 
underestimation are then stored. The entire process is then repeated 104 times 
storing the values of each of the variables for each iteration of the simulation. The 
stored results are then output in the form of a data frame (.csv file) which is used to 
analyse the relationship between the variables (see Figures 5.1. to 5.3). Repeating 
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the simulation in this way captures the variability inherent in what is, for samples 
with sub-patent infection intensities, a stochastic process 
5.2.2. Determination of the relationship between th e infection intensity in an 
individual host and the probability of false negati ve results 
In order to determine the relationship between infection intensity in a single host and 
the probability of obtaining false negative results from a single host, a simple 
simulation was constructed. The simulation assumed that the parasite was randomly 
distributed in the blood volume, so that counts of the parasite per blood volume were 
Poisson distributed.  The mean count of parasites per blood volume was used as 
the mean of the Poisson distribution and was calculated from the infection intensity 
at that iteration of the simulation. For example, for an infection intensity of 1,000 
parasites per millilitre a mean count per analysed volume of sample of one was 
used for the Poisson distribution. At this infection intensity there would on average 
be one parasite per each microlitre of blood. 
In the simulation the distribution of the parasite in 1 litre of blood was modelled for 
each microlitre of that volume using a Poisson distribution. The simulation then drew 
one sample from this volume and determined a diagnostic result as positive or 
negative dependent on if a parasite appeared in the sample of blood drawn. The 
simulation assumed that the diagnostic technique was capable of detecting a single 
parasite. This was repeated 100 times and the number of positive results counted to 
give the probability of obtaining repeated positive results from that positive sample. 
This value was then subtracted from one to give the probability of obtaining a false 
negative for this level of infection intensity. This process was then repeated a further 
hundred times for the same level of infection intensity. The mean probability and 
associated 95% confidence intervals were then calculated from this data. This 
process was then repeated for different infection intensities from 100 parasites per 
millilitre to 10,000 parasites per millilitre and the results recorded for each level. 
5.2.3. Determination of the relationship between th e mean infection intensity 
of a population and the probability of false negati ve results 
The code for the simulation is included in Appendix Figure 5.8. Briefly, for each level 
of mean infection intensity the simulation was conducted as follows: 
The level of overdispersion was randomly chosen from possible values between k = 
0.1 to 0.4. A population of hosts was generated where infection intensities were 
spread through the population according to a negative binomial distribution with 
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parameters k (overdispersion) and P (mean infection intensity). 382 samples were 
then drawn from the population to simulate random selection of samples from a 
population in an epidemiological study. A positive or negative screening result was 
then generated for each sample according to the infection intensity assigned to each 
sample. This process was repeated five times for each sample and the repeatability 
for each infected sample was then calculated by dividing the number of positive 
results obtained by the number of times the samples were screened. The mean 
probability of obtaining a false negative result for all infected samples was then 
calculated and the results stored. The process was then repeated for different levels 
of overdispersion 1000 times (for the same level of mean infection intensity of the 
population) in order to allow for variation in results due to stochastic effects, and the 
results stored. The mean and 95% confidence intervals were then calculated for the 
resulting data. This process was repeated for each level of mean infection intensity 
of the population. 
5.3. Results 
5.3.1. Exploration of the relationship between the five variables 
Using a simple simulation, a data frame containing 104 data points for values of 
overdispersion (K), mean infection intensity (P), population prevalence, diagnosed 
prevalence and underestimation of population prevalence was generated. An extract 
from the data frame is shown in Table 5.1. The relationship between the variables 
was then explored using a series of contour plots. For all the contour plots the 
variable of interest is shown in terms of the mean infection intensity of the population 
(P) and overdispersion of the population (K).  







 Intensity  
(P) 
Population 
Prevalence Diagnosed Prevalence Underestimation 
      
1 0.18 327 0.7375 0.206806283 0.530693717 
2 0.19 301 0.75 0.217277487 0.532722513 
3 0.35 338 0.9132 0.238219895 0.674980105 
4 0.3 150 0.8478 0.154450262 0.693349738 
5 0.22 1838 0.8652 0.426701571 0.438498429 
6 0.07 939 0.4851 0.17539267 0.30970733 
↓ ↓ ↓ ↓ ↓ ↓ 
9996 0.4 1644 0.963 0.557591623 0.405408377 
9997 0.02 1038 0.1921 0.081151832 0.110948168 
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These two variables are the parameters of the population of interest and have no 
relation to each other as each is chosen randomly in the simulations to give unique 
populations. The contour plot showing the relationship of population prevalence to 
the population parameters K and P is shown in Figure 5.1. There is a simple relation 
with overdispersion in that as overdispersion increases so does the population 
prevalence. After an overdispersion value if approximately K = 4, the population 
prevalence reached 100%. There appears to be no strong relationship between 
mean infection intensity (P) and population prevalence.  
The contour plot describing the relationship of diagnosed prevalence to 
overdispersion and mean infection intensity is shown in Figure 5.2. Here diagnosed 
prevalence seems to be equally influenced by both the population parameters, only 
reaching its highest values when mean infection intensity of the population is high 
and overdispersion is high. 
Figure 5.1. Contour plot giving an overview of the relationship between 
overdispersion (K), mean infection Intensity (P) an d population prevalence 
 
The contour plot shown above gives an overview of the relationship between overdispersion 
(K), the mean infection intensity of the population (P) in parasites per millilitre, and the 
population prevalence. Different levels of the population prevalence are shown as colour 
coded contours in the plot area. Details of the colour codings and bands used are shown in 




The contour plot describing the relationship between underestimation of prevalence 
and the population parameters K and P is shown in Figure 5.3. Here the relationship 
is more complex. Underestimation is lowest for the lowest values of overdispersion 
(K), initially as overdispersion increases so does the underestimation of prevalence. 
However above an overdispersion value of approximately 0.2, the degree of 
underestimation begins to be influenced by the mean infection intensity of the 
population with the lowest levels of underestimation being obtained only at the 
highest values for P. 
Figure 5.2. Contour plot giving an overview of the relationship between 
overdispersion (K), mean infection Intensity (P) an d diagnosed prevalence 
 
The contour plot shown above gives an overview of the relationship between overdispersion 
(K), the mean infection intensity of the population (P) in parasites per millilitre, and the 
diagnosed prevalence obtained from a single screening of 382 samples from the population. 
Different levels of the population prevalence are shown as colour coded contours in the plot 
area. Details of the colour codings and bands used are shown in the legend to the right of 
the plot. 
A more detailed representation of the relationship between population prevalence 
and overdispersion (K) can be shown with a two dimensional scatter plot (Figure 
5.4), as there is no relationship between either of these variables and mean infection 
intensity of the population. The data suggests that the relationship is that of an 




Figure 5.3. Contour plot giving an overview of the relationship between 
overdispersion (K), Mean infection Intensity (P) an d underestimation of prevalence  
 
The contour plot shown above gives an overview of the relationship between overdispersion 
(K), the mean infection intensity of the population (P) in parasites per millilitre, and the 
underestimation of prevalence obtained from a single screening of 382 samples from the 
population. Different levels of the population prevalence are shown as colour coded contours 
in the plot area. Details of the colour codings and bands used are shown in the legend to the 














Figure 5.4. Scatter-plot showing the relationship b etween overdispersion and 
population prevalence 
 
The scatter-plot shows a more detailed view of the relationship between the population 
prevalence and the level of overdispersion. A smoothed curve fitted to the data is shown in 
red. 
5.3.2. Determination of the relationship between th e infection intensity in an 
individual host and the probability of false negati ve results 
The results (Figure 5.5) show that the mean probability of obtaining a false negative 
result does not reach zero until the host infection intensity reaches 8,750 parasites 
per millilitre. Whilst at 800 parasites per millilitre the probability of obtaining a false 
negative result is 0.5. At the theoretical detection threshold of the technique, 1,000 
parasites per millilitre (a mean of one parasite for every microlitre of blood) false 









Figure 5.5. The relationship between infection Inte nsity in an individual host and the 
probability of obtaining a false negative diagnosti c result from a sample taken from 
the infected host 
 
 
The scatter plot shows the results of a simulation to determine the relationship between 
infection Intensity in a host and the probability of obtaining a false negative test result from a 
sample taken from a host with a given infection intensity . The mean probability (red line) and 
the associated 95% confidence intervals (black lines) are shown. The results shown apply to 
a diagnostic technique with an assay volume of 1 microlitre which is capable of detecting a 







Figure 5.6. The relationship between the mean infec tion intensity of the sampled 
population and probability of obtaining false negat ive diagnostic results 
 
The figure shows the results of a simulation to determine the mean probability of obtaining a 
false negative result from a population for different levels of mean infection intensity of the 
population. The simulation assumes the parasite distribution across the population conforms 
to a negative binomial. The Monte-Carlo simulations for each level of mean infection 
intensity were conducted for all possible levels of population prevalence. The associated 
95% confidence intervals are shown by the black lines. The results shown apply to a 
diagnostic technique with an assay volume of 1 microlitre which is capable of detecting a 
single parasite in that volume. 
5.3.3. Determination of the relationship between th e mean infection intensity 
of the population and the probability of false nega tive results 
For all levels of mean infection intensity of the population there exists a high level of 
occurrence of false negative results. Even at the highest level of mean infection 
intensity of the population (10,000 parasites per millilitre) false negative results still 
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occurred with a mean probability of 0.19. The greatest variability in the levels of 
false negative results occurred at mean infection intensities of less than 1,000 
parasites per millilitre. 
5.4. Discussion 
In the previous chapter repeated screening of a range of samples revealed a 
number of problems associated with current methods of screening for infection 
status. Many false negative results occurred, leading to a potentially large 
underestimation of population prevalence. In addition, it was shown that this 
phenomenon can lead to serious misinterpretation of the epidemiological state of a 
pathogen. Empirical results suggested that the underestimation was related to 
infection intensity (IRFN). In order to fully understand this problem it is necessary to 
understand the relationship between five parameters namely; population 
prevalence, mean infection intensity, overdispersion, diagnosed prevalence and 
underestimation of prevalence. A detailed study is clearly not possible with field 
samples as these population parameters are essentially unknown and work with 
artificially constructed samples could not provide the volume of information 
necessary to examine the relationship fully. Furthermore, experimental studies of 
this kind are time consuming and expensive. As the process of screening samples 
from an infected population with a diagnostic technique is essentially a simple one 
and because the lack of repeatability and underestimation of prevalence is related to 
a stochastic phenomenon, the problem lends itself well to mathematical modelling.  
In order to investigate the problem a simple computer simulation was constructed to 
randomly select different values for the population parameters and to calculate the 
diagnostic results of screening a number of samples from that population. The 
resulting data was then examined to determine the relationship between the 
variables and determine the nature of the causes of this lack of repeatability and 
underestimation of population prevalence.  
There is an important, but logical, correlation that should be understood before the 
data presented in this chapter can be interpreted correctly. As the population 
prevalence decreases, clearly the diagnosed prevalence will decrease and so the 
potential for underestimation of prevalence will also decrease. At very low 
population prevalence’s there is no potential for high levels of either diagnosed 
prevalence or underestimation of prevalence.  
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The strongest relationship is that between population prevalence and the 
overdispersion of the population (Figures 5.1 and 5.4). There is a clear correlation 
between the two parameters; this is perhaps not surprising as the overdispersion 
factor of the negative binomial distribution is heavily influenced by the frequency of 
zero values (uninfected hosts). In this case the overdispersion parameter (K) is 
related to the number of uninfected hosts within the population, which in turn 
determines the prevalence of infected cases. A more detailed representation of this 
potentially important relationship is shown in Figure 5.4. A trend line superimposed 
on the data suggests that an asymptotic exponential may describe the relationship. 
This may be useful, in that a good estimation of overdispersion (K) may allow 
calculation of the ‘true’ population prevalence with some accuracy, thereby 
circumventing the underestimation problem previously described. However, an 
estimation of overdispersion can only be made if the samples are assessed in a 
quantitative manner. 
Additionally the strong relationship between overdispersion and population 
prevalence explains how underestimation of prevalence and diagnosed prevalence 
are influenced by overdispersion (K). Clearly, as population prevalence and 
therefore overdispersion decrease so does the potential for underestimation of 
prevalence. This shows that overdispersion limits the underestimation but is not the 
direct cause of that underestimation, the cause of underestimation must therefore be 
the mean infection intensity of the population (P). 
It is interesting to note that for the ranges of population parameters and distribution 
assumptions investigated in this model there is clearly always an underestimation of 
the true prevalence, except in some cases where the population prevalence is close 
to zero (See Figure 5.3). 
Probability of obtaining false negative results fro m an individual host 
Assuming a uniform distribution of parasites in the blood volume would give 
consistently repeatable positive results at an infection intensity of 1,000 parasites 
per millilitre (assuming the diagnostic technique is capable of detecting a single 
parasite and assays one microlitre of blood). However, the parasites will not be 
uniformly distributed; the distribution is more likely to be random (Poisson) in nature. 
Modelling a Poisson distribution of the counts of parasites within each microlitre 
volume of the blood showed that the probability of obtaining false negative results 
did not reach zero until the parasite was present with an infection intensity of 8,750 
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parasites per millilitre. This is a surprisingly high level of infection intensity and it 
quite probable that the host would be seriously affected if it were able to sustain this 
high intensity of infection. At 1,000 parasites per millilitre the probability of obtaining 
false negative results was 0.4.  These results show that the occurrence of false 
negative results is likely to be present in cases were the parasite is present at 
intensities below 5,500 parasites per millilitre. If the parasites are overdispersed in 
the blood volume then the frequency of false negative results is likely to increase still 
further. 
Determination of the relationship between the mean infection intensity of the 
population and the probability of false negative re sults 
Since the underestimation of prevalence when screening samples is related to the 
frequency of false negative results and therefore the infection intensity, then a 
measure of the probability of obtaining false negative results becomes an important 
index of the potential for underestimation of prevalence in a sampled population. 
The relationship described in Figure 5.6 is both interesting and important. It is 
important to note that the frequency of occurrence of false negative results at mean 
population infection intensities of 10,000 parasites per millilitre still remains relatively 
high (P = 0.19), implying that even at this level of mean infection intensity the 
population prevalence will still be underestimated. Extrapolation of the relationship 
beyond infection intensities of this level shows that complete repeatability is never 
likely to be reached and it is doubtful that hosts could survive for any length of time 
with infection intensities of above 10,000 parasites per millilitre. These results 
assume that the parasite is distributed throughout the population according to a 
negative binomial distribution, and some evidence has been presented for this (see 
Section 4.3.). However, not all infected hosts within the population will have high 
infection intensities and therefore some hosts will present with low levels of infection 
and some with high as a result of variations in susceptibility, time since infection, 
age, co-infections and previous exposure. Even if the NBD were not an appropriate 
description of the distribution of infection intensities within the host population, these 








Chapter 6: Methods for epidemiological screening 




6.1. Introduction  
The work presented to this point has established that for populations where infection 
with haemoparasites is widespread and present at low intensities, the prevalence 
obtained from a single screening of each sample can seriously underestimate 
population prevalence. The cause of this underestimation in prevalence has been 
shown to be due to the levels of infection intensity present in the population and 
hence the phenomenon has been termed ‘Intensity Related False Negatives’ 
(IRFN). Furthermore, a single diagnostic test per sample approach to screening is 
not capable of differentiating between populations with ‘sub-patent’ infections (which 
produce an underestimation of the true prevalence) and populations with patent 
infections (where diagnosed prevalence is representative of population prevalence).  
Having explored the consequences and importance of the IRFN effect, it is 
necessary to develop tools which can help to overcome the problems previously 
described. Any techniques which are aimed at overcoming these problems should in 
the first instance be able to differentiate when the IRFN effect is occurring and when 
it is not occurring and be applicable in both instances. Secondly, it is evident that 
methods aimed at dealing with this problem should take a quantitative or at least a 
semi-quantitative approach to analysing the samples. The methodology should not 
only determine the infection status of the host but give some indication of the 
intensity of infection within the host. This is an essential prerequisite for any method 
attempting to deal with IRFN.  
An obvious method for quantitatively assessing the level of infection intensity within 
each host would be to process the samples using real time PCR (RT-PCR). Whilst 
RT-PCR can provide a quantitative evaluation for samples with complete 
repeatability, i.e. patent infections, the technique is not useful for quantifying for sub-
patent infections of the type that produce the IRFN effect. This is because the basis 
of RT-PCR is the polymerase chain reaction, it therefore is affected by IRFN in the 
same way as other diagnostic screening techniques, some alternate approach is 
required. A semi-quantitative measure of infection intensity can be obtained by 
assessing the degree of repeatability of results from each sample. For example a 
sample screened five times and found positive three times would have a 
repeatability value of 0.6 (3 divided by 5). 
For repeat testing of samples the number of samples tested (n) by the number of 
repeat tests on each sample (r) can be regarded as a sampling strategy (n x r). In 
order to develop methods that use repeat testing of samples, it is necessary to 
determine the relative importance of number of samples analysed (n) and the 
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number of repeat tests per sample (r), the relative efficiency of each sampling 
strategy should be assessed. 
Routine epidemiological calculations such as those for sample size and power and 
for determination of confidence intervals are not applicable where IRFN is present. 
Therefore, new methods of calculating these important epidemiological parameters 
for studies based on the repeatability of the samples should be developed. 
The objectives of this chapter are therefore to (i) Determine the relative accuracy of 
different sampling strategies (e.g. number of samples and number of repeat tests on 
each sample) in estimating the population overdispersion (K) and population mean 
infection intensity (P). (ii) To assess the relative performance of different approaches 
(combinations of statistical and sampling methodologies) in detecting significant 
difference between populations. (iii) To develop a method for estimating the true 
population prevalence in populations with sub-patent infection intensities. 
6.2. Materials and Methods – A general overview 
The simulations used in this chapter are all similar, with only minor differences 
depending on the purpose of the analysis. The basis of the code for all simulations 
is shown in Figure Appendix 6.4. Simulations were written in the mathematical 
programming language of ‘R Version 2.3.0. Each parameter in the simulations has 
been given a symbol. The key to the symbols is given below (Table 6.1). More 
detailed methods for specific simulations are described separately in each results 
section of this chapter. Each simulation is described with its own flowchart when 
necessary (See Appendix). 
6.3. Specific Methods & Results 
6.3.1. Assessment of the accuracy of different samp ling strategies in 
estimating overdispersion (K) and mean infection in tensity (P) of the 
population 
Description of ‘Simulation 1’  
The objective of this simulation was to determine which sampling strategy (n 
samples by r repeats) most accurately estimates the overdispersion (K) and mean 
infection intensity (P) of the population. The error of the estimates for each sampling 
strategy is calculated as Ka=K-Ke for overdispersion, and Pa=P-Pe for the mean 
infection intensity. 
The uncertain variables in this simulation were the mean infection intensity of the 
population (P) the overdispersion (K) of the population and the screening strategy (n 
x r). The simulation was repeated 1.0 x 105 times to produce a data frame of 
estimate errors for different sampling strategies, different population mean infection 
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intensities and overdispersion values. An extract from the data frame is shown in 
Table 6.2. 
Table 6.1. Key to the parameters used in the simula tions 
Variables  
Ii Infection intensity of the i
th sample (i.e. parasites per millilitre) 
ρi Probability of determining the i
th sample as positive 
ke Estimate of overdispersion (K) 
Pe Estimate of mean infection intensity (P) 
ka Accuracy of estimate of overdispersion (K) 
Pa Accuracy of estimate of mean infection intensity (P) 
r Number of repeated screens on each sample 
Θr Test result of screening the r
th repeat of sample i 
Cu Upper 95% Confidence Interval 
Cl Lower 95% Confidence interval 
Ф Accuracy of calculated confidence intervals 
ωp Population prevalence 
ωe Estimated prevalence 
ωk Estimated prevalence based on assessment of overdispersion 
ωs Standard estimate of prevalence 
ωc Cumulative estimate of prevalence 
Randomly chosen parameters 
P Mean infection intensity of the Negative Binomial Distribution. 
Chosen from the range P = 100 to 1000 parasites per millilitre 
K Overdispersion of the Negative Binomial Distribution 
Chosen from the range K = 0.1 to 0.4 
n Number of samples to screen 
Chosen from n = 30 to 100 
Constants  
N Total population size = 1.0 x 105 samples 











Table 6.2. Extract from the dataset obtained from ‘ Simulation 1 ’ to determine the 
accuracy of estimates of overdispersion and mean in fection intensity of the 
population for different sampling strategies 
   Population Values Estimates 
Iteration Population Prevalence Repetitions Infection Intensity (P) 
Overdispersion 
(K) ke Pe 
       
1 0.60 30 410 0.11 0.06 1015 
2 0.66 46 1000 0.11 0.19 2467 
3 0.64 32 200 0.14 0.15 485 
4 0.84 35 930 0.22 0.27 2256 
5 0.60 74 1000 0.10 0.07 2422 
6 0.59 32 400 0.11 0.14 966 
7 0.61 36 940 0.10 0.19 2265 
↓ ↓ ↓ ↓ ↓ ↓ ↓ 
9,994 0.72 50 770 0.15 0.20 1832 
9,995 0.26 33 750 0.05 0.10 775 
9,996 0.59 33 500 0.10 0.182 1176 
9,997 0.67 32 680 0.12 0.15 1595 
9,998 0.74 43 880 0.15 0.20 2052 
9,999 0.65 61 420 0.12 0.17 971 
10,000 0.74 33 150 0.20 0.52 346 
 
The construction of the model is shown in the form of a flowchart in Figure Appendix 
6.5. The simulation first determines the parameters of a negative binomial 
distribution (NBD) that describes the distribution of infection intensities within the 
population. The values of mean infection intensity (P) and overdispersion are 
chosen randomly from a vector of possible values (for P = 100 to 1000 parasites per 
millilitre and K = from 0.1 to 0.4). The maximum value of 0.4 for overdispersion was 
chosen as this gives a population prevalence of 100% [see Section 6.3.3.]. A 
population of 1.0 x 105 samples is then generated, each with an infection intensity 
value (Ii). When Ii = 0 this denotes an uninfected individual or sample. The 
probability of obtaining a positive diagnostic result from each sample in the 
population is as described for previous simulations (See Section 4.2.5). 
The simulation then determines the sampling strategy. All sampling strategies (n x r) 
use a maximum of 300 total screenings (diagnostic tests). This figure was chosen 
for reasons of practicality, economy and convenience in conducting the required 
number of diagnostic tests. The total number of samples to be screened (n) is 
chosen randomly from a vector of values (from n = 30 to 100). The number of repeat 
screenings is then determined by dividing the total number of screenings allowed 
(300) by the number of samples to be screened and rounding to the nearest integer. 
The samples for screening (n) are then randomly selected from the population and a 
positive or negative screening result (θi) is generated according to the probability of 
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finding each sample positive. This process is then repeated for the number of times 
the samples are to be repeat screened (r). The estimates of overdispersion (ke) and 
mean infection intensity (Pe) are then calculated and the accuracy of each estimate 
determined by comparison with the corresponding population values. The process is 
then repeated for 1.0 x 105 iterations to obtain results across the range of the 
uncertain variables. The data obtained from ‘Simulation 1’ is then output in the form 
of a data frame which can be used to determine the distribution of errors for each 
sampling strategy, as shown in Table 6.2. 
The data created from ‘Simulation 1’ is shown in the form of double conditioning 
plots in Figures 6.1a and 6.1b. The distribution of the data across the lattice of 
conditioning plots consistently shows a decreasing level of error toward sampling 
strategies that analyse greater numbers of samples with fewer repeat samplings of 
the same sample. The most accurate strategy of those tested would appear to be 
the maximum number of samples tested (n = 100) with three repeats for each 
sample (r = 3), as this produces the lowest and least dispersed errors in the 
estimated parameters. For estimations of overdispersion (Figure 6.1a) estimates 
always tend to overestimate the population value and the dispersion of the errors 
increases as the mean infection intensity of the population increases. As the mean 
infection intensity of the population decreases the error of the estimates become 
less. Estimation of mean infection intensity (Figure 6.1b) always tends to 
underestimate the population mean infection intensity. Whilst the underestimate is 
reduces the dispersion of estimates increases as the mean infection intensity of the 












Figure 6.1a. Conditioning plot showing the accuracy  of the estimate of overdispersion 
for different sampling strategies 
 
The co-plot shows the range of results obtained from ‘Simulation 1’ designed to determine 
the accuracy of different sampling strategies using a fixed number of tests. The sampling 
strategies comprised different combinations of number of samples tested by number of 
repeat tests on each sample (n x r). The x axis shows the number of samples tested (n), as 
300 tests were used in total, the number of repeat tests (r) in each case is 300 divided by the 
number of samples tested. For example; 50 samples were tested six times, 100 samples 
were tested three times. The y axis shows the accuracy of the estimate of the 
overdispersion. The secondary x and y axis are designed to show the effects of mean 
infection intensity of the population and the overdispersion of the population on the accuracy. 
In the co-plot the results are dived into a lattice of 36 segments, columns from right to left 
show the effect of increasing mean infection intensity on the results. Each column represents 
the range of infection intensities indicated by the six bars in the top box. Similarly the rows 
show the affects of decreasing overdispersion for ranges of overdispersion indicated by the 
bars in the box to the left of the co-plot. In this way the minimum range infection intensity and 
overdispersion is shown in the bottom left plot of the lattice, whilst the maximum infection 
intensity and overdispersion range is shown in the top right box. The plot shows there is a 
trend toward less error with increasing number of samples analysed (as opposed to 
increasing the number of repetitions on fewer samples), and decreasing error with higher 




Figure 6.1b. Conditioning plot showing the accuracy  of the estimate of mean infection 
intensity for different sampling strategies 
 
The co-plot shows the range of results obtained from ‘Simulation 1’ designed to determine 
the accuracy of different sampling strategies using a fixed number of tests. The sampling 
strategies comprised different combinations of number of samples tested by number of 
repeat tests on each sample (n x r). The x axis shows the number of samples tested (n), as 
300 tests were used in total, the number of repeat tests (r) in each case is 300 divided by the 
number of samples tested. For example; 50 samples were tested six times, 100 samples 
were tested three times. The y axis shows the accuracy of the estimate of mean infection 
intensity The secondary x and y axis are designed to show the effects of mean infection 
intensity of the population and the overdispersion of the population on the accuracy. In the 
co-plot the results are dived into a lattice of 36 segments, columns from right to left show the 
effect of increasing mean infection intensity on the results. Each column represents the 
range of infection intensities indicated by the six bars in the top box. Similarly the rows show 
the affects of decreasing overdispersion for ranges of overdispersion indicated by the bars in 
the box to the left of the co-plot. In this way the minimum range infection intensity and 
overdispersion is shown in the bottom left plot of the lattice, whilst the maximum infection 
intensity and overdispersion range is shown in the top right box. The plot shows there is a 
trend toward less error with increasing number of samples analysed (as opposed to 
increasing the number of repetitions on fewer samples), and decreasing error with higher 




6.3.2. Comparative efficiency of different methods of detecting significant 
difference in patterns of infection when comparing host populations 
A Monte Carlo simulation (‘Simulation 2’) was developed using the basic code 
described in Figure Appendix 6.4. in order to assess the efficiency of different 
methods in determining significant difference of infection between two populations. 
The tests were conducted over a range of assumptions for overdispersion of 
infections and mean infection intensity in the populations. The tests were also 
assessed for ranges of values where the mean infection intensities were low and 
overdispersion was high (low K values) in order to determine how the methods 
performed under a scenario where the populations might present with widespread 
sub-patent infections. 
The different methods comprised different sampling strategies and statistical 
methodologies, a method equivalent to the way samples are currently screened 
(prevalence based method) and compared statistically and a method based on the 
number of positive results obtained from repeat screenings of the samples 
(repeatability based method). The compared populations were selected so that there 
was always a difference of prevalence of at least 10% and a difference in mean 
infection intensity of at least 100 parasites per millilitre. This minimum difference 
was selected so that the performance of the techniques could be compared, but was 
not intended to be a definitive measure of true significant difference in populations.  
‘Simulation 2’ determines a mean figure for the probability of finding a significant 
difference between populations given different sampling strategies and statistical 
methodologies. Associated 95% confidence intervals are generated for each mean 
probability. 
6.3.2.1. The different methods of sample analysis 
Prevalence based method for 100 and 500 samples per  population 
Each sample was tested once, and a prevalence of infection was then calculated for 
each population. The Chi square test statistic was used to compare number of 
infected samples and number of samples tested for each population. This method 
was conducted, using 100 and then 500 samples. Single screening of samples (i.e. 
one diagnostic test per sample) is currently the conventional method of assessing 
differences in prevalence. 
Repeatability method for 3 and 5 repeat tests per s ample 
Each sample was repeatedly tested, and the result of each test recorded for each 
sample. Data obtained for each sample were arranged in a data frame containing 
columns for 1/. Sample number, 2/. Number of positive tests and 3/. Population label 
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(A or B). Generalised linear modelling with Poisson errors was used to compare 
infection prevalence between populations. This method was conducted twice, using 
3 and 5 repeated tests for n = 100 samples. The residual scaled deviance ‘a’ of the 
GLM model should be approximately equal to the model’s residual degrees of 
freedom ‘b’. In cases where the ratio a/b is >1, then the assumption that the 
dispersion (or scale) parameter of the model equals one, does not hold.  In such 
cases correction for overdispersion required specifying a different error structure 
(i.e. “family=quasipoisson”) and the use of the F test rather than the Chi square test 
statistic was employed.  
Description of ‘Simulation 2’ 
In this simulation the variable of interest was the mean probability of detecting 
differences in prevalence and mean infection intensity between populations where a 
minimum difference in prevalence of 10%, and a minimum difference in mean 
infection intensity of 100 parasites per millilitre exists. The construction of 
‘Simulation 2’ is shown in the form of a flowchart in Figure Appendix 6.6.  
‘Simulation 2’ is similar to ‘Simulation 1’ except for the following modifications. The 
methods were assessed using three separate simulations. Each simulation uses 
different ranges of possible values for the distribution parameters describing 
infection intensity and overdispersion in two separate populations (See Table 6.4a 
and 6.4b). 
In ‘Simulation 2’ the mean infection intensity and overdispersion parameters of the 
two populations are first selected randomly from the range of values for that 
particular analysis. The prevalence (ω) and the mean infection intensity in each 
population is then determined and stored. Only those pairs of populations, with 
differences greater than or equal to the benchmark values, are selected and 
compared using the eight sample analysis methodologies described earlier. For 
each method, a p-value resulting from the corresponding test statistics is obtained at 
each iteration. A p-value of < 0.05 is recorded as a statistically significant result and 
assigned a value of 1. A p-value ≥ 0.05 is recorded as a not statistically significant 
result and coded as 0. The process is repeated for 100 iterations, each time taking 
different samples from each population. On completion, the mean probability of 
obtaining a statistically significant result for each method is recorded. These results 
are then stored in a vector.  
For each sample analysis method, the whole process is conducted for 1000 
population pairs. This results in 1000 values of ‘probability of a statistically 
significant result’ which are then stored in a vector. Upon completion of the 
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simulation, the values are used to calculate the mean probability (and 95% 
confidence intervals) of determining a statistically significant result for each method.  
For all sample analysis methods, the mean probability of a significant result is lowest 
when the range of infection intensities for the populations is lowest. The mean 
probability of a significant result increases as the range of infection intensities for the 
populations increases. The prevalence based method simulates a standard 
approach to screening samples for haemoparasites, in that each sample is 
subjected to a single diagnostic test to determine infection status. Using this method 
to compare populations with low mean infection intensities and high overdispersion 
(low K value), results in a very low probability of detecting a significant difference 
between populations (P = 0.3). Under any assumption for the range of the mean 
infection intensity and overdispersion, this method always presents with the lowest 
probability for obtaining a significant difference as compared to the other sample 
analysis technique.  
Using repeat samplings (Repeatability Method) proves to be the most reliable 
method (that with the highest probability of detecting a significant difference). In 
cases where mean infection intensities are low, the probability of obtaining a 
statistically significant result is 0.56 for three repeated samplings and 0.65 for five 
repeated samplings. In methods involving repeated testing of samples, five repeated 
tests resulted in an increase in the probability of obtaining a statistically significant 
result as compared to three repeated tests only for those populations with the lowest 
range of mean infection intensities. See Table 6.4a. 
Table 6.3. Summary of the different approaches to s creening samples used in the 














100 1 Chi-square test of prevalence results obtained from a single 
screening of each population. A standard approach 
 500 1 As above except with 500 samples 
Repeatability 
Method 
100 3 Test of results of number of positives obtained and number of 
repeat screenings for each population using a Generalised Linear 
Model with Poisson errors and an F-test 




Table 6.4a. Probability of detecting a significant difference of greater than a minimum level in two p opulations under different ranges of infection 
intensity patterns for two different methods  
Range  
Prevalence Method - Single Test per Sample 
 
K P  100 Samples 500 Samples 
     
0.01 to 0.6 100 to 300  0.30 (0.22 ~ 0.38) 0.42 (0.34 ~ 0.50) 
0.01 to 0.6 300 to 1000  0.49 (0.36 ~ 0.58) 0.56 (0.49 ~ 0.64)  
0.01 to 0.6 1000 to 10,000 0.63 (0.56 ~ 0. 70) 0.70 (0.60 ~ 0.80) 
     
   
Repeatability Method 
 
   
Three Repeat tests on 100 
Samples 
Five Repeat Tests on 100 
Samples 
     
0.01 to 0.6 100 to 300  0.56 (0.47 ~ 0.64) 0.65 (0.58 ~ 0.73) 
0.01 to 0.6 300 to 1000  0.66 (0.57 ~ 0.75) 0.73 (0.65 ~ 0.80) 
0.01 to 0.6 1000 to 10,000 0.67 (0.56 ~ 0.75) 0.74 (0.64 ~ 0.81) 
 
The table shows the results of a simulation and analysis of resulting data to determine the efficiency of eight different approaches to sampling and statistically 
testing for significant difference between two populations. The far left columns show the ranges of distribution parameters from which the corresponding values 
for each of the populations was selected. The results and associated 95% confidence intervals indicate the probability of that particular method of determining a  
P-value of less than 0.05, indicating a significant difference in two populations with differences greater than a minimum value (minimum levels: Prevalence >10% 
difference and / or mean infection intensity difference of > 100 parasites per millilitre). A brief description of the methods used is given in table 6.3. Methods 
using the cumulative prevalence and using data on infection intensity were also tested (data not shown) both methods were found to be better than testing 







Table 6.4b. Probability of detecting a significant difference of greater than a minimum level in two p opulations under different ranges of 
overdispersion for two different methods 
Range  
Prevalence Method - Single Test per Sample 
 
K P  100 Samples 500 Samples 
     
0.01 to 0.2 100 to 10,000  0.55 (0.43 ~ 0.68) 0.64 (0.55 ~ 0.73 
0.2 to 0.4 100 to 10,000  0.41 (0.31 ~ 0.52) 0.44 (0.38 ~ 0.46)  
0.4 to 1 100 to 10,000 0.49 (0.39 ~ 0.61) 0.61 (0.50 ~ 0.69) 
     
   
Repeatability Method 
 
   
Three Repeat tests on 100 
Samples 
Five Repeat Tests on 100 
Samples 
     
0.01 to 0.2 100 to 10,000  0.70 (0.62 ~ 0.77) 0.74 (0.65 ~ 0.86) 
0.2 to 0.4 100 to 10,000  0.46 (0.40 ~ 0.55) 0.56 (0.50 ~ 0.65) 
0.4 to 1 100 to 10,000 0.42 (0.32 ~ 0.49) 0.51 (0.42 ~ 0.58) 
The table shows the results of a simulation and analysis to determine the efficiency of eight different approaches to sampling and statistically testing for 
significant difference between two populations. The far left columns show the ranges of distribution parameters from which the corresponding values for each of 
the populations was selected. The results and associated 95% confidence intervals indicate the probability of that particular method of determining a P-value of 
less than 0.05, indicating a significant difference between populations with differences greater than a minimum value (minimum levels: Prevalence >10% 
difference and / or mean infection intensity difference of > 100 parasites per millilitre). A brief description of the eight methods used is given in table 6.3. Methods 
using the cumulative prevalence and using data on infection intensity were also tested (data not shown) both methods were found to be better than testing 
prevalence from a single screening but not as efficient as the repeatability method. 
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6.3.3. Development of a method for estimating the t rue population prevalence 
in populations with sub-patent infection intensitie s 
Results presented in chapter five showed a strong relationship between the 
overdispersion parameter of a negative binomial distribution and population 
prevalence. See Figure 5.4. 
This relationship may be useful in predicting the true level of prevalence in 
populations with widespread sub-patent infection, when diagnosed prevalence is 
unreliable. However, in order for the overdispersion to be useful in this way there 
must also exist a strong relationship between the population prevalence and an 
estimate of overdispersion derived from samples drawn from the population. In order 
to explore the potential of this relationship a simulation was constructed which 
estimated the overdispersion parameter (K) from screening a set of samples drawn 
at random from a population and subject to repeat screening. 
Description of simulation 3 
The purpose of this model was to provide data to allow analysis of the relationship 
between the estimate of overdispersion (Ke) and the population prevalence (ωp). In 
this simulation the variable of interest was the estimate of overdispersion. The 
uncertain variables in this case were the mean infection intensity of the population 
(P) and the overdispersion (K) of the population. The construction of the model is 
shown in the form of a flowchart in Figure Appendix 6.7.. The simulation first 
determines the parameters of a negative binomial distribution (NBD) that describes 
the distribution of infection intensities across the population. The values of mean 
infection intensity and overdispersion are chosen randomly from a vector of possible 
values (for P = from 100 to 1500 parasites per millilitre and K = from 0.1 to 1). A 
population of 1.0 x 105 samples is then generated each with an infection intensity 
value (Ii), where the distribution of infection intensity values conforms to that of the 
distribution assumption selected in the previous step and where a value of zero 
denotes an uninfected individual or sample. The probability of obtaining a positive 
diagnostic result from each sample in the population is as described in Section 
4.2.5. The simulation then determines the prevalence of infected samples within the 
population and stores the result. Samples are then selected at random from the 
population (n = 382) and positive or negative results are generated for each sample 
(θi) according to the probability of finding the sample positive (ρi). This process is 
repeated three times (r = 3) and the results of each round are stored. 
The estimated prevalence from the first screening and the cumulative prevalence for 
all three repeat screenings are then calculated and stored. The repeatability of each 
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sample is then calculated by dividing the number of positives obtained by the 
number of repeat screenings. The overdispersion of the proportion of positive results 
for the samples is then estimated using maximum likelihood methods and the result 
is stored. The entire process is then repeated 1.0 x 105 times to produce a large 
data frame for analysis.  
Table 6.5. Extract of the data frame obtained from the simulation for determining the 
estimate of overdispersion from repeated screening results 
Iteration 









       
1 700 0.79 0.99495 0.791914 0.727749 0.520942 
2 1500 0.21 0.84522 0.21436 0.424084 0.442408 
3 1000 0.46 0.97135 0.431379 0.557592 0.510471 
4 1200 0.47 0.97559 0.460965 0.612565 0.615183 
5 300 0.27 0.85103 0.235826 0.36911 0.232984 
6 100 0.08 0.43293 0.066666 0.10733 0.078534 
7 200 0.8 0.98816 0.57938 0.494764 0.227749 
8 200 0.6 0.96855 0.560322 0.468586 0.212042 
9 1500 0.77 0.99693 0.712168 0.748691 0.672775 
10 700 0.69 0.99173 0.58444 0.63089 0.492147 
11 1500 0.86 0.99803 0.833981 0.743455 0.701571 
↓ ↓ ↓ ↓ ↓ ↓ ↓ 
99,996 400 0.76 0.99152 0.648253 0.625654 0.366492 
99,997 800 0.32 0.9183 0.297177 0.458115 0.403141 
99,998 800 0.31 0.91173 0.316702 0.494764 0.421466 
99,999 400 0.57 0.97573 0.474913 0.539267 0.361257 
100,000 1500 0.91 0.99899 1.045518 0.780105 0.772251 
 
A plot of the relationship between estimated overdispersion and population 
prevalence obtained from a second simulation is shown in Figure 6.2. Although the 
relationship is not as strong as the relationship between population prevalence and 
overdispersion parameter K, there is still potential for using the estimate of K to 









Figure 6.2. Relationship between estimates of overd ispersion and population 
prevalence 
 
The scatter-plot shows the relationship between estimates of overdispersion and the 
population prevalence. The relationship is strong although slightly more dispersed than the 
relationship between population overdispersion and population prevalence (Figure 5.4.). A 
prediction of the asymptotic exponential function derived from the non-linear regression 
analysis is shown in red 
Non-linear regression analysis of data 
The data obtained from the simulation was used to determine the relationship 
between the estimate of overdispersion (Ke) and population prevalence (ωp) in a non 
linear regression analysis. The two variables were plotted on a scatter-plot and after 
visual inspection of the data a three parameter asymptotic exponential curve of the 
form y  = a – be-cx  and a two parameter asymptotic exponential curve of the form y = 
a (1 – e-cx) were both fitted to the data. 
The results of the non-linear regression analysis of the relationship between 
estimated overdispersion and population prevalence are shown in Table 6.6. For the 
three parameter model all terms were found to be significant in deletion tests so the 
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initial model was accepted as the minimal model. Comparison of this model to a two 
term asymptotic exponential model of the form y = a (1 – e-cx ) by ANOVA showed 
that the residual standard error (RSE) for the two term model was slightly higher 
(RSE = 0.03201 as opposed to RSE = 0.03099 for the three parameter model) and 
that the two models were significantly different (df = 1, F-value = 67.574, P-value = 
<0.001). In this case the three term model was accepted as the most appropriate 
model. The minimum model for determination of population prevalence from 
estimates of overdispersion is shown in Table 6.8., a plot of the predictions of the 
model is shown superimposed on the data in Figure 6.2. 
Table 6.6. Results of the non-linear regression ana lysis of data showing populations 
prevalence values for estimated overdispersion valu es 




N = 1.0 x 105  
Model Term Estimate Df F-value P-value 
     
a 0.993331 997 20,719 <0.001 
b 0.938248 997 91.626 <0.001 
c 8.466109 997 13,305 <0.001 
The table shows the results of the non-linear regression analysis to determine the 
relationship between the population prevalence and the estimates of overdispersion. The 
data was fitted to a asymptotic exponential model of the form y = a – be-cx. The estimate is 
the value of each of the constants in the fitted model predicted by the regression analysis. 
The P-value indicates whether a model not containing each term was significantly different 
form a model containing that term. All three terms were found to be significant in deletion 
tests and so the initial model was accepted as the minimal model. Comparison of this model 
to a two term asymptotic exponential model using ANOVA showed that the models were 
significantly different and that the three term model had a slightly smaller residual standard 
error. The minimum three term model was therefore accepted as the most appropriate 
description of the relationship. 
6.3.3.1. Determining the confidence intervals of es timated prevalence. 
Description of simulation 4 
In order to provide a means of calculating 95% confidence intervals for estimated 
prevalence (ωe) derived from estimation of overdispersion (K), a new data frame 
was created by adapting simulation 2. The simulations were identical except the 
new simulation provided and estimate of the population prevalence based on the 
estimate of overdispersion using the function derived from the previous non-linear 




To provide a means of calculating 95% confidence intervals for estimates of 
population prevalence derived from an estimation of overdispersion (K), a data 
frame of 1.0 x 105 data points each containing the population prevalence and the 
estimated prevalence derived from the estimate of overdispersion. For each level of 
estimated prevalence (0 to 1 in 0.01 increments) the population prevalence values 
associated with each level were extracted from the data frame and the 95% 
confidence intervals of the population prevalence data were calculated. This 
produced a new data frame listing the confidence intervals for each level of 
estimated prevalence, the relationship between these variables was then assessed 
with a non-linear regression analysis.  
Non-linear regression analysis of the data 
The plots of the data for the upper and lower confidence intervals suggested a 
quadratic relationship, a function of the form y = ax2 + bx + c was fitted to both upper 
and lower confidence interval data. 
The results of a non-linear regression analysis of the data frame detailing 
distributions of population prevalence for each level of estimated prevalence is 
shown in Table 6.7. A quadratic model successfully described the relationship 
between the confidence limits and the estimated prevalence in both cases. For the 
upper confidence limit all three parameters in the model were found to be significant, 
so the initial model was accepted as the minimal model. For the lower confidence 
interval a model without the term c was found not to be significantly different from 
the initial model and the reduced model resulted in a slight decrease in residual 
standard error (RSE = 0.0187 as opposed to RSE = 0.01999 for the initial model), 
so the reduced model was accepted as the minimum model. A summary of the 
minimum models for the estimation of population prevalence and the upper and 









Table 6.7. Results of the non-linear regression ana lysis and deletion tests to 
determine the relationship between the confidence i ntervals of population prevalence 
and the estimate of prevalence based on overdispers ion 
Upper Confidence Interval (C u) 
Minimum Model:      Cu = a ωe 2 + b ωe +c 
N = 10,000  
Model Term Estimate Df F-value P-value 
     
a -0.42826 996 525.89 <0.001 
b 1.41088 996 34.162 <0.001 
c 0.02912 996 2.993 0.1271 
     
Lower Confidence Interval (C u) 
Minimum Model:      Cl = a ωe 2 + b ωe  
N = 10,000  
Model Term Estimate Df F-value P-value 
     
a 0.439110 997 143.16 <0.001 
b 0.507743 997 160.81 <0.001 
c 0.001574 997 0.0045 0.9485 
The table shows the results of the non-linear regression analysis to determine the 
relationship between the upper and lower confidence intervals of population prevalence 
results associated with each level of estimated prevalence. For both models quadratic 
functions of the form y = ax2 + bx + c where fitted to the data. The estimate is the value of 
each of the constants in the fitted model predicted by the regression analysis. The P-value 
indicates whether a model not containing each term was significantly different from a model 
containing that term. For the upper confidence interval all three terms in the model were 
significant so the initial model was accepted as the minimum model. During model 
simplification the lower confidence interval the term c was found not to be significant, and a 
two term model without c was found not to be significantly different from the initial model. In 
addition the reduced model provided a slightly smaller residual standard error (initial model 
RSE = 0.01999, reduced model RSE = 0.0187) so the reduced model was accepted as the 





Table 6.8. Summary of the functions derived from th e non-linear regression analysis 
of data produced from the simulations 
eK
e e
466109.8938248.0993331.0 −−=ω  
02912.041088.142826.0 2 ++−= eeuC ωω  
eeuC ωω 51372.043437.0
2 +=  
Where: 
ωe = Estimated prevalence 
Cu = Upper 95% confidence interval 
Cl = Lower 95% confidence interval 
Ke = Estimated overdispersion. 
6.3.3.2. Accuracy of the functions describing the c onfidence intervals of the 
estimated prevalence 
Description of simulation 5 
To test the accuracy of the confidence intervals, simulation 3 was adapted to 
calculate confidence intervals using the functions derived from the non-linear 
regression analysis. The model was set up to test if the population prevalence fell 
within the calculated confidence intervals, giving a value of one for a true evaluation 
and zero for a false evaluation. This data was collected for 1.0 x 104 iterations of the 
model, the results were summed and divided by the number of iterations to produce 
a figure for the accuracy of the confidence intervals that ranged between zero for 
complete inaccuracy and one for total accuracy. 
Results 
The results of the test showed that the population prevalence fell within the 
calculated confidence intervals 8440 times out of 1.0 x 104 simulations, achieving an 
accuracy of 0.844. These results show that under all conditions of overdispersion, 
mean infection intensity and population prevalence the functions derived from the 
non-linear regression analysis are can reliably predict population prevalence in close 
to 85% of cases. A plot of the estimated prevalence of three techniques is shown for 
comparison in Figure 6.3. The data obtained from 1.0 x 104 iterations of the model 
(simulation 5) shows prevalence estimates using a standard sample screening 
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technique (n samples screened only once), a cumulative prevalence estimate from 
three repeated screenings of the samples and an estimate of prevalence derived 
using the estimate of overdispersion. The results clearly show the greatly improved 
accuracy of the newly developed method and the poor performance of more 
conventional approaches to obtaining prevalence estimates. It should be noted that 
the methodology described for calculating estimates of population prevalence based 
on an estimate of overdispersion only apply to cases where there exists a 
distribution of infection intensities in the host population that can be described by the 
negative binomial distribution. 
Figure 6.3. Estimates of population prevalence obta ined from three different methods 
 
The figure shows the accuracy of estimates of population prevalence obtained by three 
different methods over a range of different population mean infection intensities, 
overdispersion and population prevalence. The estimates obtained from a conventional 
method of screening the samples once are shown in blue. The cumulative prevalence 
estimates obtained from screening the samples five times are shown in black. The estimates 
obtained from the newly described method based on assessment of overdispersion in the 
samples are shown in red. The method based on cumulative prevalence and estimation of 
overdispersion are obtained from screening three 382 samples three times each. Trend lines 
for each estimate type are shown by the solid lines. The results show that the overdispersion 
(K) based method is capable of accurately assessing the population prevalence, whilst more 
conventional methods are inaccurate. These data apply to populations where the infection 




Work in previous chapters has highlighted the importance and consequences of 
intensity related false negatives (IRFN). The relationship among each of the five 
variables involved has also been explored. The work in this chapter attempted to 
develop methods of dealing with the underestimation of prevalence that arises as a 
result of IRFN. This work also attempted to develop methods that can overcome the 
effects of IRFN in addition to highlighting the benefits of taking a quantitative or 
semi-quantitative measure of the parasite population.  
Quantifying the infection intensity in sub-patent samples is complicated by the 
effects of IRFN, for samples that have complete repeatability and where there is no 
IRFN effect, RT-PCR can be used to determine accurate quantitative information. 
However, without repeat testing of the samples it is not possible to know from any 
single diagnostic result if IRFN is present. Hence, samples must still be assessed for 
IRFN and if repeatability is not complete, samples measured by RT-PCR must still 
be averaged over repeated tests. Since the IRFN effect is caused by low infection 
intensity of the parasite, then it follows the number of positive results obtained from r 
repeated screenings of a sample is therefore a semi-quantitative representation of 
infection intensity, the more repeated samplings the greater the resolution of the 
measure. The estimated repeatability is important at two levels, firstly the 
repeatability of an individual sample is a measure of the level of infection intensity 
within that host / sample. Secondly, the repeatability values for all samples 
represents the distribution of parasites in the host population, this is important if the 
epidemiology of the parasite is to be fully understood. 
With a single diagnostic test per sample the power of the screening is directly 
related to the sample size (n). However, with the repeat screening the relationship 
between the number of samples, the number of repeat tests per sample and the 
statistical power of the screening is not clear. In order to determine the relative 
importance of the number of samples and the number of repeat screenings the 
accuracy of different sampling strategies was assessed with a simulation designed 
to obtained estimates of population overdispersion (K) and mean infection intensity 
(P) by using a range of different sampling strategies. In order to have comparable 
results the total number of diagnostic tests was fixed at 300. The accuracy of the 
different strategies was measured by the percentage difference of each estimate 
from the population value. The results showed that, over a range of values for mean 
infection intensity and overdispersion of the population, the error was minimal when 
the maximum number of samples was analysed as opposed to an increased number 
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of repeat tests on each sample. In the simulation, with a fixed amount of tests (300) 
the most reliable sampling strategy was that of 100 samples tested three times 
each. The results presented here indicate that given a limited number of diagnostic 
tests available, which is likely to be the case in practice, it is more efficient to 
maximise the number of samples with a minimum of three repeat tests per sample.  
It is proposed that by obtaining semi quantitative measure of infection intensity 
results from repeat screening of samples (i.e. assessing the diagnostic repeatability 
of each sample) that the effects of IRFN can be mitigated. However, it is necessary 
to determine the relative efficiency of such semi-quantitative methods in comparison 
to the more standard method of assessing prevalence from a single screening. To 
test the performance of the two methods (prevalence based and repeatability based) 
in detecting significant difference between two populations, a simulation was 
constructed that collected and analysed the data from screening a randomly 
selected set of samples from two different populations. In this way the performance 
of each method in detecting significant difference between two populations with 
known minimum difference, could be compared for each of the two methodologies. 
The results of these comparative tests are presented in Tables 6.1a and 6.1b in the 
form of a probability of the detection of a significant difference. The most striking 
feature of the results is the very poor performance of prevalence based method 
(single screening of the samples and Chi square test of prevalence). When 
comparing populations with low mean infection intensities (100 to 300 parasites per 
millilitre) and using 100 samples, a statistical test of diagnosed prevalence from 
each population, using a Chi-Square test, was only able to detect significant 
difference with a probability of 0.30. In other words on 70% of occasions when there 
was a known minimum difference between the compared populations this method 
was not able to detect a significant difference. Furthermore, increasing the number 
of samples screened in this manner only increases the probability to 0.42, still a very 
inefficient level of detection. Considering, that obtaining prevalence from a single 
diagnostic test per sample is the most widely used method for comparing infection in 
two populations these results suggest that it performs very poorly on populations 
with sub patent infections. 
The performance of this method improves as the mean infection intensity increases, 
where for populations with mean infection intensities between 1,000 and 10,000 
parasites per millilitre the probability of detection rises to 0.63 for 100 samples and 
0.70 for 500 samples, still surprisingly less efficient than might be expected. 
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In contrast, the probability of significant difference using an estimate of repeatability 
for each sample (instead of diagnosed prevalence) in populations with the lowest 
mean infection intensities was 0.56 for three repeat tests on 100 samples, a 
significant improvement on using the diagnosed prevalence from 100 samples (+ 
0.26). It is notable that even though this repeat screening method utilised 300 
diagnostic tests in total it was still more efficient than estimating from a single test 
per sample prevalence of 500 samples. The probability of detecting significant 
difference rose by 0.09 when 100 samples were screened with five repeat tests. 
Again the probability rose as the mean infection intensity of the populations 
increased. However, for the comparisons between populations, where mean 
infection intensity was highest, the difference between the different methods of 
screening the samples was minimal. These results indicate that the more standard 
methodology of assessing diagnosed prevalence is only efficient, for populations 
with high mean infection intensities. Methods using the cumulative prevalence and 
using data on infection intensity (with a Wilcoxen test) were also tested (data not 
shown), both these methods were found to be better than testing prevalence from a 
single screening but not as efficient as the repeatability method. 
Comparison of the results obtained using three and five repeated tests showed that 
as might be expected, five repeated tests increases the mean probability of 
detecting significant difference of between 0.7 to 0.9. Whether three or five repeat 
tests are used on a sample set will depend on whether the extra investment of 
conducting the extra tests is feasible. The comparison made here gives valuable 
information that can help inform such decisions. 
Repeating this test for different ranges of overdispersion (K) (as opposed to different 
ranges of mean infection intensity), showed that the probability did not vary greatly 
for the different ranges. The lack of variability when tested with different ranges of 
overdispersion (K) provides further evidence that the main cause of underestimation 
of prevalence and therefore the lack of sensitivity in these tests is due to low 
infection intensities. 
The comparative analysis just described undoubtedly shows, that for populations 
with sub-patent infections, a semi-quantitative assessment of the infection intensity 
of each sample (by means of repeat screening of samples) improves the probability 
of detecting significant difference between populations. However there are a number 
of important potential limitations. The results of the simulations presented here all 
rely on the assumption of the distribution of the parasite fitting that of a negative 
binomial. There is no obvious reason why these findings should not also apply to 
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patterns of parasite distribution other than the negative binomial; although the 
comparative efficiency may change under different distribution assumptions. It is 
important that testing should be conducted to extend this work to other assumptions 
for the distribution pattern of the parasites. Whilst the use of repeatability is an 
undoubted improvement over the use of prevalence, a probability of detecting a 
significant difference in populations that are known to have a minimum level of 
difference of 0.56 is still a relatively insensitive level of detection. This highlights the 
need for further improvement in the diagnostic techniques, data collection and data 
analysis. 
The comparative analysis presented in Tables 6.1a and 6.1b. highlight the 
inadequacies of methods associated with diagnosed prevalence in detecting 
significant difference. The table provides valuable information that comparatively 
quantifies the improvements that might be made by adopting different approaches. 
This information is important in deciding the approach to screening a population 
especially if the prior information on the potential mean infection intensity of the 
target populations is known.  
The overdispersion parameter K of the negative binomial distribution is strongly 
influenced by the number of zero values present, which equates in this case to the 
number of uninfected hosts. This gives K a very strong relationship with population 
prevalence, as shown in Figure 5.4. As diagnosed prevalence underestimates 
population prevalence in populations with sub-patent infections, fitting a distribution 
to the data obtained from repeat screening of each sample allows an estimation of 
K. By use of the strong relationship between K and population prevalence, an 
estimate of the population prevalence that is less affected by IRFN can be 
calculated. Testing this method of estimating population prevalence using a 
simulation showed that it was many times more accurate than using either the 
prevalence from a single screening or the cumulative prevalence from repeated 
testing of the samples (see Figure 6.3.). The results obtained from the diagnosed 
prevalence method (the standard methodology) severely underestimated the 
population prevalence. The estimates derived from the estimation of the 
overdispersion parameter K spread around the actual population prevalence values, 
this allowed development of a method for calculating confidence intervals. This 
method for estimating population prevalence further increases the usefulness of 
using repeatability data from repeated screening of samples rather than simple 
diagnosed prevalence. The method described in this simulation utilised 382 samples 
repeat screened three times each. However, it would depend on the distribution of 
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parasites fitting a negative binomial and it is possible that this may not be the case. 
It may be possible to adapt the methods for inference of population prevalence for 
other distribution assumptions. 
In summary, the results presented in this chapter show that for populations where 
the infections are present at high mean intensity, the use of diagnosed prevalence 
from a single screening for both representing the number of infected hosts and for 
comparing differences between populations is an appropriate method. However, if 
the populations have a significant proportion of sub-patent infections, then the use of 
diagnosed prevalence is inadequate in both representing the numbers of infected 
hosts and in determining differences between populations. For these types of 
infection patterns within populations the use of repeat testing of samples provides a 
significant improvement in detecting differences between populations. The inference 
of population prevalence from the repeat test data via an estimate of the 
overdispersion parameter (K) provides much more accurate estimates than the use 
of diagnosed prevalence. Additionally, the use of data from repeat screening of 
samples provides quantitative information on the distribution and numbers of the 
parasite population that is lacking when diagnosed prevalence from a single 































Discussion of the results obtained from empirical a nd theoretical work 
Although there have been vast improvements in the techniques used to screen field 
samples for the presence of African trypanosomes, epidemiological research in this 
area is still difficult. Current protocols require the use of a species specific PCR 
protocol for each species of trypanosome that may be present. The use of separate 
screening protocols is both time consuming and makes inefficient use of valuable 
research funds. In addition, each separate protocol may have different diagnostic 
sensitivities and protocols must be selected according to what species of 
trypanosome are expected to be present in the samples. These limitations are not 
conducive to acquiring high quality and representative epidemiological data. 
In the first part of this work (Chapter 2) a new PCR based screening technique was 
developed which allowed field samples to be screened for all important African 
trypanosome species with a single protocol. The technique was developed to 
function on whole blood applied to filter paper cards. This development allowed 
major simplification of the entire sample processing protocol whilst at the same time 
allowing the same diagnostic sensitivity to be applied in the detection of all Important 
African trypanosome species. This rationalisation of the sample screening 
methodology overcomes many of the problems with the current methodology, and 
significantly reduces the cost and time involved in sample processing. Creating a 
more efficient protocol in this way allows valuable research funds to be targeted 
elsewhere. 
Assessing the infection intensity of a parasite quantitatively presents a number of 
problems. Firstly, it is not possible to definitively count even macro-parasites, such a 
procedure would require a post-mortem examination, and this is certainly neither 
practical nor ethical. For micro-parasites the situation is even more complicated, as 
the small size of the parasites makes them much more difficult to enumerate. A 
definitive enumeration of parasite load would require examination of the entire blood 
or tissue volume of the sample of hosts under study. Instead quantitative measures 
must be inferred from samples in the same manner as prevalence is inferred from a 
population by selecting a sufficient number of samples. To represent the number of 
parasites within a host, according to statistical reasoning, would require the 
enumeration of parasite load in a statistically significant number of aliquots of blood 
from the host. However there are still many problems, the parasites may not be 
distributed evenly in the blood, the parasite may exhibit cyclical patterns of migration 
(e.g. from peripheral blood to venous blood). Without knowledge of these aspects 
quantification is difficult. Never the less, the benefits of a quantitative assessment 
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may well outweigh the difficulties. This approach was adopted with a number of 
randomly chosen blood samples taken from apparently healthy African zebu cattle 
of unknown infection status (n = 35). Repeated PCR assays were conducted on 
each sample, so that the results of up to 114 diagnostic tests for each host were 
available. Relating the spatial position of these results back to the position of the 
punch / aliquot taken from the filter paper card showed the ‘sparse’ distribution of 
trypanosomes within the blood samples. Whilst this approach is clearly not practical 
for large numbers of samples, it was hoped that it would provide a unique insight 
into the distribution of each species of trypanosome in a relatively small number of 
hosts (Chapter 3). 
Such an ‘in depth’ analysis of field samples has never been attempted before. The 
results revealed that most (85.7%; n=30) of the cattle were infected with 
trypanosomes and many harboured mixed species infections (60%). Analysis of the 
resulting data failed to reveal any evidence of interaction between the infecting 
species, although some of the species combinations were at levels close to the 95% 
confidence intervals of the expected values, suggesting that a larger study may 
reveal important interactions between the trypanosome species. 
In addition, the data obtained from repeat screening of these thirty five field samples 
revealed that although the mean prevalence for any trypanosome species after 
many rounds of screening was 9.8%, the cumulative prevalence reached 85.7%. 
These results indicated that diagnosed prevalence from a single screening of 
samples seriously underestimates the true level of population prevalence. The 
underestimation was shown to be due to a large number of false negative results 
obtained from infected samples. The occurrence of these false negative results was 
found to be due to the intensity of infection present in the host (Chapter 4). 
Repeated examination of a range of other samples from different hosts and 
geographical areas revealed that false negative diagnostic results occurred at a high 
level in all the infected samples examined. Because the false negative diagnostic 
results where shown to be caused by low infection intensities present in the host 
population (sub-patent infection) the phenomenon was termed ‘Intensity Related 
False Negatives’ (IRFN). The occurrence of IRFN results in a range of randomly 
chosen samples is of great importance to epidemiological study of trypanosomiasis. 
Evidence in the literature of the occurrence of false negative results in 
epidemiological studies was presented (Chapter 1), making the occurrence of IRFN 
of potential importance to a wider range of pathogens. 
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In order to describe the distribution of trypanosomes across the host population the 
data obtained from repeated screening of the 35 cattle samples was fitted to 
negative binomial and Poisson distributions. The data was significantly different from 
that of a Poisson. Although there was too little data to allow fitting of all the individual 
species of trypanosome, except for T. theileri, the frequency distributions of all 
species were overdispersed and visually suggestive of a negative binomial 
distribution (NBD). The data obtained for all species combined and T. theileri 
separately, proved to be not significantly different from a negative binomial 
distribution. This is the first case where evidence has been presented for African 
trypanosomes being distributed according to a NBD. This kind of information 
regarding the distribution of the parasites is of importance in modelling and in 
determining the transmission dynamics of the parasite. In this work the NBD was 
subsequently utilised as a model for the distribution of trypanosome species across 
the host population. Although other distribution assumptions could equally have 
been used. 
Stochastic mathematical modelling techniques were employed to demonstrate the 
consequences of IRFN. The results from these simulations demonstrated that, due 
to the effects of IRFN, it is possible to obtain the same diagnosed prevalence from 
populations with very different levels of true population prevalence and patterns of 
infection (Section 4.3). Data obtained from further simulations showed that for 
individual hosts with infection intensities of below 6,000 to 8,000 parasites per 
millilitre and a diagnostic technique analysing a volume of one microlitre of sample 
(the typical assayed volume of a PCR protocol), false negative results are certain to 
occur, albeit at an initially low level, 1% to 2% (mean probability  = 0.01 ~0.02). 
Whilst for a host with an infection intensity of 1,000 parasites per millilitre false 
negative results will occur with a mean probability of 0.4. For populations of hosts 
with parasites distributed according to a negative binomial distribution with a mean 
infection intensity in the population of 10,000 parasites per millilitre false negative 
results will occur with a mean probability of 0.19. Given that field infections are likely 
to occur with lower levels of mean intensity than this, these results strongly suggest 
that false negative results are likely to occur in most epidemiological situations. 
In chapter 6, quantitative methods of sample collection were advocated to 
counteract the effects of IRFN results. The poor performance of current approaches 
to statistical comparison of different populations was highlighted in further simulation 
studies. Statistical comparisons of prevalence obtained from single screenings of 
two populations only identified difference between compared populations with a 
probability of 0.3 (Tables 6.4a and 6.4b) when a large difference in prevalence and 
 
132 
infection pattern was present. The work carried out in this chapter demonstrated that 
improvement in epidemiological analysis can be achieved by using a quantitative 
method of sample analysis. A method for statistical comparison between different 
populations was also tested and found to offer improvements over currently used 
techniques (Section 6.3.2) in situations where IRFN is present. Furthermore, a 
method of calculating the true level of prevalence in a population via estimation of 
the parameters of a negative binomial distribution was shown to give estimates 
which were, theoretically, an order of magnitude more accurate than conventional 
methods. However, this method of estimation of population prevalence should be 
supported with empirical work. 
The work presented throughout this thesis has attempted to demonstrate that IRFN 
results are very likely to occur under field conditions. And that sole reliance on 
assessment of prevalence can lead to serious misinterpretation of the 
epidemiological state of the pathogen in question. Adopting a quantitative approach 
to screening field samples can help to both identify and overcome this problem. In 
addition assessment of the distribution of pathogens across host populations 
provides an additional dimension to the available data for epidemiological 
investigation.  
The implications of failing to account for the pres ence of IRFN 
The occurrence of IRFN is of great concern as many epidemiological studies 
depend upon reporting diagnosed prevalence or on comparing diagnosed 
prevalence between two or more populations. Important results may therefore be 
easily missed or misinterpreted. In fact, although African trypanosomiasis has been 
closely studied for more than 100 years, there are many aspects of the 
epidemiology that still remain unclear. It is possible,  that an over reliance on 
prevalence information and a failure to ascertain quantitative data on the parasite 
has been a major factor hindering epidemiological discovery.  The existence of sub-
patent infection intensities in a host population (and therefore IRFN in 
epidemiological study)  has a number of serious consequences. 
Treatment regimes and control strategies 
Studies or control programmes that rely on targeted treatment of infected individuals 
can fail to diagnose a large number of the infected hosts. Failure to treat many 
infected hosts in this type of programme may lead to the failure of the control effort. 
Untreated infected hosts can provide a significant reservoir of infection and the 
transmission from these sub-patent hosts may be more important than the 
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transmission contributed by the hosts diagnosed as infected. Persistence of 
transmission of schistosomiasis after control programmes has been noted on a 
number of occasions (Polderman & de Caluwe, 1989; Webbe & el Hak, 1990; 
Butterworth et al., 1991; Gryseels et al., 1991) and ascribed to significant numbers 
of hosts with low level infection being missed by the screening methodology. 
Misleading data supplied to transmission models. 
Transmission models based on epidemiological data derived from populations 
where widespread sub-patent, low intensity infections are present may seriously 
misrepresent the true epidemiological situation. A majority of undiagnosed low 
intensity infection may contribute the majority of the transmission.  
Statistical measures and reasoning 
Epidemiological measures that depend upon accurate and repeatable identification 
of infected hosts, such as diagnosed prevalence, incidence, diagnostic sensitivity, 
diagnostic agreement between techniques, sample size and power calculations all 
have to be re-evaluated in the cases where IRFN are a significant factor. This work 
has shown the basic assumption of accurate and repeatable identification of infected 
hosts may not be reliable under conditions were sub patent infections are present. 
For  diagnostic sensitivity, diagnostic agreement between techniques, sample size 
and power calculations it follows that applicability of these measures is dependent 
upon the levels, and variations of infection intensity present in the population under 
analysis, and that they must therefore be assessed for every study population. This 
effect is known as spectrum bias (Ransoff & Feinstein, 1978). In cases where sub-
patent infections are not present these measures may be reliable, but a failure to 
assess the possibility of sub-patent infections will result in a lack of confidence in the 
results and conclusions of such studies. 
Diagnosed prevalence 
The underestimation of population prevalence resulting from the existence of low 
intensity infections in a population together with the fact that the same diagnosed 
prevalence can be obtained from populations with a true population prevalence of 
14% or 100% raises an interesting question; what is the meaning of diagnosed 
prevalence? The prevalence obtained from a single diagnostic test per sample may 
or may not be representative of the true prevalence. Without knowledge of the 
distribution of parasites the difficulty is that, for current approaches, it is not possible 
to calculate what proportion of the true prevalence the diagnosed prevalence 
represents. Although multiple tests per sample can give an increased estimation of 
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prevalence (cumulative prevalence), as has been demonstrated here and elsewhere 
(de Vlas et al., 1992b), the situation remains essentially unchanged, in that the 
cumulative prevalence from n samples screened r times may still  represent only an 
unknown proportion of the true prevalence. Simply increasing the number of tests 
per sample or the sensitivity of a technique does not solve the problem. Similarly, 
increasing the volume of blood analysed will increase the diagnosed prevalence in 
the same manner as repeat testing, and again the true prevalence remains 
unknown. Therefore increasing the sensitivity of diagnostic tests or improving the 
sensitivity by extracting DNA in solution will increase the proportion of hosts 
detected as infected but will still not ensure an accurate estimation of the true 
prevalence or give any confidence in the results. The true prevalence must therefore 
be inferred from the diagnostic test data, a quantitative assessment of the parasite 
load and distribution of parasites within the samples and host population.  
Conversely, should an endemic parasite be present in most hosts in the population 
then the question arises as to what a prevalence of 90% or 100% means. If all hosts 
in the population are infected, what is the use is prevalence as an epidemiological 
measure? If all or most hosts are infected, then variations in the transmission and 
epidemiology of the disease must be based on quantitative changes in parasite load 
within individual hosts not on changes in prevalence. The epidemiological 
importance of infection status is therefore transferred from an infected / uninfected 
paradigm, to a how infected paradigm.  
It seems that in some situations the diagnosed prevalence is an unreliable, 
misleading and inadequate epidemiological measure. The only way to counteract 
this is to base epidemiological study not on prevalence but on the distribution of 
parasite load within populations. 
Limitations of this work 
Whilst the demonstration of the existence of IRFN in African trypanosomiasis 
presented in this study is based on empirical data, the worked concerned with 
demonstrating its effects and methods of dealing with the phenomenon are based 
on modelling and are therefore theoretical. Further empirical work should be 
conducted in order to validate the conclusions and findings of this study. The work 
presented in this thesis represents the early stages of investigation into the 
existence of this phenomenon and into methods of dealing with IRFN, additional 
work will undoubtedly further improve on the methods described. 
 
135 
Diurnal patterns, the negative binomial distribution and apparent sub-patent 
infections 
For parasites that replicate within the host the apparent distribution of parasites 
within the host population may be influenced or even be a result of fluctuating levels 
of parasite numbers due to either diurnal variation in parasite numbers present in 
the site from which the blood sample was drawn (venous or peripheral blood). In 
field studies, the collection of blood from a large number of hosts is spread over 
time, should there be diurnal variation in parasite numbers then the difference in 
time over which the samples were drawn could create an overdispersed distribution 
of infection intensities within the host population, and the appearance of the 
existence of widespread sub-patent infection. For example, supposing the parasites 
under study are present in low numbers in the peripheral blood early in the morning 
and gradually increase in numbers during the day reaching a peak around midday. 
An epidemiological study that collects samples from peripheral blood would show 
low infection intensities in those samples collected in the morning, as the sample 
collection process begins, and high infection intensities in those samples collected 
around midday. It is therefore possible that the distribution of infection intensities 
within the hosts are an artefact of the diurnal variation and the fact that sample 
collection is spread over time. However, this assumes that a more homogenous 
distribution of parasites within the host population underlies the diagnostic results. 
Given the number of potential factors that are capable of producing biological 
variation in the infection intensity of any host (age, previous exposure, genetic 
factor, behavioural factors etc.), this is unlikely to be the case. Whilst this does not 
affect any of the conclusions of this study, it would imply that caution and careful 
consideration are used before reaching any epidemiological conclusions. Therefore, 
the existence of any diurnal patterns of variation in infection intensity should be 
determined by empirical study as a matter of some importance. 
Future work will focus on obtaining empirical support for the findings contained in 
this thesis. In addition the relevance of this work to incidence as an epidemiological 








The main conclusions of this study are as follows: 
• The diagnosed prevalence (and incidence) determined from a single 
screening per sample can be an unreliable and misleading measure of 
infected hosts and gives little or no information on parasite distribution. 
Where sub-patent infections are present, prevalence can be severely 
underestimated. Where sub-patent infections are not present prevalence 
may be reliable, however, without a specific assessment of the existence of 
the rate of occurrence of intensity related false negatives (IFRN) there is no 
way of establishing confidence in the prevalence value obtained.  
• In order to mitigate the effects of IRFN quantitative or semi quantitative 
measures should be used in any epidemiological study.  
• The existence of IRFN should be assessed before or during any 
epidemiological study. 
• It is possible to mitigate the effects IRFN, the work presented here offers 
improved sensitivity of statistical detection of significant difference between 
populations and a method for estimating true populations prevalence. This 
work can be developed further. 
•  IRFN may be applicable to a wide range of pathogens. 
• IRFN can be a serious restriction to gaining an accurate understanding of the 
epidemiology of a pathogen. If the widespread occurrence of this problem in 
epidemiological study of schistosomiasis was enough to prompt the World 
Health Organisation to recommend the use quantitative measures (WHO, 
1967;  1980), then the problem should not be underestimated. 
• The occurrence of IRFN results in epidemiological studies may result in 
incorrect information on which transmission models and control programmes 
may subsequently be based. This incorrect information may be enough to 








Anderson, R. M. (1982) Epidemiology of infectious disease agents., Blackwell Scientific, Oxford. 
Artama, W., Agey, M., Donelson, J. (1992) DNA comparisons of Trypanosoma evansi (Indonesia) and 
Trypanosoma brucei spp., Parasitology, 104, pp 67-74. 
Ashcroft, M.T., Burtt, E., Fairbairn, H., (1959) The experimental infection of some African wild animals 
with Trypanosoma rhodesiense, T. brucei and T. congolense. Annals of Tropical Medicine 
and Parasitology. 53:147–161. 
Baker, J.R., Sachs, R., Laufer, I., (1967) Trypanosomes of wild mammals in an area northwest of the 
Serengeti National Park, Tanzania. Z. Tropenmed Parasitol. ;18:280–284. 
Barker, R. H., Jr., Banchongaksorn, T., Courval, J. M., Suwonkerd, W., Rimwungtragoon, K., Wirth, D. 
F. (1994) Plasmodium falciparum and P. vivax: Factors affecting sensitivity and specificity of 
pcr-based diagnosis of malaria, Experimental Parasitol, 79, pp 41-9. 
Barreto, M. L., Silva, J. T., Mott, K. E., Lehman, J. S., Jr. (1978) Stability of faecal egg excretion in 
Schistosoma mansoni infection, Transactions of the  Royal Society for Tropical Medicine and 
Hygiene, 72, pp 181-7. 
Barreto, M. L., Smith, D. H., Sleigh, A. C. (1990) Implications of faecal egg count variation when using 
the kato-katz method to assess Schistosoma mansoni infections, Transactions of the  Royal 
Society for Tropical Medicine and Hygiene, 84, pp 554-5. 
Barrett, M. P., MacLeod, A., Tovar, J., Sweetman, J. P., Tait, A., Le Page, R. W. F., Melville, S. E. 
(1997) A single locus minisatellite sequence which distinguishes between Trypanosoma 
brucei isolates, Molecular and Biochemical Parasitology, 86, pp 95-100. 
Becker, S., Franco, J. R., Simarro, P. P., Stich, A., Abel, P. M., Steverding, D. (2004) Real-time PCR 
for detection of Trypanosoma brucei in human blood samples, Diagn Microbiol Infect 
Dis, 50, pp 193-9. 
Beyo, J., Nibouche, S., Goze, E., Deguine, J. P. (2004) Application of probability distribution to the 
sampling of cotton bollworms (lepidoptera: Noctuidae) in northern Cameroon, Crop 
Protection, 23, pp 1111-1117. 
Bottius, E., Guanzirolli, A., Trape, J. F., Rogier, C., Konate, L., Druilhe, P. (1996) Malaria: Even more 
chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by 
the polymerase chain reaction, Transactions of the  Royal Society for Tropical Medicine and 
Hygiene, 90, pp 15-9. 
Brown, A. E., Kain, K. C., Pipithkul, J., Webster, H. K. (1992) Demonstration by the polymerase chain 
reaction of mixed Plasmodium falciparum and P. Vivax infections undetected by conventional 
microscopy, Transactions of the  Royal Society for Tropical Medicine and Hygiene, 86, pp 
609-12. 
Buscher, P., Lejon, V., (2004), Diagnosis of human African trypanosomiasis. In: The Trypanosomiasis. 
Maudlin,I., Holmes, P.H. & Miles, M.A. (eds), CABI Publishing, Wallingford, Oxfordshire, UK. 
pp203 
Butterworth, A. E., Sturrock, R. F., Ouma, J. H., Mbugua, G. G., Fulford, A. J., Kariuki, H. C., Koech, D. 
(1991) Comparison of different chemotherapy strategies against Schistosoma mansoni in 
machakos district, Kenya: Effects on human infection and morbidity, Parasitology, 103 Pt 3, 
pp 339-55. 
Cavasini, M. T., Ribeiro, W. L., Kawamoto, F., Ferreira, M. U. (2000) How prevalent is Plasmodium 
malariae in Rondonia, western Brazilian Amazon? Rev Soc Bras Med Trop, 33, pp 489-92. 
 
138 
Chappuis, F., Pittet, A., Bovier, P. A., Adams, K., Godineau, V., Hwang, S. Y., Magnus, E., Buscher, P. 
(2002) Field evaluation of the catt / Trypanosoma brucei gambiense on blood-impregnated 
filter papers for diagnosis of human African trypanosomiasis in southern sudan, Tropical 
Medicine and International Health, 7, pp 942-948. 
Clausen, P. H., Wiemann, A., Patzelt, R., Kakaire, D., Poetzsch, C., Peregrine, A., Mehlitz, D. (1998) 
In: Tropical veterinary medicine: Molecular epidemiology, hemoparasites and their vectors, 
and general topics, Vol. 849 (Eds, Jongejan, F., Goff, W.Camus, E.) Eurospan Ltd, pp. 21-31. 
Cobb, D. C., Clarkson, J. (1994) A simple procedure for optimising the polymerase chain reaction 
(PCR) using modified taguchi methods., Nucleic Acids Research, 22, pp 3801 -3805. 
Connor, R. J., Halliwell, R. W. (1987) Bovine trypanosomiasis in southern Tanzania: Parasitological 
and serological survey of prevalence, Tropical Animal Health & Production, 19, pp 165-72. 
Cox, A. P., Tilley, A., McOdimba, F., Fyfe, J., Eisler, M., Hide, G., Welburn, S. (2005) A PCR based 
assay for detection and differentiation of African trypanosome species in blood., Experimental 
Parasitology, 111, pp 24 - 29. 
Craig, M. H., Bredenkamp, B. L., Williams, C. H., Rossouw, E. J., Kelly, V. J., Kleinschmidt, I., 
Martineau, A., Henry, G. F. (2002) Field and laboratory comparative evaluation of ten rapid 
malaria diagnostic tests, Transactions of the  Royal Society for Tropical Medicine and 
Hygiene, 96, pp 258-65. 
da Cunha, A. S., Cancado, J. R., de Rezende, G. L. (1987) Therapeutical evaluation of different dose 
regimens of praziquantel in Schistosomiasis mansoni, based on the quantitative oogram 
technique, Rev Inst Med Trop Sao Paulo, 29, pp 295-304. 
de Brujin, M. H., Labrada, L. A., Smyth, A. J., Santrich, C., Barker, D. C. (1993) A comparative study of 
diagnosis by the polymerase chain reaction and by current clinical methods using biopsies 
from colombian patients with suspected leishmaniasis, Tropical  Medicine & Parasitololgy, 44, 
pp 201-7. 
de Vlas, S. J., Gryseels, B. (1992) Underestimation of Schistosoma mansoni prevalences, Parasitol 
Today, 8, pp 274-7. 
De Vlas, S. J., Gryseels, B., Van Oortmarssen, G. J., Polderman, A. M., Habbema, J. D. (1992a) A 
model for variations in single and repeated egg counts in Schistosoma mansoni infections, 
Parasitology, 104 ( Pt 3), pp 451-60. 
de Vlas, S. J., Gryseels, B., van Oortmarssen, G. J., Polderman, A. M., Habbema, J. D. (1993) A 
pocket chart to estimate true schistosoma mansoni prevalences, Parasitol Today, 9, pp 305-
7. 
de Vlas, S. J., van Oortmarssen, G. J., Gryseels, B. (1992b) Validation of a model for variations in 
Schistosoma mansoni egg counts, Transactions of the  Royal Society for Tropical Medicine 
and Hygiene, 86, pp 645. 
Desquesnes, M., Dávila, A. (2002) Applications of PCR-based tools for detection andidentification of 
animal trypanosomes: A review and perspectives Veterinary Parasitology, 109, pp 213–231. 
Diall, O., Nantulya, V. M., Luckins, A. G., Diarra, B. (1992) Evaluation of mono- and polyclonal 
antibody-based antigen detection immunoassays for diagnosis of Trypanosoma evansi 
infection in the dromedary camel, Revue D Elevage Et De Medicine Veterinaire Des Pays 
Tropicaux, 45, pp 149. 
Doherty, M. L. (1993) Clinical disease associated with Trypanosoma theileri infection in a calf in 
ireland, Veterinary Record, 132, pp 653. 
Dowling, M. A. C., Shute, G. T. (1966) A comparative study of thick and thin blood films in the 
diagnosis of scanty parasitaemia., Bulletin of the world Health Organisation, 34, pp 249 - 267. 
 
139 
Eisler, M. C., Lessard, R., Masake, R. A., Moloo, S. K., Peregrine, A. S. (1998) Sensitivity and 
specificity of antigen-capture elisas for diagnosis of Trypanosoma congolense and 
Trypanosoma vivax infections in cattle, Veterinary Parasitology, 79, pp 187-202. 
Eisler, M. C., Torr, S. J., Coleman, P. G., Machila, N., Morton, J. F. (2003) Integrated control of vector-
borne diseases of livestock - pyrethroids: Panacea or poison?, Trends in Parasitology, 19, pp 
341-345. 
Elliot, J. M. (1977) Some methods for the statistical analysis of benthic invertebrates, Freshwater 
Biological Association. 
Eppert, A., Lewis, F. A., Grzywacz, C., Coura-Filho, P., Caldas, I., Minchella, D. J. (2002) Distribution 
of Schistosome infections in molluscan hosts at different levels of parasite prevalence, 
Journal of Parasitology, 88, pp 232-6. 
Farrar, R. G., Klei, T. R. (1990) Prevalence of Trypanosoma theileri in lousiana cattle., Journal of 
Parasitology, 76, pp 734–736. 
Feng, Z., Eppert, A., Milner, F. A., Minchella, D. J. (2004) Estimation of parameters governing the 
transmission dynamics of schistosomes, Applied Mathematics Letters, 17, pp 1105-1112. 
Fevre EM, Coleman PG, Odiit M, Magona JW, Welburn SC, Woolhouse ME. 2001 The origins of a 
new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. Lancet. 
358(9282):625-8 
Flach, E. J., Ouhelli, H., Waddington, D., Elhasnaoui, M. (1993) Prevalence of theileria in the tick 
hyalomma-detritum-detritum in the doukkala region, morocco, Medical and Veterinary 
Entomology, 7, pp 343-350. 
Garcia, A., Jamonneau, V., Magnus, E., Laveissiere, C., Lejon, V., N'Guessan, P., N'Dri, L., Van 
Meirvenne, N., Buscher, P. (2000) Follow-up of card agglutination trypanosomiasis test (catt) 
positive but apparently aparasitaemic individuals in Cote d'Ivoire: Evidence for a complex and 
heterogeneous population, Tropical Medicine International Health, 5, pp 786-93. 
Gibson, W. (1986) Will the real Trypanosoma brucei gambiense please stand up, Parasitology Today, 
2, pp 255 - 257. 
Gibson, W., Ferris, V. (1992) Sequential infection of tsetse flies with Trypanosoma congolense and 
Trypanosoma brucei, Acta Tropica, 50, pp 345-52. 
Gibson, W., Mehlitz, D., Lanham, S., Godfrey, D. (1978) The identification of Trypanosoma brucei 
gambiense in Liberian pigs and dogs by isoenzymes and by resistance to human plasma, 
Tropenmed Parasitol, 29, pp 335-45. 
Goddard, M. J. (1977) On allowing for diagnostic imperfections in assessing effectiveness of treatment 
for schistosomiasis, International Journal of Epidemiology, 6, pp 381-9. 
Gonzales, J. L., Loza, A., Chacon, E. (2006) Sensitivity of different Trypanosoma vivax specific primers 
for the diagnosis of livestock trypanosomosis using different DNA extraction methods, 
Veterinary Parasitology, 136, pp 119-26. 
Gonzalez-Andujar, J. L., Saavedra, M. (2003) Spatial distribution of annual grass weed populations in 
winter cereals, Crop Protection, 22, pp 629-633. 
Greco, A., Loria, G. R., Dara, S., Luckins, T., Sparagano, O. (2000) Short communication: First 
isolation of Trypanosoma theileri in Sicilian cattle, Veterinary Research Communications, 24, 
pp 471-475. 
Gregory, R. D., Woolhouse, M. E. J. (1993) Quantification of parasite aggregation - a simulation study, 
Acta Tropica, 54, pp 131-139. 
 
140 
Gryseels, B., Nkulikyinka, L., Engels, D. (1991) Repeated community-based chemotherapy for the 
control of Schistosoma mansoni: Effect of screening and selective treatment on prevalences 
and intensities of infection, American Journal of Tropical Medicine and Hygiene, 45, pp 509-
17. 
Guglielmone, A. A., Gaido, A. B., Aguirre, D. H., Cafrune, M. M. (1997) Some quantitative aspects of 
natural babesial infection in the haemolymph of Boophilus microplus engorged female ticks, 
Parasite, 4, pp 337-41. 
Guyatt, H. L., Bundy, D. A. (1993) Estimation of intestinal nematode prevalence: Influence of parasite 
mating patterns, Parasitology, 107 ( Pt 1), pp 99-105. 
Hall, T. A. (1999) Bioedit: A user-friendly biological sequence alignment editor and analysis, Nucleic. 
Acids. Symposium. Ser, 41, pp 95-98. 
Heisch, R., McMahon, J., Manson-Bahr, P. (1958) The isolation of Trypanosoma rhodesiense from 
bushbuck, British Medical Journal, 2, pp 1203. 
Hide, G. (1999) History of sleeping sickness in east Africa, Clinical Microbiology Reviews, 12, pp 112-
125. 
Hide, G., Tait, A., Maudlin, I., Welburn, S. C. (1996) The origins, dynamics and generation of 
Trypanosoma brucei rhodesiense epidemics in east Africa, Parasitology Today, 12, pp 50-54. 
Hoare, C. A. (1956) Morphological and taxonomic studies on the mammalian trypanosomes. Viii. 
Revision of Trypanosoma evansi, Parasitology, 46, pp 130 - 172. 
Hoare, C. A. (1964) Morphological and taxonomic studies on mammalian Trypanosomes. X. Revision 
of the systematics., Journal of Protozoology., 11, pp 200-207. 
Hoare, C. A. (1966) The classification of mammalian Trypanosomes, Ergebnisse der mikroiologie, 
immunitatsforschung und experimentellen therapie, 39, pp 43 - 57. 
Hubalek, Z., Halouzka, J., Juricova, Z. (1998) Investigation of haematophagous arthropods for 
borreliae - summarized data, 1988-1996, Folia Parasitologica, 45, pp 67-72. 
Hussain, K., Brodie, B., Ott, R. S., Montealegre, F. (1985) Prevalence of Trypanosoma theileri in cows 
and fetusesat slaughters., American Journal of Veterinary Research, 46, pp 1256–1258. 
Jordan, P., Woodstock, L., Unrau, G. O., Cook, J. A. (1975) Control of Schistosoma mansoni 
transmission by provision of domestic water supplies. A preliminary report of a study in st 
lucia, Bulletin of the World Health Organasiation, 52, pp 9-20. 
Kanmogne, G. D., Asonganyi, T., Gibson, W. C. (1996) Detection of Trypanosoma brucei gambiense 
in serologically positive but aparasitaemic sleeping-sickness suspects in cameroon by PCR, 
Annals of Tropical Medicine and Parasitology, 90, pp 475-484. 
Katz, N., Chaves, A., Pellegrino, J. (1972) A simple device for quantitative stool thick-smear technique 
in Schistosomiasis mansoni, Rev Inst Med Trop Sao Paulo, 14, pp 397-400. 
Kayang, B. B., Bosompem, K. M., Assoku, R. K. G., Awumbila, B. (1997) Detection of Trypanosoma 
brucei, T. Congolense and T. Vivax infections in cattle, sheep and goats using latex 
agglutination, International Journal for Parasitology, 27, pp 83-88. 
Kennedy, M. J. (1988) Trypanosoma theileri in cattle of central alberta., Canadian Veterinary Journal, 
29, pp 937–938. 
Kidanemariam, A., Hadgu, K., Sahle, M. (2002) Parasitological prevalence of bovine trypanosomosis in 
Kindo Koisha district, Wollaita zone, south Ethiopia, Onderstepoort Journal of Veterinary 
Research, 69, pp 107-113. 
Koffi, M., Solano, P., Denizot, M., Courtin, D., Garcia, A., Lejon, V., Buscher, P., Cuny, G., 
Jamonneau, V. (2006) Aparasitemic serological suspects in Trypanosoma brucei gambiense 
 
141 
human African trypanosomiasis: A potential human reservoir of parasites?, Acta Tropica, 98, 
pp 183-8. 
Kristjanson, P. M., Swallow, B. M., Rowlands, G. J., Kruska, R. L., De Leeuw, P. N. (1999) Measuring 
the costs of African animal trypanosomosis, the potential benefits of control and returns to 
research, Agricultural Systems, 59, pp 79-98. 
Kyambadde, J. W., Enyaru, J. C. K., Matovu, E., Odiit, M., Carasco, J. F. (2000) Detection of 
trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain 
reaction, Bulletin of the World Health Organization, 78, pp 119-124. 
LeFrancois, T., Solano, P., Bauer, B., Kabore, I., Toure, S. M., Cuny, G., Duvallet, G. (1999) 
Polymerase chain reaction characterization of trypansosomes in Glossina morsitans 
submorsitans and Glossina tachinoides collected on the same game ranch of Nazinga, 
burkina faso., Acta Tropica, 72, pp 65-77. 
Lejon, V., Boelaert, M., Jannin, J., Moore, A., Buscher, P. (2003a) The challenge of Trypanosoma 
brucei gambiense sleeping sickness diagnosis outside Africa, Lancet Infectious Diseases, 3, 
pp 804-808. 
Lejon, V., Rebeski, D., Ndao, M., Baelmans, R., Winger, E., Faye, D., Geerts, S., Buscher, P. (2003b) 
Performance of enzyme-linked immunosorbent assays for detection of antibodies against T. 
congolense and T. Vivax in goats, Veterinary Parasitology, 116, pp 87-95. 
Li, F.J., Gasser, R.B., Lai, D.H., Claes, F., Zhu, X.Q., Lun, Z.R. (2007) PCR approach for the detection 
of Trypanosoma brucei and T. equiperdum and their differentiation from T. evansi based on 
maxicircle kinetoplast DNA. Mol Cell Probes. 21(1):1-7 
Lumsden, W.H., Kimber, C.D., Evans, D.A., Doig, S.J. (1979) Trypanosoma brucei: Miniatureanion-
exchange centrifugation technique for detection of low parasitaemias: Adaptation for field 
use.Transactions of the Royal Society for Tropical Medicine and Hygiene.;73(3):312-7. 
Magnus, E., Vervoort, T., Van Meirvenne, N. (1978) A card-agglutination test with stained 
trypanosomes (C.A.T.T.) for the serological diagnosis of T. b. gambiense trypanosomiasis, 
Ann Soc Belg Med Trop, 58, pp 169-76. 
Magona, J. W., Mayende, J. S. P., Olaho-Mukani, W., Coleman, P. G., Jonsson, N. N., Welburn, S. C., 
Eisler, M. C. (2003) A comparative study on the clinical, parasitological and molecular 
diagnosis of bovine trypanosomosis in Uganda, Onderstepoort Journal of Veterinary 
Research, 70, pp 213-218. 
Magona, J. W., Walubengo, J., Odiit, M., Okedi, L. A., Abila, P., Katabazi, B. K., Gidudu, A. M., Olaho-
Mukani, W. (2005) Implications of the re-invasion of southeast Uganda by Glossina pallidipes 
on the epidemiology of bovine trypanosomosis, Veterinary Parasitology, 128, pp 1-9. 
Majiwa, P. A. O., Thatthi, R., Moloo, S. K., Nyeko, J. H. P. (1994) Detection of trypanosome infections 
in the saliva of tsetse flies and buffy-coat samples from antigenaemic but aparasitaemic 
cattle, Parasitology, 108, pp 313. 
Masake, R. A., Majiwa, P. A., Moloo, S. K., Makau, J. M., Njuguna, J. T., Maina, M., Kabata, J., ole-
MoiYoi, O. K., Nantulya, V. M. (1997a) Sensitive and specific detection of Trypanosoma vivax 
using the polymerase chain reaction, Experimantal Parasitology, 85, pp 193-205. 
Masake, R. A., Nantulya, V. M., Akol, G. W., Musoke, A. J. (1984) Cerebral trypanosomiasis in cattle 
with mixed Trypanosoma congolense and t. Brucei brucei infections, Acta Tropica, 41, pp 
237-46. 
Masiga, D. K., Smyth, A. J., Hayes, P., Bromidge, T. J. (1992) Sensitive detection of trypanosomes in 
tsetse flies by DNA amplification, International Journal for Parasitology, 22, pp 909. 
 
142 
Mattioli, R. C., Faye, J. A., Buscher, P. (1999) Susceptibility of n'Dama cattle to experimental challenge 
and cross-species superchallenges with bloodstream forms of Trypanosoma congolense and 
T. Vivax, Veterinary Parasitology, 86, pp 83-94. 
McLaughlin, G., Ssenyonga, S., Nanteza, E., Rubaire-Akiki, Wafula, O., Hansen, R., Vodkin, M., 
Novak, R., Gordon, V., Montenegro-James, S., James, M., Aviles, H., Armijos, R., Santrich, 
C., Weigle, K., Saravia, N., Wozniak, E., Gaye, O., Mdachi, R., Shapiro, S., Chang, K., 
Kakoma, I. (1996) In Parasitology for the 21st century.(Eds, Azcel, M.Alkan, M.) CAB 
International, Wallingford Oxon, pp. 261–287. 
McNamara, J. J., Laveissiere, C., Masiga, D. K. (1995) Multiple trypanosome infections in wild tsetse in 
Cote D'lvoire detected by PCR analysis and DNA probes, Acta Tropica, 59, pp 85. 
Medley, G., Anderson, R. M. (1985) Density-dependent fecundity in Schistosoma mansoni infections in 
man, Transactions of the Royal Society for Tropical Medicine and Hygiene, 79, pp 532-4. 
Molineaux, L., Gramiccia, G. (1980) The Garki project: Research on the epidemiology and control of 
malaria in theSudan savanna of west Africa. World Health Organisation Geneva 
Moloo, S. K. (1982) Transmission of mixed infections of pathogenic Trypanosoma species to 
susceptible hosts by Glossina morsitans morsitans., Acta Tropica, 39, pp 303 -306. 
Moore, S. A., Richer, M., Enrile, M., Losio, E., Roberts, J., Levy, D. (1999) Resurgence of sleeping 
sickness in Tambura county, American Journal of Tropical Medicine and Hygiene, 61, pp 315-
318. 
Moser, D., Cook, G., Ochs, D., Bailey, C., McKane, M., Donelson, J. (1989) Detection of Trypanosoma 
congolense and Trypanosoma brucei subspecies by DNA amplification using the polymerase 
chain reaction., Parasitology, 99, pp 57–66. 
Mott, K. E., Cline, B. L. (1980) Advances in epidemiology survey methodology and techniques in 
schistosomiasis, Bulletin of the World Health Organ, 58, pp 639-47. 
Nantulya, V.M., Lindqvist, K.J., Stevenson, P., Mwangi, E.K. (1992) Application of a monoclonal 
antibody-based antigen detection enzyme-linked immunosorbent assay (antigen ELISA) for 
field diagnosis of bovine trypanosomiasis at Nguruman, Kenya. Annals of Tropical Medicine 
and Parasitology. 86(3):225-30 
Njagu Z, Mihok S, Kokwaro E, Verloo D. (1999) Isolation of Trypanosoma brucei from the monitor 
lizard (Varanus niloticus) in an endemic focus of Rhodesian sleeping sickness in Kenya. Acta 
Trop. Mar 15;72(2):137-48. 
Njiru, Z.K., Constantine, C.C., Guya, S., Crowther, J., Kiragu, J.M., Thompson, R.C., Davila, A.M. 
(2005) The use of ITS1 rDNA PCR in detecting pathogenic African trypanosomes. 
Parasitology Research 95(3):186-92 
Nunes, V. L. B., Silva, R. P., Takeda, G. K. F., Espinola, M. A., Cavalheiros, M. E. M. (1983) 
Ocorrˆencia de tripanossomos em bovinos na região de campo grande, mato grosso do sul,  
brasil., Revista de la Facultad de Medicina Zootecnia da Universidade de Sao Paulo (Sao 
Paulo), 20, pp 183. 
Odiit, M., Coleman, P. G., Liu, W. C., McDermott, J. J., Fevre, E. M., Welburn, S. C., Wollhouse, M. E. 
(2005) Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping 
sickness casses., Tropical Medicine and International Health, 10, pp 840 - 849. 
Ogassawara, S., Benassi, S., D’Angelino, J. L., Araujo, W. P., Gouveia, A. C. (1981) Observações 
sobre Trypanosoma (megatrypanum) theileri laveran, 1902 em bovino no estado de são 
paulo., Revista de Microbiologia, 12, pp 17–21. 
Onyango, R.J., van Hoeve, K., de Raadt, P., (1966) The epidemiology of Trypanosoma rhodesiense 
sleeping sickness in Alego location, central Nyanza, Kenya. I. Evidence that cattle may act as 
 
143 
reservoir hosts of trypanosomes infective to man. Transactions of the Royal Society of 
Tropical Medicine and Hygiene. 60:175–182. 
Ohrt, C., Purnomo, Sutamihardja, M. A., Tang, D., Kain, K. C. (2002) Impact of microscopy error on 
estimates of protective efficacy in malaria-prevention trials, Journal of Infectious Disease, 
186, pp 540-6. 
Orroth, K. K., Korenromp, E. L., White, R. G., Changalucha, J., de Vlas, S. J., Gray, R. H., Hughes, P., 
Kamali, A., Ojwiya, A., Serwadda, D., Wawer, M. J., Hayes, R. J., Grosskurth, H. (2003) 
Comparison of std prevalences in the Mwanza, Rakai, and Masaka trial populations: The role 
of selection bias and diagnostic errors, Sexually  Transmitted Infection, 79, pp 98-105. 
Owusu-Agyei, S., Smith, T., Beck, H. P., Amenga-Etego, L., Felger, I. (2002) Molecular epidemiology 
of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic 
malarious area in northern Ghana, Tropical Medicine & International Health, 7, pp 421-8. 
Pacala, S. W., Dobson, A. P. (1988) The relation between the number of parasites/host and host age: 
Population dynamic causes and maximum likelihood estimation, Parasitology, 96 ( Pt 1), pp 
197-210. 
Paris, J., Murray, M., McOdimba, F. (1982) A comparative evaluation of the parasitological techniques 
currently available for the diagnosis of African trypanosomiasis in cattle, Acta Trop, 39, pp 
307-16. 
Pecora, I. L., dos Reis, G. A., Barcinski, M. A., Dorigo, D. D. (1980) Frequency distribution of 
Trypanosoma cruzi in macrophages from resistant and susceptible strains of mice, 
Experientia, 36, pp 942-4. 
Penchenier, L., Simo, G., Grebaut, P., Nkinin, S., Laveissiere, C., Herder, S. (2000) Diagnosis of 
human trypanosomiasis, due to Trypanosoma brucei gambiense in central Africa, by the 
polymerase chain reaction, Transactions of the Royal Society for Tropical Medicine and 
Hygiene, 94, pp 392-4. 
Picozzi, K., Tilley, A., Fèvre, E. M., Coleman, P. G., Magona, J. W., Odiit, M., Eisler, M. C., Welburn, S. 
C. (2002) The diagnosis of trypanosome infections: Applications of novel technology for 
reducing disease risk, African Journal of Biotechnology, 1, pp 39-45. 
Polderman, A. M., de Caluwe, P. (1989) Eight years of targeted mass treatment of Schistosoma 
mansoni infection in Maniema, Zaire, Tropical Medicine Parasitology, 40, pp 177-80. 
Polderman, A. M., Mpamila, K., Manshande, J. P., Bouwhuis-Hoogerwerf, M. L. (1985) Methodology 
and interpretation of parasitological surveillance of intestinal schistosomiasis in Maniema, 
Kivu province, zaire, Ann Soc Belg Med Trop, 65, pp 243-9. 
Radwanska, M., Claes, F., Magez, S., Magnus, E., Perez-Morga, D., Pays, E., Buscher, P. (2002) 
Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma 
brucei gambiense, American Journal of Tropical Medicine and Hygiene, 67, pp 289-295. 
Ransoff, D.F. & Feinstein, A.r. (1978) Problems of spectrum bias in evaluating the efficacy of 
diagnostic tests. New England Journal of Medicine. v299 pp926 
Rebeski, D. E., Winger, E. M., Van Rooij, E. M. A., Schoechel, R. (1997) (ed.), Pitfalls in the 
application of antigen immunoassays: Monitoring of Trypanosoma vivax infection in two goats 
using direct and indirect diagnostic techniques, Diagnosis and control of livestock diseases 
using nuclear and related techniques: Towards livestock disease diagnosis and control in the 
21st century, Vienna, Apr, pp 577-579 
Rodrigues, A. C., Campaner, M., Takata, C. S., Dell' Porto, A., Milder, R. V., Takeda, G. F., Teixeira, 
M. M. (2003) Brazilian isolates of Trypanosoma (megatrypanum) theileri: Diagnosis and 
differentiation of isolates from cattle and water buffalo based on biological characteristics and 
randomly amplified DNA sequences, Veterinary Parasitology, 116, pp 185-207. 
 
144 
Ruiz-Tiben, E., Hillyer, G. V., Knight, W. B., Gomez de Rios, I., Woodall, J. P. (1979) Intensity of 
infection with Schistosoma mansoni: Its relationship to the sensitivity and specificity of 
serologic tests, American Journal of Tropical Medicine & Hygiene, 28, pp 230-6. 
Saah, A. J., & Hoover, D. R. (1997). “Sensitivity” and “specificity” reconsidered: The meaning of these 
terms in analytical and diagnostic settings. Annals of Internal Medicine, 126, 91–94. 
Sachs, R., Schaller, G.B., Baker, J.R., (1967) Isolation of trypanosomes of the T. brucei group from 
lion. Acta Trop.; 24:109–112. 
Samad, M. A., Shahidullah, M. (1985) Trypanosoma theileri infection in cattle of Bangladesh., Indian 
Veterinary Journal, 62, pp 903–905. 
Schafler, D. H. (1979) Trypanosoma theileri: A literature review and report of incidence in new york 
cattle., Cornell Veterinarian (Ithaca, NY), 69, pp 411 - 425. 
Scopel, K. K., Fontes, C. J., Nunes, A. C., Horta, M. F., Braga, E. M. (2004) Low sensitivity of nested 
PCR using plasmodium DNA extracted from stained thick blood smears: An epidemiological 
retrospective study among subjects with low parasitaemia in an endemic area of the Brazilian 
Amazon region, Malaria Journal, 3, pp 8. 
Seifi, H. A. (1995) Clinical trypanosomosis due to Trypanosoma theileri in a cow in Iran, Tropical 
Animal Health and Production, 27, pp 93. 
Sitja-Bobadilla, A., Padros, F., Aguilera, C., Alvarez-Pellitero, P. (2005) Epidemiology of 
Cryptosporidium molnari in Spanish gilthead sea bream (Sparus aurata l.) and European sea 
bass (dicentrarchus labrax l.) cultures: From hatchery to market size, Applied Environmental 
Microbiology, 71, pp 131-9. 
Sleigh, A., Hoff, R., Mott, K., Barreto, M., de Paiva, T. M., Pedrosa Jde, S., Sherlock, I. (1982) 
Comparison of filtration staining (bell) and thick smear (kato) for the detection of quantitation 
of Schistosoma mansoni eggs in faeces, Transactions of the Royal Society for Tropical 
Medicine and Hygiene, 76, pp 403-6. 
Snounou, G., Viriyakosol, S., Zhu, X. P., Jarra, W., Pinheiro, L., do Rosario, V. E., Thaithong, S., 
Brown, K. N. (1993) High sensitivity of detection of human malaria parasites by the use of 
nested polymerase chain reaction, Molecular Biochemical Parasitology, 61, pp 315-20. 
Snow, L. C., Michael, E. (2002) Transmission dynamics of lymphatic filariasis: Density- dependence in 
the uptake of Wuchereria bancrofti microfilariae by vector mosquitoes, Medical and Veterinary 
Entomology, 16, pp 409-423. 
Solano, P., Jamonneau, V., N'Guessan, P., N'Dri, L., Dje, N. N., Miezan, T. W., Lejon, V., Buscher, P., 
Garcia, A. (2002) Comparison of different DNA preparation protocols for PCR diagnosis of 
human African trypanosomosis in cote d'ivoire, Acta Tropica, 82, pp 349-56. 
Srividya, A., Krishnamoorthy, K., Sabesan, S., Panicker, K. N., Grenfell, B. T., Bundy, D. A. P. (1991) 
Frequency-distribution of Brugia-malayi microfilariae in human- populations, Parasitology, 
102, pp 207-212. 
Taylor, K. & Authie, E.M.-L., 2004, Pathogenesis of Animal Trypanosomiasis. In: The 
Trypanosomiasis. Maudlin,I., Holmes, P.H. & Miles, M.A. (eds), CABI Publishing, Wallingford, 
Oxfordshire, UK. pp331 
Tarimo-Nesbitt, R. A., Golder, T. K., Chaudhury, M. F. (1999) Trypanosome infection rate in cattle at 
Nguruman, Kenya., Veterinary Parasitology, 81, pp 107–117. 
Terry, R. S., Smith, J. E., Duncanson, P., Hide, G. (2001) MGE-PCR: A novel approach to the analysis 
of Toxoplasma gondii strain differentiation using mobile genetic elements, International 
Journal for Parasitology, 31, pp 155-161. 
 
145 
Tham, J. M., Lee, S. H., Tan, T. M., Ting, R. C., Kara, U. A. (1999) Detection and species 
determination of malaria parasites by PCR: Comparison with microscopy and with parasight-
Fand ICT malaria PF tests in a clinical environment, Journal of Clinical Microbiology, 37, pp 
1269-73. 
Theis, J. H., Schwab, R. G. (1992) Seasonal prevalence of Taenia taeniaeformis: Relationship to age, 
sex, reproduction and abundance of an intermediate host (Peromyscus maniculatus), Journa; 
of Wildlife Disease, 28, pp 42-50. 
Thrusfeild, M. (1986) Serological epidemiology. In: Veterinary Epidemiology. Ed. M. Thrusfield. 
London, Butterworths. pp 175-186 
Truc, P., Bailey, J. W., Doua, F., Laveissiere, C., Godfrey, D. G. (1994) A comparison of parasitological 
methods for the diagnosis of gambian trypanosomiasis in an area of low endemicity in Cote 
d'Ivoire, Transactions of the Royal Society for Tropical Medicine and Hygiene, 88, pp 419-21. 
Truc, P., Formenty, P., Diallo, P. B., Komoin-Oka, C., Lauginie, F. (1997) Confirmation of two distinct 
classes of zymodemes of Trypanosoma brucei infecting man and wild mammals in Cote 
d'Ivoire: Suspected difference in pathogenicity, Annals of Tropical Medicine and Parasitology, 
91, pp 951-956. 
Tyre, A. J., Bull, C. M., Tenhumberg, B., Chilton, N. (2003) Indirect evidence of density-dependent 
population regulation in Aponomma hydrosauri (acari : Ixodidae), an ectoparasite of reptiles, 
Austral Ecology, 28, pp 196-203. 
Urdaneta, L., Guevara, P., Ramirez, J. L. (1998) Evaluation of DNA recombinant methodologies for the 
diagnosis of Plasmodium falciparum and their comparison with the microscopy assay, Mem 
Inst Oswaldo Cruz, 93, pp 639-46. 
Van den Bossche, P., De Deken, R., Brandt, J., Geerts, S., Geysen, D., Berkvens, D. (2004a) The 
transmission of mixed Trypanosoma brucei brucei / T. Congolense infections by tsetse 
(Glossina morsitans morsitans), Veterinary  Parasitology, 119, pp 147-53. 
Van den Bossche, P., De Deken, R., Brandt, J., Seibou, B., Geerts, S. (2004b) Recirculation of 
Trypanosoma brucei brucei in cattle after T. Congolense challenge by tsetse flies, Veterinary 
Parasitology, 121, pp 79-85. 
Verloo, D., Brandt, J., Van Meirvenne, N., Buscher, P. (2000) Comparative in vitro isolation of 
Trypanosoma theileri from cattle in Belgium, Veterinary Parasitology, 89, pp 129-132. 
Vickerman, K. (1985) Developmental cycle and biology of pathogenic trypanosomes, British Medical 
Bulletin, 41, pp 105 - 114. 
Vivas-Martinez, S., Basanez, M. G., Botto, C., Rojas, S., Garcia, M., Pacheco, M., Curtis, C. F. (2000) 
Amazonian Onchocerciasis: Parasitological profiles by host-age, sex, and endemicity in 
southern venezuela, Parasitology, 121, pp 513-525. 
Waiswa, C., Katunguka-Rwakishaya, E. (2004) Bovine trypanosomiasis in south-western Uganda: 
Packed-cell volumes and prevalences of infection in the cattle, Annals of Tropical Medicine 
and Parasitology, 98, pp 21-27. 
Webbe, G., el Hak, S. (1990) Progress in the control of Schistosomiasis in egypt 1985-1988, Trans R 
Soc Trop Med Hyg, 84, pp 394-400. 
Welburn, S., Coleman, P. (2004) Are fitness costs associated with resistance to human serum in 
Trypanosoma brucei rhodesiense?, Trends in Parasitology, 20, pp 311 - 315. 
Welburn, S. C., Fevre, E. M., Coleman, P. G., Odiit, M., Maudlin, I. (2001) Sleeping sickness: A tale of 
two diseases, Trends in Parasitology, 17, pp 19-24. 
 
146 
Welburn, S., Fevre, E., Coleman, P., Maudlin, I., 2004, Epidemiology of Human African 
Trypanosomiasis. In: The Trypanosomiasis. Maudlin,I., Holmes, P.H. & Miles, M.A. (eds), 
CABI Publishing, Wallingford, Oxfordshire, UK. pp219 
Welburn SC, Maudlin I. (1999) Tsetse-trypanosome interactions: rites of passage. Parasitol 
Today.15(10):399-403 
WHO (1967) Epidemiology and control of schistosomiasis: A report of a who expert committee. World 
Health Organisation Geneva 
WHO (1980) Epidemiology and control of schistosomiasis: A report of a who expert committee. World 
Health Organisation Geneva 
WHO (1986) Epidemiology and control of African trypanosomiasis, World Health Orgasnisation 
Technical report Series, 739. 
WHO (2001) African trypanosomiasis or sleeping sickness: Fact sheet no 259 [Online], Available at 
C:\Documents and Settings\AndyC\My Documents\PhD\Endnote\Endnote Library 071102.enl, 
Accessed December 
Woo, P.T.K., (1970) The haematocrit centrifugation technique for the diagnosis of African 
trypanosomiasis. Acta Tropica 27 pp384-386 
Woolhouse, M. E. J., McNamara, J. J., Hargrove, J. W., Bealby, K. A. (1996) Distribution and 
abundance of trypanosome (subgenus nannomonas) infections of the tsetse fly Glossina 
pallidipes in southern Africa, Molecular Ecology, 5, pp 11-18. 
Zhou, G. F., Minakawa, N., Githeko, A., Yan, G. Y. (2004) Spatial distribution patterns of malaria 
vectors and sample size determination in spatially heterogeneous environments: A case study 















































































N = 105 
Infection distributed according to NBD 
Where: 
P = mean infection intensity in parasites per millilitre 
K = Overdispersion 
Using ‘R’ function 
rnegbin(N,P,K) 
 
Calculate the Population prevalence 
Randomly select n samples from population  
Calculate probability of finding each sample positi ve. 
P(+) = Infection Intensity of sample / sensitivity of diagnostic 
technique 
 
Where sensitivity of technique = 1 parasite per 1 microlitre  
= 1000 parasites per millilitre 
 
Produce binomial result of screening samples 
according to probability of detection as positive. 
Using ‘R’ function 
rbinom(n,1,samples) 
Calculate diagnosed prevalence 
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Appendix Figure 5.2. Code for basic simulation to p roduce data frame of variables 
#Simulation to create a data frame of results of screening a  
#population with a standard screening approach 
#Load appropriate package 
library(MASS) 
#Set simulation parameters 
N<-10000 #Size of the population 
n<-382#Number of samples drawn from population for study 
se<-1000 #Sensitivity of the technique 
i<-1000#Number of iterations (data points) 






##Determine range of values from which the population parameters  




for(j in 1:i){ 
#Select population parameters 
P<-sample(pvect,1)#Mean intensity of the population 
K<-sample(kvect,1)#Overdispersion of the population 
#Create the population 
pop<-rnegbin(N,P,K) 




#Screen n samples once 




#Calculate diagnosed prevalence 
estprev<-sum(sampres) 
estprev<-estprev/n 
#Calculate the underestimation 
diff<-popprev-estprev 








#Create data frame 
data1<-data.frame(K1,P1,popprev1,estprev1,diff1) 
#Output data frame 
write.table(data1, file = "C://rdata//x.csv", sep = ",", col.names = NA, na="NA", qmethod = "double") 
#Rename column labels of data frame 








Appendix Figure 5.6 Code for determining the probab ility of obtaining false negative 
results from a single host with a given infection i ntensity 
#Code for determining the repeatability threshold i n a host 










for(k in 1:100){ 
for(j in 1:100){ 
#Create volume of blood with infection 
iip<-ii/1000 
blood<-rpois(1000000,iip) 


































Appendix Figure 6.4. General ‘R’ code for all simul ations in this chapter 
All simulations described in following sections were adapted from this code. 
 















































#Estimate prevalence by ‘estimation of k’ method 
#Collect in a vector those samples that give consta nt positive (+) results 
constpos<-subset(sampprob2,sampprob2>=thresh) 
























#Count the frequency of infection intensities 
freq <- c() 
max1 <- res6  
j <- c()  
for(i in 1:max1){  
freq[i] <- length(res5[res5==i])  
}  









for(i in 1:(length(freq)-1)) a[i]<-sum(freq[-c(1:i)]) 
i<-0 









#Calculate the prevalence based on the ‘k’ estimate  
kprev<-0.993331-0.938248*exp(-8.466109*kest) 





















































Appendix Figure 6.5. Simulation 1: Flowchart descri bing the design of a simulation to 
determine the accuracy in estimating the population  overdispersion (K) and mean 
























Select Population Distribution Parameters 
Randomly selected from a 
Negative Binomial Distribution where 
P = from 100 to 2000 parasites per millilitre 
Generate population of 1.0 x 10 5 samples 
with assigned infection intensity 
I1,I2,I3…..I100,000 
Determine the number of samples to screen (n) 
Randomly selected from n = 30 to 100  
Calculate the number of repeat tests for each sampl e (r) 
r = 300/n (rounded to integer value) 
Randomly select n samples from population 
Store Data 
(n x r) 
Store Data 




























Generate positive or negative results (θj) according to 
probability of positive (pi) for each selected sample 
Repeat r times  
Calculate the Estimates of  
Population Infection Intensity (P) 
and 
Population Overdispersion (K)  
 
Calculate Accuracy of the Estimate  
 
Repeat 1.0 x 10 5 times Store Results (µ) 





Appendix Figure 6.6. Simulation 2: Flowchart descri bing the design of a simulation to 
determine the probability of detecting significant difference in the infection patterns of 

























parameters for two 
populations. 
K = From range of values  
P = From Range of values 
Generate two populations of 
105 samples with assigned 
infection intensity. 
I1,I2,I3………I100,000 
Determine the prevalence 
for each population 
(ω) 
Determine if difference 
between populations is 
greater than ‘benchmark’ 
values. 
P = +/- 100 
Prevalence = +/- 10% 
Determine the probability 
of finding each sample 
positive 
Ρi = Ii/Se 
Randomly select 100 
samples from each 
population  





























Replace sample repeatability 
values ( σi) of greater than one 
with infection intensity value 
(Ii). 
Conduct statistical tests 
of data 
P < 0.05 = Significant  
Determine the probability 
of significant results in 
populations with 
differences greater than 
benchmark  
Store Results  
Generate screening results 
(θi) based on probability of 
finding positive ( Ρi) 
Repeat r times  

































Calculate mean probability and 
CI of significant result in 
populations with differences 
greater than benchmark values. 
P = +/- 100 
Prevalence = +/- 10%  
Output results 
Store Results  
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Appendix Figure 6.7. Simulation 3: Flowchart descri bing the design of a simulation to 

























Select Population Distribution Parameters 
Randomly selected from a 
Negative Binomial Distribution where 
P = from 100 to 1500 parasites per millilitre 
Generate population of 1.0 x 10 5 samples 
with assigned infection intensity 
I1,I2,I3…..I100,000 
Determine the probability of a positive result (p) 
for each sample in the population. 
pi = Ii / se for i   
 
Calculate population prevalence ( ω) 
 
Determine the number of samples to screen (n) 
Randomly selected from n = 382  
Calculate the number of repeat tests for each sampl e (r) 
r = 5 
Randomly select n samples from population 
Store Results  (ωi) 
Store Data 
(K & P) 
Store Data 




























Generate positive or  negative results (θj)according to 
probability of positive (pi) for each selected samp le 
Repeat r times 
Calculate estimate of prevalence for single 
screening ( ωs)and cumulative prevalence of 
r screenings ( ωc) 
 
Calculate estimate of repeatability (σi)  
for each sample  
Store Results (Ke) 
for I = 1 to N 
Store Results (θj) 
For i = 1 to r 
 
Output 
Stored Data  
For those samples with repeatability value of one 
replace value with probability of positive 
Estimate overdispersion (Ke) 
Repeat N times  
N = 1.0x105 
 
Store Results   
ωs and ωc 
Estimate population prevalence 
based on overdispersion estimate 
(Ke) 
ωk = 0.9933 – 0.938e-8.5Ke 
